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I. INTRODUCTORY STATEMENT OF PURPOSE AND SIGNIFICANCE 
The objectives of the research for my dissertation 
evolved from preliminary studies of cytosolic protein phos-
phorylation in denervated slow-twitch soleus muscle of the 
rat hind l i m b ( Squint o e t a l. , 1 9 8 0). These studies showed a 
denervation time-dependent increase iu the ~D X~~IQ 
phosphorylation of soluble protein in cytosolic muscle 
fractions. However, this cytosolic protein phosphorylation 
was delayed for 3 hr and reached a peak after 24 hr when 
phosphorylation of these proteins in the denervated muscle 
was approximately twice that found in contralateral, sham-
operated muscles. To pursue the significance of this early 
denervation effect which occurred before denervation atrophy, 
but not immediately after nerve transection, I set forth the 
following specific aims: 1) to determine whether significant 
changes in the phosphorylation of soluble protein from rat 
soleus muscle are dependent upon neural influences other than 
the impulse-directed release of acetylcholine; 2) to 
characterize the denervation-dependent soluble cytosolic 
ATP:protein phosphotransferase reaction of rat soleus muscle; 
and 3) to identify the predominant soluble cytosolic phospho-
protein substrate for the denervation-dependent phosphoryla-
tion reaction. 
Research literature relevant to these specific aims 
is reviewed under section II. I will emphasize the altera-
tions in skeletal muscle which are known to occur early after 
2 
denervation and before the onset of denervation atrophy since 
these changes probably represent events more closely mediated 
by neurotrophic influences. However, other muscle parameters 
which are affected later and occur in conjunction with or 
following muscle atrophy will also be mentioned. The general 
topics which I will review in section II are sequenced 
logically in the outline presented below. A brief introduc-
tion to these general topics follows the outline. 
A. Neuromuscular Communication 
B. Effect of Alterations in Neuromuscular Communication upon 
the Integrity of Skeletal Muscle 
C. Cyclic AMP in Neuroregulatory Functions 
D. Protein Phosphorylation in Skeletal Muscle 
E. Protein Dephosphorylation in Skeletal Muscle 
F. Cyclic AMP-Dependent Protein Kinase Isozymes I and II 
Cell biologists have classically defined"trophic 
influence" in terms of a long term maintenance requirement 
necessary for the survival of a cell and supplied by extra-
cellular effectors (reviewed in Gospodarowicz, 1976). This 
concept of an extracellular influence on cell viability has 
been applied to neuromuscular communication in that motor 
neurons may exert regulatory influences upon muscle which are 
expressed as alterations in the physiology and biochemistry 
of the muscle cell. These modifications may, in turn, be 
essential in maintaining the structural and functional 
integrity of the target muscle cell. In this dissertation, 
3 
trophic influences exerted by the motor nerve upon muscle are 
defined as neural influences not related to impulse-dependent 
acetylcholine transmission. 
The motor nerve transmits information to the 
contiguous muscle cell through impulse-directed and 
spontaneously released acetylcholine. Impulse-dependent 
transmission of acetylcholine occurs in response to the 
propagation of a nerve impulse which is generated in the form 
of an action potential. When the action potential arrives at 
the nerve terminal of a functional synapse, it results in the 
release of the neurotransmitter - acetylcholine. Thus, the 
electrical signal is transformed into a chemical signal. The 
chemical transmitter, in turn, crosses the synaptic cleft 
and binds to a specific postsynaptic receptor. Upon bindir,g 
to the receptor, impulse-directed acetylcholine opens ion 
gates en the postsynaptic membrane and reconstitutes the 
electrical process through the development of endplate poten-
tials which lead ultimately to muscle contraction. 
Spontaneous transmission of acetylcholine, which can occur in 
the absence of nerve impulse activity, does not result in 
muscle contraction. However, it may have a tropt.ic role in 
regulating some properties of the muscle membrane. 
Neuromuscular communication also occurs through the 
release of putative neurotrophic factors which may be synthe-
sized in the neuronal perikarya. Much of the experimental 
evidence suggesting that trophic factors are involved in 
4 
neuromuscular communication has come from the observations 
that the motor neuron can influence the target muscle cell 
even in the absence of a functional innervation. Axoplasffiic 
transport provides a viable mechanism by which these axonal 
components are delivered from their sites of synthesis to the 
neuromuscular junction. 
The vital necessity of an intact and functional 
innervation for the maintenance of the structural and 
functional integrity of skeletal muscle is well documented. 
Denervation disrupts neural influences on the target muscle 
cell by eliminating communication between the motor nerve 
and the contiguous muscle cell which can be in the form of 
impulse-directed and spontaneous acetylcholinerelease or 
axonally-derived neurotrophic factors. Elimination of 
neuromuscular communication causes marked changes in morpho-
logical, physiological and biochemical properties of the 
muscle. These changes, in turn, result in the development of 
denervation atrophy. 
Neurotrophic factors and the postsynaptic molecular 
events affected by putative neurotrophic factors are not 
clearly defined. Additionally, the mechanisms by which 
target muscle cells translate neurotrophic messages into 
molecular events, which rnay be essential for the maintenance 
of muscle structure and function, is an intriguingly 
important and undefined aspect of this mode of neuromuscular 
communication. Elucidation of these molecular events and 
the mechanisms by which they are neurotrophically-regulated 
5 
is significant in that it may yield information useful toward 
determining the initial site of action of unidentified, 
axonally transported, trophic factors. 
Cyclic AMP has been implicated in neuromuscular 
communication, but its role is unclear. Skeletal muscle 
undergoes excitability changes upon impulse transmission and 
these changes may involve cyclic nucleotides and calcium 
ions. Denervated skeletal muscle exhibits marked changes in 
adenylate cyclase and cyclic nucleotide phosphodiesterase 
activities. These enzymes regulate cyclic AMP metabolism. 
Also, cyclic AMP and drugs which stimulate cyclic AMP 
synthesis by binding to beta-adrenergic receptor-coupled 
adenylate cyclase increase the number of acetylcholine 
receptors in skeletal muscle. 
Cyclic AMP produces many, if not all, of its effects 
in eukaryotes by stimulating the phosphorylation of cell 
proteins. Various neurotransmitters,non-steriod hormones 
and other extracellular depolarizing agents are known to 
increase the phosphorylative state of muscle proteins by 
binding to receptors coupled to adenylate cyclase. This 
binding leads to the increased synthesis of cyclic AMP and 
the stimulation of the cyclic AMP-dependent protein kinase. 
Therefore, the reversible phosphorylation-dephosphorylation 
mechanism which mediates the intracellular regulation of many 
metabolic processes may be involved in the interrelationship 
between motor neuron and contiguous muscle cell. 
6 
JI. RELEVANT LITERATURE REVIEW 
A. Neuromuscular Communication 
1. Acetylcholine 
a. role of acetylcholine in synaptic transmission 
Current knowledge suggests that the motornerve is 
limited in its mode of communication with the muscle cell. 
Presently, the most understood mode of neuromuscular communi-
cation centers around the neurotransmitter - acetylcholine. 
Electrical impulses propagate down the motor nerve axon as 
brief waves which consist of an excitation-induced depolar-
ization of the neuronal membrane followed by a spontaneous 
repolarization to the resting membrane potential. These 
brief positive changes in the membrane potential are called 
action potentials and lead to the release of acetylcholine 
from the motor endplate in multimclecular packets or "quanta" 
(reviewed in Krnjevic, 1974; Macintosh, 1981). Upon 
receiving an impulse, the nerve ending becomes depolarized 
and the frequency of acetylcholine release is greatly 
increased. At the neuromuscular junction, a few hundred 
quanta may be released almost synchronously from numerous 
sites on the motor axon's terminal region (reviewed in 
Krnjevic, 1974). During the nerve's resting state when the 
membrane potential is negative, quanta may be released 
singly. This is referred to as spontaneous quantal release. 
Acetylcholine may also be released by spontaneous leakage 
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from the nerve ending in a nonquantal form (reviewed in 
Drachman, 1974; Schmidt, 1978; Drachman et al, 1982). 
Thesleff (1983) recently reported another type of acetyl-
choline transmission which occurs as a result of a quantal 
spontaneous release of acetylcholine and wr.icb is not 
dependent upon a ca2+_mediated depolarization of the nerve 
ending. 
Acetylcholine is formed from the reaction of choline 
andacetyl CoA catalyzed by the enzyme - choline acetyltrans-
ferase. Both acetylcholine and choline acetyltransferase are 
present throughout the length of the motor neuron and are 
concentrated in the axonal endings. Cell fractionation 
studies have shown that much of the acetylcholine at the 
nerve endings is contained in the synaptic vesicles, butsome 
is free in the cytosol. However, most of the choline acetyl-
transferase is free in the cytosol, but some of it may adhere 
to the outside of the vesicles (reviewed in Fonnum, 1973). 
Acetylcholine is hydrolyzed by the enzyme - acetylcholin-
esterase. This enzyme is characteristically membrane-bound. 
At the presynaptic region, most of its active sites face 
outward enabling the enzyme to hydrolyze acetylcholine that 
has just been released. Also, a small percentage of the 
enzyme faces inward and hydrolyzes surplus acetlycholine. 
Choline acetyltransferase and acetylcholinesterase are 
synthesized in the neuronal perikarya and are transported 
down the axon to the synaptic region by axoplasmic transport. 
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These enzymes are present both at the nerve terminal and 
throughout the whole length of the cholinergic neuron 
(Hacintosh, 1981). Their highest concentrations are in the 
axon terminal. However, acetylcholine functions only as a 
synaptic transmitter and does not have a role in the conduc-
tion of impulses along the axon or the delivery of axonal 
components by axoplasmic transport. 
Acetylcholine that is released diffuses across the 
synaptic junction and binds to a highly specific postsynaptic 
receptor (reviewed in Heidmann and Changeux, 1978). The 
snake venom toxin, alpha-bungarotoxin, binds specifically and 
irreversibly to this acetylcholine receptor. These 
properties of the neurotoxin, therefore, have provided a 
useful tool for studying the biochemical properties of the 
receptor (reviewed in Devreotes and Fambrough, 1975; 
Fambrough and Devreotes, 1979; Pumplin and Fambrough, 1982). 
It is now known from these studies and studies with other 
cholinergic neurotoxins that the acetylcholine receptor is an 
integral membrane glycoprotein which can be split into 5 or 6 
non-equivalent subunits by sodium dodecyl sulfate (SDS). 
These subunits range in molecular weight from 40,000 to 
140,000 when the receptor is purified from rat skeletal 
muscle (Heidmann and Changeux, 1978; Fambrough, 1979; Conti-
Tronconi and Raftery, 1982). The proteir, subunits of the 
receptor are synthesized on polyribosomes and are immediately 
incorporated into membranes which form vesicles on the Golgi 
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apparatus where posttranslational modification of the 
receptor occurs. The vesicles migrate to and fuse with the 
external membrane exposing the acetylcholine receptor on the 
external surface. Degradation of the receptor involves its 
internalization and subsequent proteolytic cleavage in the 
lysosomes. The acetylcholine receptor is found at the 
junctional region of the postsynaptic muscle cell membrane in 
the adult muscle and at both the junctional and 
extrajunctional regions in embryonic muscle. A cherr.ical and 
physical denervation of adult muscle leads to the development 
of extrajunctional acetylcholine receptors. Extrajunctional 
receptors have a turnover time of 1 to 2 days (Burden, 1977; 
Edwards, 1979; Pumplin and Fambrough, 1982) while intact 
adult junctional receptors are more stable and have a 
turnover time of 7 to 10 days (Edwards, 1979; Linden and 
Fambrough, 1979; Loring and Salpeter, 1980; Stanley and 
Drachman, 1983). However, approximately 20% of the intact 
junctional acetylcholine receptors have a faster turnover 
time of 18 hr (Stanley and Drachman, 1983). 
A difference in electrical potential, the membrane 
potential, usually exists between the inside of the muscle 
cell and the extracellular fluid surrounding it. This is 
referred to as the resting membrane potential. Binding of 
acetylcholine to its receptor induces a transient depolariza-
tion of the postsynaptic membrane as a result of an activa-
tion of ionic channels into conductive or open states (Katz 
and Miledi, 1971; reviewed in Fambrough, 1979). Opening of 
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ion channels permits Na+2, K+ and ca+2 to move down concen-
tration gradients which depolarizes the muscle membrane and 
generates endplate potentials. Endplate potentials (epps) 
are the product of impulse-related acetylcholine transmis-
sion, while miniatureendplate potentials (mepps) are the 
result of spontaneous quantal acetylcholine transmission 
(reviewed in Drachman, 1974; Schmidt, 1978). Only epps, 
however, generate muscle contraction. Therefore, spontaneous 
quantal or non-quantal acetylcholine release may be related 
to a trophic influence of the motor nerve. 
b. role of acetylcholine in skeletal muscle contraction 
Contraction occurs in a muscle fiber as a result of 
acetylcholine-induced depolarization of the plasma membrane. 
The activation of the contractile elements (myosin, actin and 
the ATPase of myosin) which are distributed over the whole 
cross-section of the fiber depends on the spreading of the 
excitatory state from the plasma membrane transversally 
across the muscle fiber. 
There is evidence that the transverse tubule system 
( T tube system) of the sarcomere is involved in the propaga-
tion of impulses inward from the plasma membrane (Landon, 
1982). These tubules measure about 300 Angstroms in diameter 
and run in a transverse direction through the muscle fiber. 
They are called the T tubule system to distinguish them from 
the tubules of the sarcoplasmic reticulum which are mainly 
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longitudinal in orientation. On each side of a transverse 
tubule, but not continuous with it, are structures called 
terminal cisternae which form part of the sarcoplasmic reti-
culum and act as a calcium storage area. 
It is now known that the effect of an action poten-
tial propagating along the fiber membrane is to produce some 
kind of action potential in the T-tubule system and that this 
in turn causes the release of calcium ions from the terminal 
cisternae into the sarcoplasmic reticulum (Landon, 1982). 
The released ca2+ binds to the calcium binding subunit of the 
troponin protein (TN-C) and causes conformational changes 
that are transmitted to the tropomyosin protein and finally 
to the thin filament protein - actin. These structural 
changes enable actin to interact with the thick filament 
protein, myosin, resulting in muscle contraction and ATP 
hydrolysis. Muscle contraction and ATP hydrolysis will 
persist until ca2+ is removed. The relaxation stage is 
accomplished by the pumping back of ca2+ into the sarco-
plasmic reticulum by an ATP-driven ca2+ pump. 
Different types of skeletal muscles are 
characterized according to their fiber types. Fiber types 
are distinguished, however, by the kind of innervation they 
receive. In some fibers, the membrane (sarcolemma) is elec-
trically exicitable. In these fibers, an all-or-none action 
potential is generated at the neuromuscular junction and is 
propagated along the entire length of the fiber; this allows 
the whole muscle to contract. Fibers of this kind normally 
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have a single motor endplate and are described as having 
uniterminal innervation (Huddart, 1975). Included in this 
co.tegory are most of the twitch fibers in skeletal muscles. 
Other fibers have membranes that are electrically inexci-
table; in these, the action potential at the neuromuscular 
junction only causes a localized stimulation of the 
contractile apparatus. For this reason, these fibers (tonic 
fibers) tend to have multiterminal innervation. A single 
stimulus has relatively little effect on this fiber type, but 
repetitive stimulation causes the gradual development of 
muscle tension. 
Although almost all of the skeletal muscles in 
mammals are of the phasic type (uniterminal innervation), a 
considerable range of contractile activity is found. This is 
because not all fibers in a particular muscle are of the same 
type. For example, fibers can be distinguished by their 
energy supply. Those muscles whose energy supply is largely 
glycolytic are relatively fast in contractile response and 
generally appear white in color (white fast-twitch muscle). 
Those fibers that have an abundance of mitochondria are said 
to be oxidative. These fibers are relatively slow in 
contractile response and appear reddish in color because of 
the oxygen carrier protein - myoglobin. Also, there is a 
considerable overlap between the two energy sources ir. 
several fibers and these are referred to as intermediate 
fiber types. They are generally termed fast oxida-
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tive/glycolytic fibers and are often red in color. 
The slow and fast fibers are often referred to as 
Type I and Type II fibers. Type II (fast) fibers are further 
subdivided into Type IIA (fast oxidative/glycolytic) and Type 
IIB (fast glycolytic). These fiber types were originally 
distinguished most reproducibly by histochemical methods 
(Dubowitz and Brooke, 1973). Type I fibers have acid-
resistant, alkali-sensitive myofibrillar ATPase properties, 
relatively high content of mitochondria, high succinic 
dehydrogenase activity, low glycogen content and phosphory-
lase activity, a relatively poorly developed sarcoplas~ic 
reticulum, low contraction speeds and high resistance to 
fatigue (Lewis et al., 1974). Slow muscles undergo 
sustained rhythmic activity, respond to stimuli with 
prolonged contractures, constantly adjust to postural change, 
and operate during periods of prolonged anoxic stress. The 
slow muscle permits muscular contraction to proceed with 
lower utilization of ATP because it has a low amount of 
myosin ATPase activity. This facilitates the appropriate 
balance between chemical energy supply and mechanical energy 
utilization thc.t must occur in a muscle that contracts 
steadily and without rest for long periods of time. White 
fast muscles (Type II fibers) have the converse properties 
and undergo only short bursts of activity and possess little 
myoc;lobin. It is noteworthy, however, that most muscles are a 
mixture of white, red and intermediate (Type IIA) fibers and 
have properties intermediate to the main two fiber types. 
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The diversity of properties makes it difficult at times not 
only to classify particular fibers but to compare results 
using these intermediate fiber type muscles However, rat 
soleus muscle employed for all experiments reported in this 
dissertation is considered a classical example of the slow-
twitch oxidative muscle in that its fiber composition is a 
homogeneous (approximately 95%) composition of Type I fibers 
(Squire, 1981). 
2. Neurotrophic factors 
It has been proposed that neuromuscular communica-
tion also involves the delivery of putative neurotrophic 
factors to the target muscle cell (reviewed in Guth, 1968 and 
1969; Harris, 1974 and 1980; Gutmann, 1976; Varon and Bunge, 
1978; Thesleff, 1983). If trophic factors do contribute to 
the neural regulation and maintenance of skeletel muscle 
structure and function, then the motor neuron must possess 
the biochemical machinery necessary for their synthesis and a 
mechanism for the transportation of such factors from their 
site of synthesis to their release site. 
a. synthesis of transportable material 
The nerve cell displays an extreme degree of 
regional specialization in that most of the machinery for 
synthesizing proteins and other complex macromolecules is 
confined to the cell body (reviewed in Grafstein and Forman, 
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1980). The perikaryon, therefore, is the primary source of 
assembly for most of the materials needed by the long cellu-
1ar extensions that constitute the axons of neurons. These 
needed materials include membrane constituents, nucleotides, 
RNA and synaptic components. The nerve cell soma is also the 
primary site of protein synthesis in mammalian motor neurons 
and a high level of protein synthesis is continually occur-
ring there (reviewed in Lajtha, 1961+; Mcilwain and Bachelc.rd, 
1971; Barondes and Dutton, 1972; Grafstein and Forman, 1980). 
Perhaps the first definitive demonstration of protein 
synthesis occurring in the nerve cell soma was reported in 
the classic experiaents of Droz and LeBlond (1963). By 
means of high-resolution autoradiography, these workers 
demonstrated directly that after an amino acid (3H-leucine) 
had been injected systemically into adult rats and had become 
incorporated into nerve cells, a wave of radioactive protein 
moved from the scma of anterior horn cells and sensory 
ganglion cells into the region of the axon hillock. The 
radiolabeled proteins then appeared further along the axon at 
succeeding intervals of time. These studies, therefore, also 
implied a movement or flow of material from the nerve soma to 
more distal regions of the axon. Other studies have also 
examined the possibility of the nerve cell soma as the 
primary site of protein synthesis and have confirmed the 
findings of Droz and LeBlond (Taylor and Weiss, 1965; Graf-
stein, 1967; Lasek, 1968). It is interesting to note that 
more recent studies have shown that protein synthesis can 
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also occur to a limited extent in the axon (reviewed in 
Peters et al., 1976) and possibly in the dendrites of central 
nervous system neurons as well (Steward, 1982). 
b. axoplasmic transport: movement of material within the 
axon 
The intricate and detailed morphological specializa-
tions of the neuron which includes axons, dendrites and 
synapses (and possibly the maintenance of target tissues) are 
thought to depend upon the specific and targeted transport of 
macromolecules from the neuronal perikaryon (reviewed in 
Grafstein and Forman, 1980). A model of the nerve as a 
dynamic structure conducting unique functions including the 
maintenance of nerve structure, excitation and conduction of 
the nerve impulse, neurotransmission, and the release of 
trophic substances affecting cells in contact with the nerve 
terminals has developed from the studies of axoplasmic 
transport (Ochs, 1982). 
Transport of macromolecules from their site of 
synthesis in the neuronal perikarya to nerve endings was 
first inferred from the work of Waller (1850) who described a 
progressive degeneration of nerve fibers distal to the point 
of nerve transection. This process, which occurs withir, a 
few days after nerve transection, is now classically referred 
to as "Wallerian degeneration" or the "dying back 
phenomenon". In their classical studies on nerve compres-
1 7 
sion, Weiss and Hiscoe (1948) postulated that the axon was 
continuously growing from the cell body. They based this 
interpretation on their experimental observations of a swel-
ling of nerve fibers proximal to a constriction point, 
produced by nerve ligation, and a narrowing of fibers distal 
to the ligation. These results were interpreted as a demon-
stration of a continuous movement of axoplasm inside the 
nerve fiber. It has been possible to show with histofluor-
escence staining that norepinephrine and dopamine-beta-hydro-
xylase, which are both involved in noradrenergic transmission 
at noradrenergic junctions, accumulate at a nerve ligature 
(Dahlstrom, 1965). Accumulation at a constriction has also 
been demonstrated for acetylcholine (Haggendal, 1971) and 
acetylcholinesterase using an ~D x~~~~ bioassay (O'Brien, 
1978). Various enzymes accumulate at a nerve constriction 
and include lactate dehydrogenase, choline acetyltransferase, 
phosphoglucuronic dehydrogenase and catechol-0-methyltrans-
ferase (reviewed in Lubinska, 1964; Ochs, 1974, Lubinska, 
1975; Pleasure, 1980; Ochs, 1982). Electron microscopic auto-
radiography has also been used to identify structures labeled 
during the axoplasmic transport of radioactive materials. 
The label which accumulates in the nerve endings is 
concentrated in synaptic vesicles, in the presynaptic 
membrane and to a lesser extent in the mitochondria 
(Lubinska, 1975; Ochs, 1982). The fraction retained in the 
axon appears preferentially in the axolemma and in the smooth 
endoplasmic reticulum. Much of the label in the axoplasm is 
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associated with microtubules and neurofilaments (reviewed in 
Lubinska, 1975; Ochs, 1982). 
Direct microscopic observation of living nerve 
fibers show that small particles, including mitochondria and 
elements of the endoplasmic reticulum, can move within axons 
(Lubinska, 1975; Grafstein and Forman, 1980; Pleasure, 1980; 
Ochs, 1982). These observations have been made in neurites 
growing in tissue culture as well as in axon segments excised 
from an intact nerve. 
From the studies on the components of protein 
movement within neurons, a dual transport hypothesis emerged. 
For example, a population of small particulate organelles 
were found to proceed down the axon at a relatively high 
velocity while the axoplasm itself advanced very slowly 
(Grafstein and Forman, 1980; Ochs, 1982). 
The fast component appears to travel within the axon 
at a rate of 410 mm per day at 37°C (Ochs, 1974). To a 
large extent this fast moving fraction includes various types 
of vesicles derived from the Golgi system and endoplas~ic 
reticulum (Ochs, 1982). Some of these vesicles may be 
responsible for the renewal of the plasma membrane, since it 
appears likely that in the nerve cell, as in other cells, new 
Plasma membrane is formed as a continuous sheet by the 
addition to the membrane of vesicular elements that fuse to 
the membrane by exocytosis (reviewed in Lentz, 1983). The 
fast component also appears to contain elements related to 
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the transmitter storage vesicles that participate in synaptic 
transmission. These vesicles probably originate with the 
synthesis of a protein core in the rough endoplasffiic 
reticulum of the cell body. Presumably, this core material 
consists of binding proteins for the transmitter and enzymes 
involved in transmitter metabolism. The material is then 
transferred to the Golgi apparatus, packaged into membrane-
bound bodies and then conveyed along the axon by fast axe-
plasmic transport (reviewed in Ochs, 1982). 
Fast transport is critically dependent upon 
oxidative metabolism. Transport may be blocked in a nerve ~ 
y~~IQ by applying metabolic blocking agents such as sodiun 
cyanide, dinitrophenol, azide or immersing it in an 
atmosphere cf nitrogen (Ochs, 1974; Wilson and Stone, 1979; 
Ochs, 1982). The effectivness of dinitrophenol, which 
uncouples oxidative phosphorylation, shows that the transport 
requires a continuous supply of ATP. Ochs (1974 and 1982) 
has also shown that ca2+, intact microtubules and temperature 
are important in the functioning of fast transport. The 
rate of fast transport is not linked to the electrical 
activity of the axon. This has been demonstrated by showing 
that the rate of transport in an isolated inactive segment of 
nerve is the same as in an active intact nerve ~~ Y~XQ and 
electrical stimulation of an isolated nerve preparation has 
no effect on the rate of transport (Ochs, 1982). 
Additionally, axoplasmic transport is maintained in isolated 
segments of peripheral nerve (Ochs and Ranish, 1969) and, 
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therefore, is independent of a continuity between nerve cell 
soma and axon. The mechanism of fast and slow transport is 
not known (Ochs, 1982). 
The properties of slow transport have so far received 
much less attention. Slow transport reportedly has a rate of 
to 5 mm per day (Droz and LeBlond, 1963; McEwen and 
Grafstein, 1968; Lasek and Hoffman, 1975; Lasek, 1980). Slow 
transport has recently been divided into categories based on 
distinct classes of neuronal constituents commonly associated 
with slow transport, including numerous cytoskeletalelements 
such as neurofilaments, tubulin, actin and c 1 at h r in. Black 
and Lasek (1980) have described a slow component cf slow 
transport with an estimated rate of 1 to 2 mm per day (slow 
component a) and a slightly faster component of slow 
transport with an estimated rate of lj to 5 mm per day (slow 
component b). The influence of temperature, electrical 
activity and metabolism on the rate of slow transport remains 
to be established. 
Microscopy has revealed that neuronal constituents 
can move in either direction along the axon. Transport of 
materials in the disto-proximal direction is known as retro-
grade transport (Lubinska, 1975). The accumulation of 
material distal to a nerve ligation or cut has been shown to 
occur with organelles detectable with electron microscopy 
(Lubinska, 196l!). Quantitative studies on the rates of 
accumulation of various enzymes on both sides of a lesion 
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comparisons between the retrograde have made possible some 
and orthograde transport. Acetylcholinesterase, for example, 
travels in the orthograde direction with the fast component 
of protein transport while a small pecentage of the axonal 
content of the enzyme participates in the retrograde 
transport (Edstrom and Hanson, 1973). Retrograde transport 
rate is also half the rate of the orthograde transport rate 
for this particular component (Edstrom and Hanson, 1973). 
These authors also showed that the two types of axoplasrr.ic 
transport (retrograde and orthograde) had similar sensitivi-
ties to various transport blocking agents and, therefore, 
suggested that they are related. 
The significance of retrograde axoplasmic transport 
remains to be established. It has been suggested that retro-
grade transport may provide a mechanism for feedback control 
of neurons by the target tissues which they innervc.te 
(reviewed in Price, 1974; Varon and Bunge, 1978). In fact, 
recent evidence suggests that an extract of rat skeletal 
muscle may provide protein-like motoneurotrophic factors 
which stimulate neurite sprouting and cholinergic activity of 
cultured spinal motor neurons (Smith and Appel, 1983). 
Retrograde transport may also have an important function 
during the regeneration of a cut axon. After an axon is cut, 
its cell body may undergo a series of complex metabolic and 
morphological changes that may be a prelude to axonal 
regeneration (reviewed in Grafstein, 1977). These changes 
are usually initiated before any axon outgrowth is 
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detectable. It is not clear how the cell body is inforrr.ed 
of the axonal changes following nerve section. However, the 
arriv~l of some abnormal material conveyed by retrograde 
transport from the damaged area or the interruption of the 
retrograde transport of sorr.e substance originating in the 
nerve terminals might serve as a signal for the cell body 
response (Bisby, 1982). Another possibility is that some 
materials normally conveyed by orthograde transport to the 
axon terminals would be unable to reach their usual destina-
tion and might return prematurely to the cell body where they 
would alter the pattern of their own metabolism. This 
suggests that orthograde transport might play an important 
role in the neural control of metabolic activity in the 
neuron by determining the level of certain materials in the 
cell body. 
Direct evidence for the transsynaptic transport of 
trophic material from the nerve to muscle is limited at 
present. Autoradiographs have suggested a translocation of 
radiolabeled protein from the neuron to the muscle and entry 
of labeled protein into the muscle (Kerr et al., 1967; 
Musich and Hubbard, 1972; Grafstein, 1977). Additionally, 
Hines and Garwood (1977) reported a significant release of 
axonally transported proteins from frog sciatic nerve ~n 
Y~~~Q. However, it has been difficult to determine the 
mechanism of protein release and whether there is specific 
release or general leakage of this axonal material. 
23 
c. experimental analysis of trophic effects 
(1) disuse vs. surgical denervation 
In the motor system, the nerve impulse and the 
neurotrophic message can both travel in the proximo-distal 
direction from the neuronal perikaryon to the nerve terminal 
ree,icn. For this reason, it is often difficult to distin-
guish between the effects of these two kinds of neural 
influences on target muscle cells. Many early studies chose 
to operationally distinguish between neurotrophic and 
impulse-mediated influences of the nerve by comparing the 
effect of surgical denervation on muscular plasticity to that 
of muscle inactivation. In these early studies, inactivation 
(disuse) was produced by several experimental models 
including tenotomy, spinal cord isolation and limb immobili-
zation (reviewed in Jolesz and Sreter, 1981; Hoyle, 1983). 
Perhaps the first to suggest that skeletal muscle is regu-
lated by neural influences other than impulse-directed 
contractile activity alone was Tower (1941) who observed that 
the development of fibrillatory activity in denervated dog 
muscle appeared earlier and with a quantitatively greater 
response than that observed in disused but innervated muscle. 
Also, others have suggested that muscle atrophy is regulated 
by neural influences apart from impulse-directed contractile 
activity alone. Muscle atrophy can be experimentally 
Produced by inactivating physically innervated muscles 
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(reviewed in Guth, 1968 and 1969; Jolesz and Sreter 1981; 
Hoyle, 1983). The morphological changes observed in the 
inactivated muscle included myofibrillar atrophy and loss of 
nuclear integrity (Guth, 1968) as well as changes in 
sarcomere length (Williams and Goldspink, 1978) and an 
increase in protein degradation (Goldspink et al., 1983). 
The onset of these changes, however, was delayed in disused 
muscles relative to surgically denervated muscles. Also, a 
late phase of increased protein synthesis observed in 7 day-
denervated muscle did not occur with inactivation (Goldspink, 
1978). Other early studies have shown that changes in 
endplate morphology were not as pronounced in disused muscle 
when compared with denervation-induced changes (Johns and 
Thesleff, 1961). With refined techniques, however, 
including long term integrated electromyography, the use of 
experiaental models for muscle disuse has recently been 
questioned (Fournier et al., 1983). These studies showed 
that the degree of atrophy in rat soleus and gastrocnemius 
muscles was not closely related to the recorded electromyo-
graphic activity of these muscles. 
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(2) cross-reinnervation experiments 
The experimental observations of Buller, Eccles and 
Eccles (1960 and 1960a) have provided evidence suggesting 
that the dynamic properties of skeletal muscle are regulated 
by a neural influence other than impulse-directed acetyl-
choline transmission (reviewed in Close, 1972). These 
authors reinnervated a fast-contracting muscle with a nerve 
that normally supplies a slow-contracting muscle and reinner-
vated a slow-contracting muscle with a nerve that normally 
innervates a fast-contracting muscle. They found that the 
isometric contraction time of the fast-contracting muscle 
became longer and that of the slow-contracting muscle became 
I 
shorter. Subsequently, Close (1969) observed that the 
intrinsic speed of shortening of the muscle sarcomere is 
modified by these cross-reinnervation procedures and sug-
gested, therefore, that the basic properties of the myosin 
molecule might be neurotrophically regulated. A close 
correlation has been reported between the contraction of 
different skeletal muscle types and the ca2 +-activated myosin 
ATPase activity for these muscle types (Unsworth et al., 
1982). It has been shown that different muscles types 
contain myosins with different ATPase properties and that the 
Proportions of these myosin ATPase activities change as a 
result of cross-reinnervation (Guth and Samaha, 1969; Buller 
et al., 1969; Mommaerts et al., 1969; Barany and Close, 1971; 
Sreter et al., 1974; Hoh, 1975; discussed further in section 
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II B)· It has also been shown that the relative proportions 
of polymorphic forms of other contractile proteins (troponin, 
actin and tropomyosin) also change as a result of cross-
reinnervation (Amphlett et al., 1975). 
The neural message responsible for eliciting changes 
in several skeletal muscle contractile proteins and myosin 
ATPase activity of cross-reinnervated muscles is unknown. 
The authors of early studies suggested that the motor nerve 
regulates the dynamic properties of fast twitch and slow 
twitch muscle through the release of some specific neuro-
trophic factor(s). Recently, however, evidence has been 
presented which suggests that the conversion of muscle 
properties observed in cross-reinnervated muscles might be 
due to a change in the frequency and pattern of impulse 
activity (Sc.lmons and Sreter, 1976; Eisenberg and Salmons, 
1 9 80) • 
(3) experimental use of neurotoxins 
Recently, various neurotoxins which block specific 
modes of neuromuscular communication have been used to 
differentiate a role for impulse-directed acetylcholine 
release, spontaneous acetylcholine release and axonally 
transported neurotrophic factors in the regulation of 
specific muscle properties. For example, tetrodotoxin (TTX) 
has been used to successfully block nerve impulse conduction 
by inhibiting axonal sodium conductance while leaving the 
muscle physically innervated. Application of TTX to 
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peripheral nerve results in a denervation-like increase in 
extrajunctional acetylcholine sensitivity (Pestronk et al., 
1976; Bray et al., 1979) and a decline in the resting 
membrane potential (Drachman et al., 1982) of the innervated 
muscle without affecting axoplasmic transport or inducing 
nerve degeneration. The TTX-induced alterations in these 
muscle properties, however, were quantitatively less than the 
changes induced by surgical denervation. Chemical denerva-
tions producing quantitative changes in these muscle 
parameters similar to the effect of TTX have also been 
carried out with other neurotoxins (botulinum toxin and 
beta-bungarotoxin). These neurotoxins are capable of 
producing a pharmacological blockade of impulse-dependent 
acetylcholine transmission. The results of these studies 
and studies conducted with TTX have suggested that the neural 
regulation of muscle resting membrane potential and e:x.tra-
junctional acetylcholine sensitivity involves additional 
influences of the motor nerve apart from impulse-directed 
muscle contraction. 
In addition to these physiological properties of 
muscle, biochemical parameters of denervated and TTX-inacti-
vated muscle have been compared. In a study of the oxidative 
Processes in skeletal muscle, it was observed that TTX-
inactivation of rabbit soleus muscle for 2 weeks did not 
affect the activities of several mitochondrial enzymes while 
denervation for 2 weeks led to a decrease in the metabolic 
rate and in 
(Nemeth et 
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mitochondrial enzyme activity of the muscle 
al., 1980). Additionally, a recent study bas 
shown that the denervation-induced increase in cell 
proliferation occurring within 36 hours after denervation is 
not observed in muscle inactivated by TTX (Murray and 
Robbins, 1982). The decrease in acetylcholinesterase 
activity observed in denervated muscle, however, was found to 
be quantitatively equivalent to that observed in TTX-
inactivated muscle (Butler et al., 1978). 
If the neural regulation of some skeletal muscle 
properties depends on the delivery of putative neurotrophic 
factor(s) to the muscle, then blocking axoplasmic transport 
while leaving the muscle electrically active should produce 
changes in muscle properties quantitatively equivalent to 
those observed in surgically denervated muscle. Experiments 
to test this hypothesis have been done by applying the neuro-
toxins colchicine or vinblastine to the motor nerve 
(Albuquerque et al., 1972; Albuquerque et al., 1974). These 
toxins are said to interfere with fast axonal transport by 
disrupting microtubules without affecting the propagation of 
action potentials or acetylcholine transmission (Fernandez 
and Ramirez, 1974; Tiedt et al., 1977a). The techniques used 
to apply the neurotoxin to the peripheral nerve consisted of 
a single subepineural injection or a neurotoxin-impregnated 
cylindrical silastic cuff wrapped around the axon. However, 
the injection of colchicine or vinblastine beneath the peri-
neurium of the motor neuron apparently causes denervation-
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like alterations in membrane physiology in both the target 
tissue and the contralateral, control muscle (Albuquerque et 
al., 1974; Cangiano and Fried, 1977; Teidt, 1977a). This 
implies that application of neurotoxin by injection leads to 
a general systemic effect on muscle membrane physiology. 
However, it was reported that the dosage of neurotoxin 
injected was an important consideration in the design of 
these types of experiments (Guth and Albuquerque, 1979). 
Neurotoxin-impregnated cylindrical cuffs offered an advantage 
in that they affected only the motor nerve to which they were 
attached. Also, application of the neurotoxins by this 
method did not result in any morphological alteration of the 
neural membrane. Using this technique, blockage of axo-
plasmic transport with colchicine or vinblastine was achieved 
and also there was a decline in resting membrane potential, 
development of TTX-resistant action-potentials, an appearance 
of extrajunctional acetylcholine sensitivity (Albuquerque et 
al., 1972 and 1974) and the development of muscle fibril-
latory activity (Inestrosa and Fernandez, 1976). The quanti-
tative change in these membrane physiological parameters was 
equivalent to the changes induced by surgical denervation, 
but their appearance was delayed with the chemical denerva-
tion. These results implied that axoplasmic transport might 
be directly involved in the supply of some neurotrophic 
factor(s) to the post-neural cell which, in turn, may have 
some role in the neural regulation of these electrophysio-
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logical events. Inestrosa and Fernandez (1976) also showed 
that the activities of malic dehydrogenase, pyruvate kinase 
and phosphorylase b were decreased within 4 to 5 days after 
chemical denervation wih colchicine. The time course of the 
decline in enzyme activity after chemical denervation was the 
same as that observed with surgical denervation, but the 
quantitative effect was less. Therefore, these results sug-
gested a partial role for the axoplasmic transport of some 
neurotrophic factor in the regulation of these enzyme activi-
ties. 
Batrachotoxin, a toxin from frog (Phyllobates aurc-
taenic), has also been used as an experimental tool to study 
the role of axcplasmic transport in the regulation of various 
muscle parameters. This neurotoxin reportedly blocks impulse 
conduction (Albuquerque et al., 1971a) and axoplasmio 
transport, but does not affect muscle when applied directly 
to the tissue (Ochs and Worth, 1975). Studies compari~g 
impulse blockade (using TTX) to a combined impulse conduction 
c..nd axoplasmic transport blockade (using batrachotoxin) have 
demonstrated a role for axoplasmic transport in the neural 
regulation of the muscle resting membrane potential (Boegman 
et al., 1980), hydrolytic enzyme activity (Boegman and 
Soarth, 1981 and 1981a), ca2+ uptake by the sarcoplasmic 
reticulum (Wan et al., 1982) and glucose-6-phosphate 
dehydrogenase activity (Max et al., 1982). 
The role of spontaneously released acetylcholine has 
been studied recently by using the neurotoxin - alpha-
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bungarotoxin. This toxin eliminates transmission of impulse-
directed and spontaneously released acetylcholine through a 
complete pharmacological blockade of the postsynaptic acetyl-
choline receptor (Drachman et al., 
that treatment of rat soleus muscle 
1982). It was reported 
with alpha-bungarotoxin 
produced a decline in muscle resting membrane potential and 
an increase in extrajunctional acetylcholine receptor number 
quantitatively equivalent to that induced by surgical 
denervation (Drachman et al., 1982). The quantitative change 
in these t~o muscle properties observed after blocking 
impulse conduction with TTX, however, was less than the 
change induced by surgical denervation. The authors inter-
preted their findings as evidence that acetylcholine 
transmission (impulse-dependent and spontaneous) is the 
neural factor responsible for the regulation of these two 
muscle properties. Whether other specific muscleproperties 
affected by denervation are regulated entirely by acetyl-
choline has not been defined. 
(4) comparative studies: embryonic vs. adult skeletal 
muscle 
It has been suggested that trophic influences of the 
motor neuron apart from impulse-directed contractile activity 
might be of significance on an evolutionary scale by 
contributing to the development of the size, strength and 
endurance needed by skeletal muscles relative to the extent 
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to which they are used (Harris, 1980). From this it has been 
argued that the trophic actions of the nerve which are 
independent of impulse activity of the nerve may be of signi-
ficance during the embryonic maturation of the muscle. 
Experimental support for the coexistence of trophic and 
activity-related mechanisms for maintaining adult skeletal 
muscle has come from studies of embryonic muscle. Results of 
these experi~ents indicate that the relative contributions of 
trophic actions of the nerve and of impulse-related muscular 
contractions to the development of embryonic and adult muscle 
c.re not strikingly different. For example, the motor nerve 
functioning independently of iffipulse-directed acetylcholine 
release regulates acetylcholine receptor number and 
contributes to the clustering of receptors on embryonic 
muscle (Burden, 1 977). Huscle growth, however, seems to 
require impulse-directed contractile activity. Nerve stump 
length and neurotoxin experiments such as those described 
previously indicate that a trophic function of the motor 
nerve is responsible for regulating acetylcholine receptor 
number and position in adult skeletal muscle as well (Uchitel 
and Robbins, 1978; Drachman et al., 1982). Also, the 
embryonic nerve, independent of nerve in:pulse activity, 
contributes to the inhibition of extrajunctional receptor 
sensitivity as monitored by changes in acetylcholine receptor 
number (Braithwaite and Harris, 1979). This neurotropt.ic 
function is apparently important in adult skeletal muscle as 
Well (Pestronk et al., 1976; Harborne and Smith, 1979; Olek 
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et al., 1981; Steinbach, 1981; Drachman et al., 1982). 
(5) neurally-derived myotrophic factors 
It is apparent from the studies described above that 
motor neurons may influence several properties of skeletal 
muscle through a trophic function of the nerve involving 
axonally transported neurotrophic factors. The isolation and 
characterization of neurally-derived myotrophic factors, 
however, is at present limited. 
A protein purified from adult chicken sciatic nerve 
has been shown to have a trophic or "innervation-like" effect 
on embryonic muscle cells in culture (Markelonis and Oh, 
1979). This bioactive protein was shown to enhance the rate 
cf morphological maturation and protein synthesis of the 
cultured muscle cells (Markelonis and Oh, 1979; Markelonis et 
al., 1980) and maintain cross-striated myotubes in the 
absence of innervation in vitro for up to several months 
1 97 6). The myotrophic protein, referred to as "sciatin" 
( Oh, 
( Oh 
and Markelonis, 1980), has been recently reported to be 
structurally and functionally similar to the iron-carrying 
protein of chick serum - transferrin (Markelonis et al., 
1982; Oh and Markelonis, 1982). The two proteins have 
similar amino acid compositions and are indistinguishable 
immunologically. ~ vitro and ~ YiYQ immunohistochemical 
studies have demonstrated that the myotrophic protein is 
Present in the perikarya of spinal cord neurons and the 
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axoplasm of chicken sciatic nerves (Oh et al., 1981). 
Recently, it was demonstrated that the myotrophic transferrin 
= 
84,000) is synthesized in spinal neurons and co-
purifies with a protein of Mr = 52,000 which may represent 
the neuronal receptor for this trophic protein (Markelonis 
and Oh, 1983). The myotrophic 
identified by others (Popiela et 
transferrin has also been 
al., 1982). Interestingly, 
this protein is identical in structure to chicken transfer-
rins isolated from embryo extract, serum and eggs, but 
distinguishable from human and horse transferrin as 
determined by peptide mapping (Beach et al., 1983). The 
myotrophic transferrin apparently exerts its trophic effects 
by altering the cell cycle (Popiela et al., 1983). 
The 84,000-dalton myotrophic transferrin has been 
shown to cause a significant increase in acetylcholine 
receptor number and receptor clustering on aneural embryonic 
chicken skeletal muscle (Markelonis et al., 1982a; Oh and 
Markelonis, 1982). Additionally, it has been proposed that 
acetylcholine may be packaged in synaptic vesicles at the 
nerve ending together with proteins and ATP (Musich and 
Hubbard, 1972). These studies reported that ATP and acetyl-
choline-binding proteins were released, together with acetyl-
choline, upon nerve stimulation of mouse nerve-muscle 
P r e P a r a t i o n s ( p h r e n i c n e r v e - d i a p h r a g m m u s c 1 e ) .i..n .Y.i.t.r.Q . 
Other diffusable neural factors from the motor neuron have 
also been described as having a trophic effect on acetyl-
choline receptor number and receptor aggregation (Cohen an 
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Fischbach, 1977; Podelski et al., 1978; Jesse! et al., 1979; 
Kuromi et al., 1981 Kalcheim et al., 1982), but the 
biochemical isolation and characterization of these factors 
from nerve extracts has not been achieved. 
Also of interest is a report by Davis and Kiernan 
(1980) demonstrating that sciatic nerve extract was able to 
reverse some of the muscle changes characteristic of denerva-
t i o n a t r o p h y ..1.n .YJ..Y.Q ( i. e • , w e i g h t a n d p r o t e i n 1 o s s a n d 
reduction in diameter of type liB myofibrils) observed in 7 
day-denervated fast-twitch extensor digitorum longus muscle. 
Lentz et al. (1981) also described a myotrophic protein 
which they partially purified from rat brain. The proteir., 
termed "neurotrophin", was characterized as a small (3l.J,OOO-
daltons) basic protein which was able to significantly 
increase the activity of 16.5 S acetylcholinesterase in 
cultured newt triceps muscle. However, the biochemical 
mechanism of action of neurotrophin is unknown. 
B. Errect or Alterations or Neuroauscular Communication upon 
the Integrity or Skeletal Muscle 
1. Effect of denervation upon muscle ultrastructure 
When a skeletal muscle is deprived of its motor 
neuron supply (acetylcholineand axonally-transported 
neurotrophic factors), it undergoes certain anatomical and 
functional changes which collectively have been referred to 
as denervation atrophy (reviewed in Harris, 197l.J; Drachman, 
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1974; Gutmann, 1976; Harris, 1980). However, relatively few 
denervation-induced changes in skeletal muscle structure and 
function occurring before the onset of denervation atrophy 
have been described. These early changes are important in 
that they might be related to events closely regulated by a 
neurotrophic function of the motor nerve. 
Degenerative changes at the neuromuscular junctions 
of rat diaphragm muscle have been described following 
cutting of the phrenic nerve which innervates the diaphragm 
(Pullial:! and April, 1979 and 1979a). In these studies, 
particular attention was directed at unique changes in the 
various fiber types (red slow-twitch, white fast-twitch and 
intermediate muscle fibers) and also the effect of denerva-
tion period and nerve stump length on these changes. The 
axon terminals innervating white fast-twitch and intermediate 
muscle fibers were found to degenerate more rapidly than the 
axon terminals innervating red slow-twitch fibers. However, 
axon terminal degeneration preceded muscle fiber changes in 
all three fiber types and was visually apparent by 2 days 
after denervation. An increase in rough endoplasmic reti-
culum and Golgi membranes at subsarcolemmal regions were 
observ€d in all three fiber types at about 3 to 4 days after 
denerva tion. This in turn was followed by a disruption of 
sarcomere structure at 12 days post-denervation with white 
fast-twitch fibers affected greatest (Pulliam and April, 
1979; Manalov, 1974). Interestingly, the morphological 
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changes described above appear later in a muscle denervated 
with a longer distal nerve stump length left attached to the 
muscle (Pulliam and April, 1979 and 1979a). 
The relationship of denervation-induced morpho-
logical changes to the length of the distal nerve stump 
is significant in that it indicates that the alteration is 
due to an influence of the motor nerve apart from the 
impulse-directed release of acetylcholine. Impulse conduc-
tion in the distal nerve stump will cease immediately when 
the nerve is transected at any position along the length of 
the axon. How ever, neuro trophic mediators which are supplied 
by axoplasmic transport will be limited quantitatively and 
temporally by the length of the distal nerve stump attached 
to the muscle. Changes in muscle properties that are direc-
tly related to denervation period and nerve stump length, 
therefore, are interpreted to be neurotrophically regulated 
(Guth, 1968; Guth, 1974; Lubinska, 1975; Ochs, 1982). 
An early onset in the loss of the post-junctional 
sarcolemmal infolding has been reported in soleus muscles of 
the mouse denervated for 5 days (Brown et al., 1982). These 
results were also reported by Tachikawa and Clementi (1979) 
who used the technique of freeze-fracture electron microscopy 
to show that soleus muscles denervated for 5 days also have 
an increased number of intramembrane particles in the post-
synaptic infoldings as well as a significant increase in the 
number of pinocytotic vesicles. These findings are consis-
tent with a denervation-induced alteration in the turnover of 
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membrane constituents (Tachikawa and Clementi, 1979) and the 
increase in the acetylcholine receptor population at dener-
vated myoneural junctions (Levitt and Salpeter, 1981; Olek 
and Robbins, 1983). Additionally, histochemical analysis 
has indicated a loss of both endplate choline acetyltrans-
ferase (Davey and Younkin, 1978) and acetylcholinesterase 
(Davey and Younkin, 1978; Ranish et al., 1980) in muscle 
denervated for 3 days; these changes have also been related 
to denervation period and nerve stump length (Ranish and 
Dettbarn, 1978). 
My studies have focused on denervation period and 
nerve stump length-dependent phosphorylative changes in the 
slow-twitch soleus muscle of the rat. Denervation atrophy 
(i.e., loss of muscle weight and protein) occurs in this 
homogeneous (Type I fiber) muscle of the rat hindlimb 
approximately three days after nerve section when a long 50 
mm distal nerve stump is left attached to the muscle (Solandt 
and Magladery, 1940; Stonnington and Engel, 1973; Cullen ana 
Pluskal, 1977). At this time mitochondrial swelling and an 
increase in rough endoplasmic reticulum are observed (Cullen 
and Pluskal, 1977). Within 2 weeks after the mid thigh 
denervation, soleus muscle is reduced to one half its origi-
nal weight (Solandt and Magledery, 1940) with myofibrillar 
Proteins affected more than sarcoplasn:ic proteins (Goldberg, 
1969). At 2 weeks post-denervation the cross-sectional myo-
fibril area is also significantly decreased and by 4 to 8 
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weeks myofibrils are often completely lost when studied by 
light microscopy (Gutmann and Zelena, 1962). Early electron 
microscopy studies confirmed the finding of a decreased myo-
fibril cross-sectional area and also revealed a proliferation 
of the sarcoplasmic reticulum and the transverse tubule 
system (Pellegrino and Franzini, 1963; Romanul et al., 1965; 
Engel and Stonnington, 1974). The decrease in the size of 
the myofibrils was interpreted to occur by a progressive 
lysis of the peripheral filaments. Interestingly, similar 
morphological changes were described in denervated muscle by 
Tower as early as 1939 and were also interpreted to 
represent a process of myofibrillar degeneration. 
Sarcoplasmic changes that have been observed in 
denervated muscle include an increase in size and relative 
number of sarcolemmal nuclei (Sunderland and Ray, 1950; Guth, 
1968). Also, the nuclei appear more rounded and migrate i~to 
the more central regions of the fibers (Guth, 1968). The 
increase in the number cf sarcolemmal nuclei is apparently 
relative and this has been demonstrated bioche~ically by the 
finding of a constant total amount of DNA in muscles 
denervated for two weeks (Hogan et al., 1965). An increase 
in the relative amount cf interfiber connective tissue has 
also been reported without a change in the total amount of 
collagen (Fischer and Ramsey, 1946; Stewart, 1955). 
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2 . Effect of denervation upon muscle membrane electro-
physiology 
Denervation produces several changes in the elec-
trophysiological properties of the muscle membrane. These 
electrophysiological changes in the muscle membrane are the 
earliest reported alterations observed in the denervated 
muscle. A reduction in the resting membrane potential occurs 
within 3 to 18 hours after denervation when a short nerve 
stump (2 mm or less) is left attached to the muscle. This 
response is delayed several hours when a long (30 to 40 mm) 
distal nerve stump was left attached (Albuquerque et al., 
1971; Bray et al., 1976; Deshpande et al., 1980; Stanley and 
Drachman, 1980; Drachman et al., 1982). The denervation-
induced decline in resting membrane potential occurs 
initially at the endplate region and then spreads to the 
extrajunctional region at later periods (Bray et al., 1976). 
The quantitative fall in potential is approximately 10 mV. 
The decline in resting membrane potential is thought to be 
related to the loss of some membrane component responsible 
for electrogenic hyperpolarization of the endplate (Bray et 
al., 1976) since the potential can be restored in denervated 
rat soleus muscle by increasing the activity of the Na+;K+ 
pump (Clausen and Flatman, 1977). Also, the quantitative 
fall in membrane potential is also obtained following a block 
or the pump with ouabain (Locke and Solomon, 1967). The 
rapidity of the denervation-induced partial depolarization of 
41 
the motor endplate (3 to 18 hr after denervation) suggestec 
that it might be the initial and rate-limiting step in a 
chain of neurally-regulated membrane events (Deshpande et 
al., 1976). 
Other changes in membrane physiology follow the 
decline in resting membrane potential. Resistance to the 
neurotoxin, tetrodotoxin (TTX), is observed at the endplate 
region within 2 days after denervation (Harris and Thesleff, 
1972) and at any region of the muscle fiber after one week 
(Redfern and Thesleff, 1971). The denervation-dependent 
change ir, TTX resistance has also been related to the length 
of distal nerve stump left attached to the muscle since the 
effect appears earlier when the nerve is transacted closer to 
the muscle (Thesleff, 1974). TTX is known to inhibit the 
propagation of the action potential by blocking Na+ conduct-
ance. 
Additionally, denervated muscle develops acetyl-
choline supersensitivity in the extrajunctional region as 
early as two days after denervation (Miledi and Potter, 1971; 
Harris and Thesleff, 1972; Uchitel and Robbins, 1978; Olek 
et al., 1981; Steinbach, 1981). The increase in extrajunc-
tional acetylcholine supersensitivity has been described in 
terms of ionotophoretic changes involving changes in 
membrane permeability (Miledi and Zelena, 1966; Miledi and 
Potter, 1971; Kuffler and Yoshikawa, 1975). Also, an 
apparent increase in acetylcholine receptor number has been 
reported (Pestronk et al., 1976; Olek et al., 1981; 
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steinbach, 1981; Drachman et al., 1982) which has been 
related to nerve stump length in denervated diaphragm muscle 
(Uchitel and Robbins, 1978). Denervation accelerates the 
turnover of junctional acetylcholine receptors from a half 
life of ten days to approximately two to three days (Loring 
and Salpeter, 1980; Levitt et al., 1980; Olek and Robbins, 
1983; Stanley and Drachman, 1983) and also extrajunctional 
receptors from a half-life of 1 to 2 days to approximately 18 
hours (reviewed in Fambrough, 1979; Pumplin 
1 9 82) . 
and Fambrough, 
Finally, fibrillatory potentials (which are observed 
no earlier than 42 hr after denervation when a short (5 mm) 
nerve stump is left attached to the soleus muscle and 48 hr 
when a longer (30 mm) nerve stump is left attached) usually 
appear near the endplate region first and then propagate froc 
there along the entire length of the muscle fiber (Salafsky 
et al., 1968). A nerve stump length-related alteration in 
the fibrillatory activity of denervated muscle has also been 
reported by others (Luco and Eyzaguirre, 1955; Thesleff, 
1974). Fibrillatory activity has been classified recently 
as an electrophysiological membrane parameter regulated by a 
trophic influence of the nerve possibly through the non-
quantal release of acetylcholine (Thesleff, 1982). 
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3. Effect of denervation upon muscle biochemistry 
The neuroregulation of the biochemical properties of 
skeletal muscle provides a molecular basis for neural 
maintenance of muscle structure and function. Early bio-
chemical changes in muscle which have been related to 
denervation period and nerve stump length are summarized in 
Table and include an increase in muscle proteolytic 
activity (McLaughlin et al., 1974), an increase in RNA 
synthesis (Politoff and Blitz, 1978), an increase in cyclic 
adenosine 3':5' n.onophosphate (Carlsen, 1975), an increase in 
the concentration of phosphatidyl ethanolamine (Fernandez et 
al., 1979), a decrease in glucose-6-phosphate dehydrogenase 
activity (Robbins and Carlson, 1979; Wagner and Max, 1979; 
Robbins, 1981) and a decrease in endplate acetylcholin-
esterase activity (Davey and Younkin, 1978; Ranish and Det-
tbarn, 1975; Ranish et al., 1980). The denervation period 
and nerve stump length-dependent change in glucose-6-phos-
phate dehydrogenase activity, however, was not observed when 
the slow-twitch rat soleus muscle was examined (Wagner and 
.-:ax, 1979). Although the nerve stump length-dependent bio-
chemical changes described occur within 12 to 72 hr after 
denervation, only those changes occurring before the onset 
of denervation atrophy are potentially important in defining 
the early muscle processes closely regulated by non-impulse 
mediated neural influences. 
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TABLE 1. BIOCHEMICAL PARAMETERS RELATED TO DENERVATION 
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aBiochemical parameters which are altered after denervation 
and are temporally related to the denervation period and the 
length of the distal nerve stump left attached to the 
muscle. Relevant references are cited in the text. 
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Other biochemical changes occur in muscles 
denervated for a longer period of time and after the onset cf 
denervation atrophy. The ca+2-activated adenosine triphos-
phatase (ATPase) activity, the actomyosin ATPase activity and 
the sarcoplasmic ca+ 2 transport rate are altered in a muscle 
denervated for week (Margreth et al., 1972; Palexas et al., 
1981; Tate et al., 1983). Inhibition of ca2+ uptake by the 
sarcoplasmic reticul~m in muscles denervated for 9 days has 
also been confirmed by others (Wan et al., 1982). It is 
significant that the ca+2_transport process as well as the 
ca+2-dependent hydrolysis of ATP is affected after a 1 week 
denervation period. C a2 + is known to regulate a 
activated protease (Reddy et al., 1983) which may play a 
significant role in the development of muscle necrosis at the 
neuromuscular junction by catalyzing the dissolution of the 
Z-disks (Leonard and Salpeter, 1979). Furthermore, the 
denervation effect upon the functional properties of the 
sarcoplasmic reticul~m may be important since these proper-
ties are closely correlated with the contractile properties 
of the muscle fibers (Heilmann and Fette, 1977; Wan et al., 
1982). 
The turnover of muscle membrane components mayalso 
be altered following denervation. A change in both ganglia-
Side and lipid composition in skeletal muscle denervated for 
7 to 9 days has been reported (Max et al., 1970; Kabara and 
Tweedle, 1981, respectively). These changes may be related 
46 
to the removal and insertion of membrane constituents by the 
process of endo- and exocytosis which also appear to be 
altered following denervation of skeletal muscle (Sellin et 
1 1980). An elevated rate of endocytosis has been observed a . , 
by following the increased uptake of extracellular markers 
(i.e.,3H-inulin and horseradish peroxidase) into denervated 
fast-twitch extensor digitorum longus (EDL) and slow-twitch 
soleus muscle (Libelius et al., 1981; Boegman and Scarth, 
1981 and 1981a). Tbis change along with a denervation-induced 
increase in lysosomal enzyme activity (Weinstock and Iodice, 
1969) may be important in the turnover of membrane consti-
tuents in the denervated muscle. Interestingly, these bio-
chemical changes are preceded by certain membrane physiologi-
cal changes; i.e., the decline in resting membrane potential 
and the appearance of TTX-resistant action potentials (Sellin 
et al., 1980). 
4. Neural regulation of skeletal muscle gene expression 
I t h a s be e n s u g g e s t e d t h a t p e r i ph e r a 1 m o t o rn e u r o n s 
exert a control over the skeletal muscles they innervate 
which may be expressed at the level of genome. This is based 
on the elimination of denervation-induced alterations ir. 
skeletal muscle with inhibitors of RNA and protein synthesis 
and also the effect of denervation upon the synthesis of 
specific muscle proteins. Blocking RNA synthesis with a 
Single dosage of actinomycin D prevents the development of 
TTX-resistant action potentials, extrajunctional acetyl-
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choline supersensitivity and the decline in the resting 
membrane potential for up to four days in a denervated muscle 
(GramPP et a 1., 1972). These parameters could also be 
blocked for longer periods with repeated injections of the 
antibiotic. Blocking transcription with a single dose of 
actinomycin D also delays the fibrillatory activity 
associated with denervated muscle for as long as three days 
(Muchnik et al., 1973). The increased number of extra-
junctional acetylcholine receptors observed in denervated 
muscle as measured by 125I-labeled alpha-bungarotoxin binding 
was blocked by actinomycin D and cycloheximide (Fambrough, 
1979). This suggests that the increase in receptor numb~r 
involved an acceleration of receptor biosynthesis (Fambrough, 
1 97 9). Actinomycin D was also shown to prevent the increase 
in glucose-6-phosphate dehydrogenase activity observed in 
rabbit muscle denervated for 18 hr (Ilyin et al., 1979). 
The neural regulation of skeletal muscle gene 
expression has also been suggested from studies showing an 
effect of den~rvation, inactivity and cross-reinnervation 
upon the synthesis of specific proteins. In addition to the 
den~rvation-induced increase in the synthesis of the extra-
junctional acetylcholine receptor protein described above 
(Fambrough, 1979), denervation also causes an increase in 
sarcoplasmic reticulum proteins (Pellegrino and Franzini, 
1963) with a concomitant decrease in the synthesis of 
contractile proteins such as myosin (Goldberg, 1969). It 
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baS also been shown that the myosin protein isolated from 
fast and slow-contracting muscle are qualitatively different 
and that these differences in the structure of the myosin 
molecule are reversed by cross-reinnervation of these muscles 
(Guth and Samaha, 1969; Buller et al., 1969; Mommaerts et 
al., 1969; Barany and Close, 1971; Sreter et al., 1974; Hob, 
1975). Myosins from slow and fast-contracting muscle can be 
distinguished on the basis of their light chain patterns 
resolved on polyacrylamide gels and also by the pattern of 
peptides generated by proteolytic digestion of the heavy 
chains (Unsworth et al., 1982; Pluskal and Sreter, 1983). 
Unsworth et al. (1982) also reported that immobilization (for 
6 weeks) caused the slew-twitch soleus muscle to resemble a 
fast-twitch muscle in contractile properties, myosin-ATPase 
activity and the heavy chain pattern of myosin. 
Immobilization, however, did not affect these properties of 
fast-twitch muscle. Also, denervation caused a change in 
the isozyme patterns of glucose-6-phosphate dehydrogenase and 
lactate dehydrogenase which were restored upon reinnervation 
(Ilyin et al., 1979). The amount of a particular protein 
within the cell is controlled by its rate of synthesis and 
degradation and these processes, in turn, are controlled by a 
variety of biochemical mechanisms. The qualitative expres-
sian of a protein, such as that observed for myosin, glucose-
6-phosphate dehydrogenase and lactate dehydrogenase, is 
determined by the activity and regulation of the genome. 
Therefore, it has been suggested that several bioche~ical 
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properties of skeletal muscle may be exerted through a 
regulation of gene expression in the muscle cell (reviewed in 
auth, 1969). 
The neural regulation of skeletal muscle 
transcriptional and translational events has been studied 
more specifically by showing an effect of denervation upon 
these processes. It has been reported that an increase in 
the activities of the nuclear RNA polymerases I and II in 
skeletal muscle occurs within 48 hr after rr..idthigh denerva-
tion of the rat soleus (Held, 1978). Using a cell-free 
translational assay system and eDNA/RNA hybridization 
techniques, Metafora et al. (1980) reported a sequence-
selective alteration in mRNA translation products at later 
times after denervation (8 days). It was suggested from 
these studies that the neural control of the types of muscle 
mRNA is at the level of transcriptional events. These 
results indicate the importance of defining early genetic 
changes associated with denervation. Alterations in genetic 
parameters which occur prior to denervation atrophy (but not 
immediately after the cessation of impulse-directed acetyl-
choline transmission) are of significance because they may 
suggest a neurotrophic regulation of muscle protein syn-
thesis. 
Several biochemical studies of denervated muscle 
have also focused on the neuroregulation of protein turnover 
in skeletal muscle. There is evidence that marked changes 
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in the average rate of protein degradation, as well as syn-
thesis, contribute to muscle wasting during denervation 
atrophy and muscle growth during compensatory hypertrophy 
(Goldberg et al, 1974; Goldspink et al, 1983). Also, it is 
generally agreed that the appearance of denervation atrophy 
is relc.ted to an increased rate of protein degradation with 
little change or a decrease in protein synthesis (Goldberg, 
1969; Goldspink, 1976, 1977 and 1978; Goldspink et al., 1983; 
Goldspink and Goldspink, 1977; Ramirez, 1980). 
c. Cyclic AMP in Neurotrophic Functions 
The molecular mechanism by which the muscle cell 
translates neurotrophic messages into biological responses is 
not known. Cyclic AMP has been implicated in the regulation 
of various intracellular processes, particularly in the 
translation of extracellular influences exerted by protein 
hormones, various neurotransmitters and depolarizing drugs 
into intracellular effects. These extracellular trophic 
effectors exert their effects in eukaryotic cells through the 
activation of receptor-coupled adenylate cyclase which 
generates cyclic AMP from ATP. The specific mode of action 
of cyclic AMP is to stimulate the inactive cytosolic cyclic 
AMP-dependent protein kinase holoenzyme which exists as a 
tetramer consisting of two catalytic subunits (C) and two 
cyclic AMP-binding regulatory subunits (R). Cyclic AMP 
activates the enzyme by binding to the R subunits. Binding 
leads to a rapid dissociation of the C and R subunits to 
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yield the free, active C subunit according to the following 
stoichiometry (Builder et al., 1980): 
Activation of the cyclic AMP-dependent protein kinase by 
cyclic AHP leads to the subsequent phosphorylation of cell 
proteins (reviewed in Greengard, 1978; Cohen, 1982). Also, 
activation of the cyclic AMP-dependent protein kinase is the 
only known function of cyclic AMP in eukaryotic cells 
(Greengard, 1978). 
Numerous properties of skeletal muscle are affected 
by the motor neuron through synaptic transffiission and/or 
neurotrophic factors and some of these effects may be 
mediated by cyclic AMP. 
AMP may be involved in 
The evidence suggesting that cyclic 
neuromuscular communication centers 
around its role in pre- and post-synaptic events which 
occur in innervated tissue following nerve terminal 
depolarization (Greengard, 1978). One example involves 
synaptic transmission where neurotransmitters alter the endo-
genous cyclic AMP concentration of their target cells. Nor-
epinephrine, epinephrine, dopamine, histamine, serotonin, 
glutamate, aspartate and octopamine all were shown to alter 
cyclic AMP concentration of the cerebral cortex, cerebellum 
and striatum in several species, including rat, rabbit, 
monkey and man (Kebabian, 1977). 
It is thought that the membrane receptors for these 
neurotransmitters may be closely associated with the 
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regulatory subunit of adenylate cyclase - the membrane-bound 
enzyme which catalyzes the formation of cyclic AMP from 
adenosine triphosphate (Ross and Gilman, 1980). When the 
neurotransmitter or hormone binds with the regulatory subunit 
of the enzyme, the catalytic subunit (thought to be located 
on the inner surface of the cell membrane) is stimulated to 
form cyclic AMP which then mediates the intracellular effects 
of the extracellular effector (Ross and Gilman, 1980). 
cyclic AMP is hydrolyzed in the cell by cyclic nucleotide 
phosphodiesterase to 5'-AMP (Appleman et al., 1973). 
Interestingly, it has been reported that the activities of 
both adenylate cyclase and phosphodiesterase are increased in 
skeletal muscle denervated for 1 to 2 days (McLane and Held, 
1981). These results suggest that cyclic AMP metabolism in 
skeletal muscle is dependent upon a functional innervation. 
Also, the concentration of cyclic AMP in the target muscle 
cell is nerve stump length-dependent (Carlsen, 1975). 
The intracellular effects of hormones and catechol-
amine neurotransmitters upon skeletal muscle which are 
mediated by the activation of membrane-bound adenylc:te 
cyclase are initiated at the cell membrane by binding to 
beta-adrenergic receptors coupled to adenylate cyclase. In 
homogenized muscle tissue, changes in beta-adrenergic 
receptor functions have been inferred from reported changes 
in membrane-bound adenylate cyclase activity and by using 
highly specific radiolabeled receptor binding analogs of 
beta-adrenergic agonists such as 3H-dihydroalprenolol 
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(reviewed in Minneman et al., 1981; Chan-Palay et al., 1982). 
This radiolabeled receptor ligand has been used to obtain 
information regarding the neural regulation of beta-
adrenergic receptors on skeletal muscle. Banerjee et al. 
(1977) reported a marked increase in the specific binding of 
3H-dihydroalprenolol to muscle particulate fractions as early 
as lj days after denervation. However, Smith et al. (1978) 
reported that the population of beta-adrenergic receptors en 
skeletal muscle denervated for 5 days did not differ from 
unoperated control muscles. It has been proposed that neural 
factors ether than acetylcholine released by the motor neuron 
may participate in the regulation of beta-adrenergic receptor 
density at post-synaptic sites (Banerjee et al., 1977). The 
neural factor has not been determined, but catechclami~e 
synthesizing enzymes and peptides have been found at the 
neuromuscular junction (Chan-Palay et al., 1982; Adams and 
O'Shea, 1983). 
Other evidence suggesting that cyclic AMP is a 
mediator of some neurotrophic message is less direct and 
involves the ability of cyclic AMP to affect the morphology 
of the motor endplate and to stimulate and maintain cellular 
differentiation in embryonic skeletal muscle. Cyclic AMP 
has an effect similar to peripheral nerve extracts in 
maintaining the endplate acetylcholinesterase activity in 
denervated muscle (Lentz, 1972 and 1 972a). Also, its 
concentration in cultured embryonic chick muscle cells is 
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affected by a neurally-derived myotrophic protein and this 
myotrophic protein increases the acetylcholine receptor 
number of aneural embryonic chick skeletal muscle (Markelonis 
et al.,1982a; Oh and Markelonis, 1982). It was suggested 
from these studies that the myotrophic protein might induce 
acetylcholine receptor synthesis via regulation of muscle 
cyclic AMP concentration. This is an attractive hypothesis 
in view of the findings which indicate that cyclic AMP 
regulates acetylcholine receptor number directly (Blosser and 
Appel, 1980) and indirectly through beta-adrenergic receptor 
activation by isoproterenol (Blosser, 1983). When skeletal 
muscle treated with cyclic AMP is examined microscopically, 
the morphology of the endplate is maintained in a manner 
similar to muscle cells cultured in the presence of 
peripheral nerve extract (Lentz, 1 972a). Cyclic AMP, 
therefore, appears to have some influence on the structure 
and biochemical properties of the endplate. However, this may 
not be a specific effect since cyclic AMP generally 
stimulates the growth, differentiation and shape of the 
neural cell (Prasad et al., 1972; Prasad and Kumar, 1975; 
Oey, 1975). Cyclic AMP also mimics some of the neural 
influence on muscle by stimulating the efflux of sodium ions 
in muscle fibers (Bittar et al., 1976). 
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D. protein Phosphorylation in Skeletal Muscle 
1. Types of protein kinases 
The biochemical basis for the ability of mammalian 
skeletQl muscle protein kinases to alter the activity and 
regulatory function of key cellular proteins lies in the 
ability of these proteins to preserve some of the high energy 
of the nucleoside triphosphate bond within their structure 
when phosphate is covalently bound to a specific residue 
(i.e., usually serine or threonine). Protein kinases (EC 
2.7.1.37-ATP:protein phosphotransferases) are enzymes wt.ich 
catalyze the transfer of the terminal (gamma) phosphate of 
ATP to the hydroxyl containing amino acid (reviewed in 
Carlson et al., 1979). Initially, the classification of the 
various protein kinases from mammalian skeletal muscle was 
based upon the specificity of the kinase with respect to the 
protein substrate (Krebs et al., 1972; Krebs, 1983). 
However, the protein kinases activated by cyclic AMP have a 
broad substrate specificity and several of the substrates for 
cyclic AMP-dependent protein kinase are phosphorylated by 
other protein kinases not affected by cyclic AMP. Thus, the 
classical nomenclature becomes inoperable. Weller (1979) has 
organized a classification system for protein kinases based 
on both substrate specificity and the nucleotide de pendency 
or independency of the phosphotransferase reaction. Type a 1 
Protein kinases are defined as catalyzing the phosphorylation 
or histones and other proteins and are stimulated by cyclic 
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P Type a 2 kinases also catalyze the phosphorylation of AM • 
bistones, but are activated by cyclic GMP. Type b proteiL 
kinases catalyze the phosphorylation of phosvitin and are not 
affected by cyclic nucleotides. Type c kinases are generally 
considered to be nuclear kinases and phosphorylate histones, 
but are cyclic AMP-independent. 
a. type a 1 protein kinases 
The activation of cyclic AMP-dependent protein 
kinases occurs by a cyclic AMP-promoted dissociation of the 
holoenzyme to yield the catalytic species (C) and a complex 
consisting of regulatory subunit (R) and cyclic AMP as 
described earlier in this literature review (pg. 49). The 
concentration of cyclic AMP necessary to obtain half-maximal 
phosphotransferase activity (Ka) for pure preparations of 
holoenzyme was found to be in the range of 0.2 to 0.3 
mieromolar (Flockhart and Corbin, 1982). The maximum amount 
of cyclic AMP bound to skeletal muscle holoenzyme is 4 moles 
of cyclic AMP per mole of tetramer. 
The effect of MgATP on the holoenzyme is to 
increase the apparent dissociation constant for cyclic AMP by 
a factor of approximately 10-fold (Hofmann et al., 1975). As 
a result, the activation of holoenzyme can be modulated by 
the range of cyclic AMP and ATP concentrations found in the 
tissue. In skeletal muscle the ATP concentration is in the 
Dlillimolar range; therefore, the holoenzyme should contain 
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bound ATP under most conditions. The result of MgATP binding 
is to increase the Kd for cyclic AMP to coincide with the 
physiological concentrations of that effector. It has been 
suggested that any agent capable of altering ATP bir.ding 
would offer an additional regulatory feature to the enzyme 
(Flockhart and Corbin, 1979). 
The concentration of cyclic AMP in skeletal muscle 
isapproximately equivalent to the Ka (0.2 to 0.3 micromolar) 
of the holoenzyme for cyclic AMP (Beavo et al., 1974). As a 
result, a number of investigators have speculated that much 
ofthe cyclic AMP in the cell must be compartmentalized for 
otherwise protein kinase would always be completely activated 
by the basal level of cyclic AMP in the muscle cell (Walsh et 
al., 1972). However, another intracellular regulator known 
to affect the activity of cyclic AMP-dependent protein kinase 
is the heat-stable protein kinase inhibitor first described 
by Ashby and Walsh (1972). The inhibitor binds tightly to 
the free catalytic subunit, but not to the regulatory-
catalytic subunit complex (Ashby and Walsh, 1972). These 
authors speculated that enough of this protein is present in 
most tissues to inhibit about 20% of the total protein kinase 
activity present in the tissue. As such, the inhibitor could 
indirectly alter the amount of cyclic AMP needed to allow 
expression of protein kinase activity. Kinetic studies have 




et al., 1978; 
to ATP and protein substrates 
Ashby and Walsh, 1972). However, 
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rurther studies based upon analyses of tightly bound 
substrates suggested that it is a competitive inhibitor with 
K. of 2 x 10-9M (Demaille et al., 1978). a ~ 
b. type a 2 protein kinases 
Guanosine 3':5'-monophosphate-dependent protein 
kinase has been identified in various tissues of many species 
(reviewed in Glass and Krebs, 1980). However, the concentra-
tion of this enzyme is reportedly highest in mammalian brain 
(Aswad and Greengard, 1981) and lowest in mammalian skeletal 
muscle (Lincoln and Corbin, 1977). In analogy with the 
observations that cyclic AMP effects are mediated through 
cyclic AMP-dependent protein kinase, Kuo and Greengard (1970) 
have proposed that a specific cyclic GMP-dependent protein 
kinase mediates the biological effects of cyclic GMP. Cyclic 
GMP-dependent protein kinase resembles the cyclic AMP-depen-
dent protein kinase in exhibiting high specificity and 
affinity for the cyclic nucleotide and in the ability of the 
enzyme to catalyze the transfer of ATP to protein, usually to 
serine residues (Glass and Krebs, 1980). Studies of the 
subunit structure of the holoenzyme have been carried out 
with the enzyme isolated from bovine lung and have shown that 
the enzyme is composed of two identical 75,000-dalton 
subunits (Gillet al., 1977). Unlike the cyclic AMP-depen-
dent Protein kinase, the subunits of the cyclic GMP-dependent 
Protein kinase do not dissociate upon activation by cyclic 
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aHP (Gill et al., 1977). However, the cyclic GMP- and cyclic 
AMP-dependent protein kinases are similar with respect to 
substrate specificity, in particular histone, and both 
enzymes show a 70% similarity in amino acid composition. 
some authors have suggested that these kinases evolved from a 
common ancestral protein (Gill, 1978; Lincoln and Corbin, 
1 97 7) . 
Cyclic GMP-dependent protein kinases are not 
affected by the heat-stable inhibitor which acts on the free 
catalytic subunit of the cyclic AMP-dependent protein kinase. 
However, crude preparations of the inhibitor protein were 
found to stimulate cyclic GMP-dependent protein kinase 
activity, but this was later found to be due to a modulator 
protein which co-purified with the inhibitor (Kuo et al., 
1 97 6). This modulator does not affect cyclic AMP-dependent 
yrotein kinase activity. It has also been shown that cyclic 
GMP-de pendent protein kinase can under go an au to phos po ry 1 a-
t ion reaction of unknown function (Foster et al., 1981; Takio 
et al., 1983). 
c. cyclic nucleotide-independent protein kinases 
The function and regulation of the cyclic 
nucleotide-independent protein kinases in skeletal muscle has 
not received as much attention as the cyclic nucleotide-
dependent protein kinases and, therefore, much less is known 
about these enzymes. Cyclic nucleotide-independent protein 
kinases which are activated by ca2+ and calmodulin (Cheung, 
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1980) and ca2+ and phospholipid (Katoh et al., 1983) have 
been isolated from skeletal muscle and characterized. 
various studies have established that these kinases play 
important roles in the regulation of muscle contraction 
through the phosphorylative modification of myofibrillar 
proteins (Adelsteir. et al., 1981; Walsh and Guilleux, 1981; 
Marston, 1982; Katoh et al., 1983). In contrast, the physio-
logical significance of the cyclic nucleotide- and ca2+_ 
independent protein kinases is unknown. This class of 
protei~ kinase, initially isolated as casein kinase, have 
been shown to phosphorylate glycogen synthetase (DePaoli et 
al., 1981), protein synthesis initiation factors (Hathaway et 
al. 1979), non-histone nuclear chromatin proteins (Christman 
an Dahmus, 1981) and troponin T (Villar-Palasi and Kumon, 
1981). Although many of these phosphorylations were reported 
in tissues other than skeletal muscle, it is interesting that 
a protein kinase from rabbit skeletal muscle which functions 
independent of ca2+ and cyclic nucleotides was found to 
phosphorylate glycogen synthetase, phosphorylase kinase, 
troponin, myosin light chain and myosin light chain kinase 
(Singh et al., 1982). 
2 . P h y s i o 1 o g i c a 1 f u n c t i o ns o f p r o t e i n k i n a s e s 
The role of cyclic AMP-dependent protein 
Phosphorylation as an important mechanism involved ir. the 
regulation of various cellular processes was first discovered 
6 1 
in skeletal muscle by studies of the neural and hormonal 
regulation of glycogen metabolism (reviewed in Krebs et al., 
1 972; Krebs and Beavo, 1979; Cohen, 1980; Adelstein et al., 
1981; Cohen, 1983). Glycogen is a major source of energy for 
muscle contraction. Its breakdown and synthesis (glycogen 
metabolism) and utilization in the form of glucose 
(glycolysis) are regulated by neural influences related tc 
muscle contraction and by hormones through changes ir. the 
phosphorylation of muscle proteins. This regulatory scheme 
is now known to involve several protein kinases, protein 
phosphatases and specific cytosolic and particulate muscle 
proteins. Some of these proteins are phosphorylated in 
response to the second messengers ca2+ and cyclic AMP. Phos-
phorylation reactions in skeletal muscle may also be 
important for the regulation of the impulse-dependent 
contractile process. Calcium ions released from the sarco-
plasmic reticulum in response to a nerve stimulus activate 
the interaction between the thick myosin filaments and the 
thin filaments of actin. The interaction between these two 
major contractile proteins, actin and myosin (and other 
Proteins such as tropomyosin and troponin) contribute to the 
regulation of muscle contraction. This may occur through the 
Phosphorylative modification of these proteins (Adelstein et 
al., 1981). 
These systems (glycogen metabolism, glycolysis and 
muscle contraction) and associated enzymes and substrates 
Provide a detailed examination of the phosphorylation-
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dephosphorylation process in skeletal muscle. A review of 
these processes during the course of my research was 
pertinent toward characterization of the denervation per·iod 
and nerve stump length-dependent phosphorylation reaction 
(specific aim 2) and identification of the substrate(s) for 
this neurally-regulated reaction (specific aim 3). 
a. protein phosphorylation and the regulation of muscle 
glycogen metabolism 
Although an important aspect of the regulation of 
glycogen metabolism in skeletal muscle involves the 
interaction of metabolites with key enzymes (i.e., allosteric 
or metabolic control), the major regulatory mechanism 
governing the rate of glycogenesis and glycogenolysis in this 
tissue is the metabolic interconversion of enzymes by phos-
phorylation and dephosphorylation. Studies of these pathways 
led to the initial identification of cyclic AMP (Rall et al., 
1957) and the cyclic AMP-dependent protein kinase (Walsh et 
al., 1968). When skeletal muscle is stimulated electro-
chemically by the transsynaptic diffusion of acetylcholine, 
calcium ions from the sarcoplasmic reticulum initiate muscle 
contraction and also activate phosphorylase kinase. As a 
result, glycogen phosphorylase undergoes phosphorylative 
modification and glycogenolysis is increased to provide ATP 
required to sustain muscle contraction. Phosphorylase 
k' lnase, in turn, phosphorylates glycogen synthetase. This 
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results in a decrease in activity of glycogen synthetase. 
Thus, the two opposing pathways are regulated. Glycogen 
synthetase is the rate-limiting enzyme in the biosynthetic 
pathway and exists 
phosphorylated or 
in a non-phosphorylated or "I" form and a 
"D" form (Friedman and Larner, 1963). 
Glycogen synthetase I, the glucose-6-phosphate independent 
form of the enzyme, is considered to be more active physio-
logically than the glucose-6-phosphate dependent or "D" form 
which is strongly inhibited by metabolites. Recent evidence 
suggests that the conversion may be complex, potentially 
involving multiple phosphorylation sites on the 85,000-dalton 
glycogen synthetase subunit and several distinct protein 
kinases (reviewed in Scderling, 1979). For example, both 
cyclic AMP-dependent protein kinase and phosphorylase kinase 
can phosphorylate and inactivate glycogen synthetase (DePaoli-
Roach et al., 1979a). It has also been established that 
another general class of protein kinase, unaffected by cyclic 
AMP, can phosphorylate glycogen synthetase (DePaoli-Rcach et 
al., 1981). 
Phosphorylase ki~ase is the key to both the neural 
and hormonal mechanisms for stimulating glycogenolysis. This 
enzyme is dependent on ca+2 and can also be activated by 
cyclic AMP-dependent protein kinase. Phosphorylase kinase 
acts en glycogen phosphorylase b to catalyze a ca+2_dependent 
Phosphorylation of phosphorylase b to yield the active "a" 
form (reviewed in Krebs and Beavo, 1979). Skeletal muscle 
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phosphorylase kinase is currently believed to be a hexa-
decamer with four different types of subunits designated 
alpha, beta, gamma and delta (Shenolikar et al., 1979). The 
alpha and beta subunits each contain a unique amino acid 
sequence with a serine residue as phosphate acceptor (Yeaman 
et al., 1977). Phosphorylation of these sites is catalyzed 
by cyclic AMP-dependent protein kinase. The beta subunits 
are phosphosphorylated most readily and this action has been 
correlated with activation of the enzyme (Cohen, 1973). 
catalytic activity has been correlated with the beta and 
gamma subunit of the enzyme (Skuster et al., 1980). 
The relationship of calcium to phosphorylase kinase 
is complex. For example, the recently detected small 
molecular weight gamma subunit has been shown to be identical 
to calmodulin - a calcium binding protein first identified in 
brain (Shenolikar et al., 1979; Grand et al., 1981). 
Calmodulin has been shown to activate cyclic nucleotide 
phosphodiesterase (Teo and Wang, 1973), myosir. light chain 
kinase (Yagi et al., 1978) and ca+2-dependent adenosine 
triphosphatase(Gopinath and Vincenzi, 1977). Also, it is 
becoming increasingly evident that calmodulin is a primary 
intracellular calcium binding protein. The biochemistry of 
calmodulin has been recently reviewed (Cheung, 1980; Wolff 
and Brostrom, 1979; Klee et al., 1980; Means and Dedman, 
1980). A second role of calcium in the regulation of 
Phosphorylase kinase has recently been determined. This 
regulatory role is also due to the calcium/calmodulin 
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complex. In this case, cc.lmodulin is not acting as the gamma 
subunit, but in a looser association with phosphorylase 
kinase. This exogenous calmodulin has been shown to activate 
phosphorylase kinase to a greater extent than that observed 
with calcium alone (DePaoli-Roach et al., 1979a). Apparently, 
phosphorylase kinase possesses two types of calmodulin 
binding sites. Picton et al. (1980) have presented evidence 
through the use of a cross-linking reagent that an associa-
tion exists between the gamma and delta subunits and between 
exogenous calmodulin and both alpha and beta subunits. 
Finally, a calcium-dependent protease can irreversibly 
activate phosphorylase kinase by cleavage of a peptide from 
the protein (Huston and Krebs, 1968). 
It has also been recently demonstrated that cyclic 
GMP-dependent protein kinase can phosphorylate the same two 
serir.e residues on phosphorylase kinase as cyclic AMP-
dependent protein kinase (Cohen, 1980). The physiological 
significance of the cyclic GMP-dependent phosphorylation is 
questionable, however, in that it occurs at a very slow rate 
and the concentration of cyclic GMP in skeletal muscle is 
very low (Lincoln and Corbin, 1977). 
Also, rabbit skeletal muscle phosphorylase kinase is 
activated through a cyclic nucleotide and calcium-independent 
Phosphorylation reaction (Singh et al., 1982). The protein 
kinase involved in this phosphorylation reaction was also 
found to phosphorylate troponin, myosin light chain and 
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rn y 0 s i n 1 i g h t c h a i n k i n a s e .i.n .Y.i..t..r.Q ( S i n g h e t a 1 . , 1 9 8 2 ) . 
These results suggest that this protein kinase may resemble 
the cyclic AMP-dependent protein kinase in that it appears to 
have multiple cellular functions. 
b. protein phosphorylation 
muscle glycolytic enzymes 
and the regulation of 
Although the cyclic AMP-mediated regulation of 
glycolysis in liver has been well documented (reviewed in 
Exton and Harper, 1975), a role for this nucleotide ir 
skeletal muscle glycolysis is not firmly established. 
Studies of the cyclic AMP-dependent phosphorylation of 
glycolytic enzymes in skeletal muscle have focused on two key 
regulatory enzymes ir. glycolysis - phosphofructokinase and 
pyruvate kinase. 
Phosphofructokinase is subject to a complex 
allosteric regulation by a number of metabolites (reviewed in 
Uyeda, 1979). It has been shown that skeletal muscle 
phosphofructokinase exists in a partially phosphorylated 
s t a t e ..1..n .Y...i.YQ ( H u s s e y e t a 1 . , 1 9 7 7 ; H o f e r a n d S o r e n s o n -
Ziganke, 1979) and consists of 4 phosphates per tetramer when 
the muscle is at rest and 8 phosphates per tetramer when the 
muscle is stimulated to contract (Hofer and Sorenson-Ziganke, 
1979). Furthermore, the ..1..n .Y..i..t..r.Q phosphorylation of the 
enzyme by the catalytic subunit of cyclic AMP-dependent 
Protein kinase has been demonstrated (Riquelme et al., 1978 
and 1982). It has been reported that the phosphorylation of 
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phosphofructokinase by the cyclic AHP-dependent protein 
kinase leads to inactivation of the enzyme (Schaftingen et 
al., 1981). Also, it is now known that the ~D X~XQ site of 
phosphorylation by the cyclic AMP-dependent protein kinase 
occurs on an 80,000-dalton subunit of skeletal muscle phos-
phofructokinase (Schaftingen et al., 1981). 
Other studies have attempted to demonstrate the 
cyclic AMP-dependent phosphoryl&.tion of skeletal muscle 
pyruvc;.te kinase. Pyruvate kinase is also involved in a key 
irreversible reaction in glycolysis by catalyzing the 
conversion of phosphoenolpyruvate to pyruvate. To date, 
however, no known phosphorylation of skeletal muscle pyruvate 
kinase has been demonstrated (Humble et al., 1975; Cohen et 
al., 1975; Berglund et al., 1977; Kirschenlohr and Hofer, 
1983). In fact, only phosphofructokinase has been 
demonstrated to be a physiologically important soluble 
phosphorylatable glycolytic enzyme in skeletal muscle 
(Kirschenlohr and Hofer, 1983). 
c. protein phosphorylation and the regulation of muscle 
contraction 
Among the myofibrillar proteins shown to be 
Phosphoryl&.ted are the light chains of skeletal muscle myosin 
(Perrie et al., 1973; Adelstein and Eisenberg, 1980; Stull, 
1980; Adelstein et al., 1981). The myosin light chains are 
Phosphorylated bya myosin light chain kinase dependent on 
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ca+2;calmodulin (reviewed in Stull, 1980; Adelstein and 
Eisenberg, 1980) and also by a protease-activated kinase I 
independent of ca+ 2 ;calmodulin (Tuazon et al., 1982). It is 
currently thought that phosphorylation of the smooth muscle 
myosin light chains may play a major role in regulating the 
actin-activated adenosine triphosphatase activity of myosir.. 
Phosphorylation apparently reverses the inhibition of the 
20,000-dalton light chain on the actin-activated adenosine 
triphosphatase activity (Seidel, 1980). The role of myosin 
light chain phosphorylation in skeletal muscle is currently 
unclear. Recent reports suggest that myosin light chain 
phosphorylation is correlated with a decrease in the myosin 
adenosine triphosphatase activity in the fast-twitch extensor 
digitorum longus muscle in~' but this was not observed in 
the slow-twitch soleus muscle (Crow and Kushmerik, 1982). 
Also, it was reported that myosin light chain phosphorylation 
in skeletal muscle was increased in ~ following stimula-
tion of the muscle with a low frequency electrical probe 
(Klug et al., 1982; Stull et al., 1983). Phosphorylation was 
increased in tetanized fast and slow-twitch muscle also 
(Barany et al., 1983). 
Another myofibrillar protein known to undergo 
enzymatic phosphorylation-dephosphorylation is troponin 
(Stull t 1 e a . , 1972). This protein is necessary for the 
Calcium sensitization of the actomyosin adenosine 
triphosphatase activity. Examination of the individual 
subunits of rat skeletal muscle troponin revealed that cyclic 
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AMP-dependent protein kinase phosphorylates the inhibitory 
subunit of troponin (troponin I) ~ vitro (Bailey and Villar-
palasi, 1971 ). However, troponin T (tropomyosin binding 
subunit) and troponin C (calcium binding subunit) did not 
undergo this cyclic AMP-dependent phosphorylative 
modification (Bailey and Villar-Palasi, 1971; Perry and Cole, 
1973). It was also shown that phosphorylase kinase could 
phosphorylate troponin I (Stull, 1972) as well as purified 
troponin T (Perry and Cole, 1973). Currently, an association 
between the phosphorylation of troponin T or I and changes in 
the contractile properties of skeletal muscle has not been 
demonstrated. 
Smooth muscle myosin light chain kinase can also 
serve as a substrate for the cyclic AMP-dependent protein 
kinase (reviewed in Adelstein et al., 1981). When the 
calmodulin-bound myosin light chain kinase is used as a 
substrate for cyclic AMP-dependent protein kinase, there is 
an inhibition of the phosphorylation of one of the two 
acceptor sites on the enzyme. Additionally, cyclic AMP-
dependent phosphorylation of the myosin light chain kinase 
leads to a marked decrease in the binding affinity of the 
enzYme for c a 1m o d u 1 in which, in turn, 1 e ads to a decrease in 
myosin light chain kinase activity (reviewed in Adelstein et 
al., 1981). The dynamic interactions between myosin light 
chain kinase, calmodulin and cyclic AMP-dependent protein 
kinase which lead to an alteration of myosin light chain 
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kinase activity have not been demonstrated for skeletal 
muscle. 
E. Protein Dephosphorylation in Skeletal Muscle 
The level of phosphorylation of any cellular protein 
is dependent on the balance of the activities of the protein 
kinases and protein phosphatases that act on it. It is 
becoming increasingly clear that protein phosphatases like 
protein kinases are the target of extracellular effectors of 
skeletal muscle function. Four distinct protein phosphatases 
which are termed protein phosphatase 1, 2A, 2B and 2C have 
been isolated and characterized from skeletal muscle 
(Ingebritsen and Cohen, 1983). These are capable of 
dephosphorylating the enzymes of glycogen metabolism (Cohen, 
1981). Protein phosphatase 1 specifically dephosphorylates 
the beta subunit of phosphorylase kinase and is inhibited by 
protein phosphatase inhibitors and 2. The type 2 
phosphatases preferentially dephosphorylate the alpha subunit 
and are net affected by the inhibitor proteins (Cohen, 
1981). The concentrations of phosphatases 2A and 2C are very 
low and only account for a small percentage of the phospha-
tase activity directed towards the enzymes of glycogen 
metabolism (Cohen, 1978). 
Protein phosphatase is probably the most important 
of the dephosphorylating enzymes in skeletal muscle since it 
is the major phosphatase for glycogen synthetase, glycogen 
Phosphorylase and the beta subunit of phosphorylase kinase 
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(Cohen et al., 1982; Cohen, 1983). Also, protein phosphatase 
is not only associated with glycogen (Ingebtitsen and 
Cohen, 1983), but also with microsomes. This suggests a role 
for protein phosphatase in cholesterol synthesis and 
protein synthesis (Ingebritsen and Cohen, 1983). In liver, 
this phosphatase dephosphorylates acetyl-CoA carboxylase, 
hydroxy-methylglutaryl-CoA (HMG-CoA) reductase and HMG-CoA 
reductase kinase (Ingebritsen et al., 1981). 
Protein phosphatases 2A and 2C have been isolated 
from muscle as myosin light chain phosphatases and may be 
involved in the regulation of muscle contraction (Ingebritsen 
and Cohen, 1983). However, protein phosphatase and 2B are 
also myosin light chain phosphatases ~D x~~rQ and are also 
the major phosphatases which dephosphorylate protein 
synthesis initiation factor eiF-2 (Ingebritsen and Cohen, 
1 9 83) . 
Protein phosphatase 2B is a calcium/calmodulin-
dependent protein phosphatase and is present at high 
concentrations in skeletal muscle and brain (Ingebritsen and 
Cohen, 1983). It appears to be identical to calcineurin - a 
major calcium binding protein in brain (Stewart et al., 
1982). Its immunohistochemical localization at postsynaptic 
densities and microtubules of postsynaptic dendrites has 
suggested a role for this enzyme in neurotransmitter action 
and microtubular function (Wallace et al., 1980). Although 
.it may be the primary alpha-phosphorylase kinase phosphatase 
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(Cohen et al., 1982), the function of phosphatase 2B in 
skeletal muscle is still unclear. 
F. Cyclic AMP-Dependent Protein Kinase Isozymes I and II 
1. Holoenzymes 
In mammalian systems there are two types of sol~ble 
cytosolic cyclic AMP-dependent protein kinases (I and II) 
which are distinguished by their elution from anion exchange 
resins (Beavo et al., 1975; Corbin et al., 1975; Corbin and 
Keely, 1977). Type I protein kinases are eluted with 
approximately 0.1 M NaCl, whereas type II kinases are eluted 
at higher NaCl concentrations of 0.15 to 0.2 M. In addition 
to electrostatic differences, the two types of cyclic AMP-
dependent protein kinases differ immunologically (Fleischer 
et al., 1976; Hofmann et al., 1977; Weber et al., 1981) and 
genetically (Costa et al., 1976a). Differences are also 
observed in the kinetics of their subunit (regulatory and 
catalytic) dissociation/reassociation in the presence of 
cyclic AMP (Hofmann et al., 1975; Rosen and Erlichman, 1975; 
Rangel-Aldao and Rosen, 1977). Additionally, the inactive 
holoenzyme of type I protein kinase has a high affinity 
(dissociation constant= 50 nanomolar) binding site for ATP 
Which serves as an important regulatory mechanism for tl:.is 
isozyme (Bechtel et al., 1975). Also, the regulatory and 
catalytic subunits of the two protein kinase isozymes frcm 
several diverse species can form heterologous holoenzymes 
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which indicates that these proteins contain highly conserved 
structures. 
2. Catalytic subunits 
The C subunits of types I and II cyclic AMP-
dependent protein kinase appear to be identical proteins 
(reviewed in Flockhart and Corbin, 1982). Both proteins have 
a relative molecular weight on SDS polyacrylaiLide gels 
between 37,000 and li1 ,000 (Hofmann et al., 1975; Taylor and 
Stafford, 1978). The isoelectric profiles of the type I 
catalytic subunit indicates that this protein has two 
isoelectric points of 7.l! and 8.5 which are similar to those 
reported for the type II enzyme (Bechtel et al., 1977; Peters 
et al., 1977). These authors also showed that the two 
proteins have similar amino acid compositions and contair. a 
high proportion of serine and glycine residues. The complete 
amino acid sequence of the 3li9-residue catalytic subunit of 
bovine cardiac muscle is known and the molecular weight of 
the protein predicted from the amino acid sequence is 40,580 
(Shoji et al., 1981). The type I subunit has been shown to 
undergo an autophosphorylation reaction when incubated with 
32P-ATP .i.n .Y .. Lt...LQ (Chiu and Tao, 9 7 8) . This 
autophosphorylation reaction has not been demonstrated for 
the type II enzyme, but phosphate bound to serine and 
threonine residues has been found in the purified protein 
(Shoji et al., 1979; Shoji et al., 1981). Schwoch et al. 
(1980) has determined that the catalytic subunits from types 
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r and II protein kinases are immunologically 
indistinguishable. Also, the catalytic subunits have a 
similar Km for ATP (approximately 2 millimolar) and 
phosphorylate the same protein substrates in ~~~£Q with 
similar reaction rates (reviewed in Flockhart and Corbin, 
1982). They also have a similar ability to interact with 
either type I or type II regulatory subunits (reviewed in 
Flockhart and Corbin, 1982). 
3. Regulatory subunits 
The differences in the proteir. kinase isozymes 
appear to be due to differences in the regulatory subunits 
only (Hofmann et al., 1975). The regulatory subunit of the 
type I kinase (RI) has an estimated molecular weight of 
47,000 to 49,000 as determined by SDS gel electrophoresis 
(Hofmann et al., 1975; Zoller et al., 1979). In contrast, 
the cyclic AMP-binding subunit of the type II cyclic AMP-
dependent protein kinase (RII) has a molecular weight of 
55,000 to 56,000 estimated by SDS polyacrylamide gel 
electrophoresis (Zoller et al., 1979) and exists as a dimer 
of two 56,000-dalton proteins (Erlichman et al., 1973; Corbin 
et al., 1978). 
The RI protein can be phosphorylated by C in an 
intermolecular reaction (Huang et al., 1983). RII not only 
differs significantly from RI in its primary structure, but 
also in its ability to undergo an autophosphorylation 
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catalyzed in an intramolecular reaction by C (Erlichman et 
al., 1974; Hofmann et al., 1975; Rangel-Aldao and Rosen, 
1977; Geahlen et al., 1982; Erlichman et al., 1983). The 
phosphorylation was determined to be an intramolecular 
reaction because the rate of the reaction was not affected by 
either serial dilution of the enzyme or by the presence of an 
inhibitor of the free cyclic AMP-dependent protein kinase 
catalytic subunit (Erlichman et al., 1983). 
RI can also be phosphorylated by cyclic aMP-
dependent protein kinase ~~ x~~IQ and~ x~XQ (Geahlen and 
Krebs, 1980; Geahlen et al., 1982). The physiological 
significance of RI phosphorylation by cyclic GMP-dependent 
protein kinase in tissues like skeletal muscle which have low 
cyclic GMP concentrations is questionable (Lincoln and 
Corbin, 1977). Also, the reaction proceeds at a veryslow 
rate (Geahlen et al., 1982). 
The cyclic AMP-binding sites on the regulatory 
subunits of types I and II cyclic AMP-dependent protein 
kinase have been shown to differ considerably with respect to 
cyclic nucleotide analog specificity (Yagura et al., 1980). 
A 1 s o , t h e e f f e c t o f ~1 g A T P o n t h e d i s s o c i a t i o n o f c y c 1 i c A M P 
from the regulatory subunits differs in the two isozymes 
(Hoppe et al., 1977). The RI protein is known to have a high 
affinity binding site for MgATP which is not found on the RII 
Protein. The effects of analogs on cyclic AMP dissociation 
from the regulatory subunits also indicates that these two 
Proteins have different cyclic AMP binding sites. Using 
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intrinsic tryptophan fluorescence and a fluorescent analog of 
cyclic AMP, it was experimentally determined that the RI 
subunits appear to have only one class of cyclic AMP-binding 
site (LaPorte et al., 1980; Smith et al., 1981) because each 
0 f t h e t w o R I s u b u n i t s b i n d 2 m o 1 e c u 1 e s o f c y c 1 i c A fvl P w i t h 
positive homotropic cooperativity (Sn:.ith et al., 1981). Two 
cyclic AMP-binding sites on RII (A and B) have been 
described. It has been reported that cyclic AMP will bind to 
5 i t e A a t a f a s t e r r a t e t h a n i t w i 11 b i n d t o s i t e B l..n .Y.i...t..r:Q 
under reaction conditions of 37°, pH 7.0 and 0.15 M KCl 
(Ogreid and Doskeland, 1981). These authors have also 
suggested that only site B can react with cyclic AMP ~ ~. 
Binding of cyclic AMP to site B presumably alters the 
conformation of RII allowing the more rapid binding of cyclic 
AHP to site A under physiological conditions. This 
cooperativity of cyclic AMP binding to RII has also been 
recently described by Robinson-Steiner et al. (1983). These 
authors also reported that binding of cyclic AMP to both 
sites is necessary for dissociation of the Rand C subunits 
and, therefore, enzyme activation. Additionally, the 
conformational change in the RII protein first suggested by 
Ogreid and Doskeland (1981a) is now known to occur via an 
intersubunit crosslinking reaction which is a consequence of 
the binding of cyclic AMP to RII at site B (Huang, 1982). 
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4. Physiological roles 
It is currently thought that the structural and 
functional differences in the cyclic AMP-dependent protein 
kinases may be related to subcellular localization of the 
isozymes and, in turn, to specification of their physio-
logical functions. It is known that the two isozymes differ 
in their tissue distribution and vary in their relative 
amounts during development (Corbin et al., 1975; Lee et al., 
1976). Type I kinase accounts for about 70% of the total 
soluble cyclic AMP-dependent protein kinase activity of 
skeletal muscle and type II accounts for the remaining 30% 
(Corbin et al., 1975). 
Although very little is currently known about the 
biological differences of these two isozymes, they apparently 
have differing effects on the regulation of normal cellular 
processes such as cell proliferation (Fleischer et al., 
1976), differentiation (Lee et al., 1976; Russell, 1976; 
Haddox et al., 1979; Boynton et al., 1981; McClung and 
Kletzian, 1981 Kwost-Welfeld and Kaniuga, 1981), hormonal 
and mitogenic cellular stimulation (Harper et al., 1981; 
Koide et al., 1981; Mednieks and Jungmann, 1982) as well as 
abnormal processes such as tumor cell growth (Majumder, 
1977; Walter et al., 1979; Evans et al., 1982; Mednieks et 
al., 1982; Cho-Chung, 1979). 
Additionally, the RII subunit, unlike the RI 
Protein, can be separated into a subclass that appears to be 
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neural tissue specific and another subclass of non-neural 
origin (Erlichman et al., 1980). The subclassification of 
these proteins was based on immunochemical analysis where the 
type II protein derived from neural tissues bound anti-RII 
antibodies raised against neural RII more tightly than RII 
proteins from non-neural tissues. A comprehensive analysis 
of the RII protein from a variety of tissues using type-
specific antibody has demonstrated the presence of cyclic 
AMP-binding proteins of 52,000 and 50,000-daltons (Weber et 
al., 1981). These cyclic AHP-binding proteins have been 
found in kidney, HeLa cells, lymphocytes (Weber et al., 1981) 
and adrenal chromaffin secretory granule cells (Treiman et 
al., 1983). Although these proteins have been referred to as 
RII variants (Weber et al., 1981), there is some evidence 
that they may represent proteolytic 





authors also found the 52,000-dalton RII protein in heart 
muscle which also had an identical tryptic peptide mapping 
pattern as the 56,000-dalton RII protein. 
protein have not been demonstrated. 
Variants of the RI 
It is generally believed that several normal and 
abnormal cellular functions are regulated by extracellular 
effectors which are capable of dissociating soluble cyclic 
AMP-dependent protein kinase by increasing cyclic AMP levels. 
This is followed by an alteration in nuclear protein 
Phosphorylation as a result of a cyclic AMP-mediated 
translocation of regulatory and catalytic subunits of 
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cytoplasmic protein kinase to the nucleus (reviewed in 
Jungmann et al., 1975; Jungmann and Russell, 1977; Jungmann 
and Kranias, 1977; Rosenfeld and Barrieux, 1979; Sharma, 
1 9 82). This series of events provides a molecular mechanism 
ror the transfer of regulatory information from the cell 
membrane to the nucleus via cyclic AMP-dependent protein 
kinase. In support of this hypothesis, several reports have 
appeared showing the regulatory role of cyclic AMP and 
translocated cyclic AMP-dependent protein kinase in the 
structural and functional modification of eukaryctic 
chromatin via phosphorylation of chromatin-associated histone 
and non-histone proteir.s (Costa et al., 1976; Spielvogel et 
al., 1977; Chuang et al., 1977; Cho-Chung et al., 1979; 
Murdoch et al., 1982). Also, cyclic AMP regulates the 
induction of specific mRNA's (Bachrach, 1978; Derda et al., 
1980; Kumar et al., 1980; Miles et al., 1981; Murdoch et al., 
1982; Cimbala et al., 1982). These changes in eukaryotic 
gene activity have been functionally linked with the 
selective phosphorylative modification of nuclear proteins by 
translocated cyclic AMP-dependent proteir. kinase isozymes 
(Harrison et al., 1980; Murdoch et al., 1982; Harrison et 
al., 1983). 
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Jl. MATERIALS AND METHODS 
A. Description and Care of Animals 
Male albino Sprague-Dawley rats (approximately 90 
days of age) were obtained from King Animal Laboratories 
(Oregon, WI) and housed in groups of 3 to 5 in the Animal 
care Facility of both Hines Veterans Administration 
Hospital, Hines, IL and Loyola University Stritch School of 
Medicine, Maywood, IL. The animals were maintained on a 12 
hr light/dark cycle at ambient temperature and received food 
and water ~g ~~~~~Mm. The average age of the animals used 
during this research project was 118 days with a range of 84 
to 195 days. 
B. Denervation Surgery 
The various ani~al groups (usually 3 rats per group) 
used during this research project are described in Table 2. 
For all experimental groups an initial incision of 20 em was 
made through the skin of the left hindlimb approximately at 
midthigh. Following this surgical procedure, the 20 em cut 
was also performed on the right hindlimb at midthigh in order 
to carry out the sham-operation as described below. All 
surgical procedures were carried out while the animal was 
under light ether anesthesia. 
In group one the soleus muscle in the left hindlin:b 
was denervated by surgically removing a 2 mm segment of the 
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Table 2 














left sciatic nerve 
cut proximally 
(32-35 mm) 
same as 1 + 
intermediate cut 
( 17-20 mm) 
same as 1 + 
low cut (2 mm) 
no surgery 
same as 3 
right soleus 
right sciatic nerve 
sham-operation 
right sciatic nerve 
sham-operation 
right sciatic nerve 
sham-operation 
no surgery 









*Solei of the rat hindlimb (3 muscles pooled/ group) were 
treated as described in the Table and in detail in Method B. 
** Animals were sacrificed at 1, 3, 6, 12, 18, 24, 36, 48 
and 72 hr after the surgical procedures described. 
***Animals were sacrificed at 3, 12, 24, 30, 36, 42, 48, 
54, 60, 66 and 72 hr after the surgical procedures described. 
****Animals were sacrificed at 3, 12, 24, 36, 42, 48, 54, 
60, 66, 72 and 78 hr after the surgical procedures described. 
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left sciatic nerve at midthigh level to leave a distal, long 
nerve stump of 32 to 35 mm (Figure 1A). In the second group 
of animals the left soleus was denervated by cutting the left 
tibial branch of the sciatic nerve at the level of the popli-
teal fossa to leave a distal, intermediate nerve stump of 17 
to 20 mm (Figure 1E). In the third group of animals a lower 
skin incision of 10 em was also carefully made with a scalpel 
to prevent excessive bleeding. The denervation surgery was 
then carried out by cutting the left soleus branch of the 
tibial nerve to leave a distal, short nerve stump of 2 mm 
attached to the muscle (Figure 1C). When the nerve was cut 
distally at either the intermediate (17 to 20 mm nerve stump) 
or low (2 mm nerve stump) location, first the proximal cut 
was also made. A "double denervation" protocol was carried 
out on a separate group of animals (group 5). That is, the 
left soleus was denervated by cutting the left sciatic nerve 
at both the proximal (32 to 35 mm) and distal (2 mm) loca-
tions. Then the right, contralateral soleus muscle was also 
denervated by cutting the right sciatic nerve at the proximal 
location only. 
In groups 1, 2, and 3 the right soleus served as the 
control muscle in that a sham-operation was performed on this 
muscle. First a 20 em incision was made through the skir, at 
the mid thigh regia n. 
by gently pulling on 
Then the sham-operation was performed 
the sciatic nerve at a distance of 
approximately 32 to 35 mm from its point of insertion into 
the muscle. This protocol allowed for a similar surgical 
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common ~----/--tibial n. 
peroneal n. aeep 
super f i cia I I ~--r=::,..__._,.~,*""~~..w-- per one a I n. 
peronea n. soleus n. 
extensor 
digitorum longus gastroc. lat. 
soleus gastroc. med. 
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trauma to the sciatic nerve on both the left (denervated) and 
right (sham-operated) side at an equal distance from inser-
tion into the muscle. In animal group 3, a lower skin inci-
sion was also made on the right side of the animal. 
Additionally, unoperated solei (group 4) were obtained from 
either the left or right hindlimb. 
All surgical preparations for animal groups 
through 5 were carried out at 2:00 AM, 5:00 AM, 7:00 AM, 8:00 
AM, 2:00 PM or 8:00 PM. Animals were consistently sacrificed 
between 8 and 9 AM. Animals were sacrificed by decapitation 
at 0 (unoperated), 1, 3, 6, and 6 hr intervals thereafter to 
78 hr following the surgical procedures. Animals recovered 
from the surgical procedures and anesthesia within 2 to 5 min 
as monitored by their increased activity and alertness. 
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preparation of Soluble Cytosolic Protein Fraction from c. 
Rat Soleus Muscle 
Within 2 to 3 min following sacrifice of the animals 
by decapitation, the denervated and sham-operated solei were 
removed and placed in ice-cold homogenizing media consisting 
of 0.32 M sucrose (ribonuclease-free from Schwarz/Mann Co., 
orangeburg, NY) and 3 mM MgC1 2 (Fisher Chemical Co., Fair 
Lawn, NJ), pH 6.5. Tendons were carefully removed with a 
scalpel while the muscles were en a chilled cutting surface 
(parafilm covered glass on ice) in a cold room. Muscles were 
then blot-dried with a disposable wiper (Kimwipes, Kimberly-
Clark Corp., Neenah, WI), weighed on a top-loading Mettler 
balance (Mettler Instrument Corp., Highstown, NJ) and minced 
with scissors while in a cold room. Homogenization of three 
muscles (denervated or sham-operated solei pooled fro~ 3 
rats) was performed at one time with a Virtis blade-type 
homogenizer (Virtis Co., Inc., Gardiner, NY) in sufficient 
homogenizing media to give a final muscle concentration of 
2.5% (w/v). The Virtis homogenizer was set at 50 and homo-
genization was carried out for 5 consecutive 30 second inter-
Vals. Vacuum filtration of the homogenate was done 
consecutively through 50-, 100-, and 150-mesh stainless steel 
screens. The filtered homogenate was centrifuged first at 
Boo x g and 4oc for 20 min in an International centrifuge 
(International Instrument Corp., Needham Heights, MA). The 
supernatant was recovered by pouring off the aqueous layer. 
, 
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Five milliliters of the supernatant was then ultracentrifuged 
(Beckman L2-65, Beckman Spinco, Palo Alto, CA) at 105,000 x g 
and 4oc for 45 min. The high speed supernatant fraction 
obtained after the ultracentrifugation step is referred to as 
the soluble cytosolic protein fraction. Only freshly 
prepared soluble cytosolic protein fractions were used in the 
protein phosphotransferase assays described in Method E. The 
protein content of these fractions was quantitated by the 
method of Lowry et al. (1951) as described below. 
D. Protein Determination 
The two distinct steps which lead to the color 
development in the Lowry method (1951) for the quantitation 
of protein are as follows: (1) a reaction of protei~ with 
copper in alkali; and (2) a reduction of the phosphomolybdic-
phosphotungstic acid reagent by the copper treated proteir •. 
One milliliter of reagent "C" (described below) was placed in 
each of a series of 12 x 75 mm glass tubes. Two hundred 
microliters of the high speed supernatant fraction (soluble 
cytosolic protein fraction) from denervated and sham-operated 
solei (60 to 180 ug protein diluted 15 times) was added to 
appropriately marked tubes and 200 ul of glass-distilled 
water was added to a pair of tubes which served as "blank". 
The contents of the tubes were mixed and allowed to 
stand for ten min. One hundred microliters of N Falin-
Ciocalteu reagent (Fisher Scientific Co., Fair Lawn, NJ) was 
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added to each tube and the tubes were mixed thoroughly with a 
vortex mixer immediately after addition of reagent. The 
reaction mixtures were allowed to stand at least 30 min but 
no longer than 1 hr to allow for full color development. The 
absorbance of the sample solutions was determined with a 
Gilford model 250 spectrophotometer (Gilford Instrument Co., 
Oberlin, OH) at a wavelength of 750 nanometers (nm). The 
instrument was zeroed against glass-distilled water. A 
standard curve was prepared using bovine serum albumin as a 
reference protein each time this procedure was used for 
protein determinations. The concentration of the unknown 
soluble cytosolic protein sample was derived from the slope 
of the linear regression line for the standard curve (4 to 25 
ug of protein). All calculations (linear regression analysis 
and protein concentrations) were carried out with a computer 
program and a Hewlett-Packard model 9830A computer. 
s 0 1 u t i 0 n.§. 
1. Reagent .A. 
20 g of Na 2 co 3 , 4 g NaOH and 200 mg of 
KNa c4 H4 o6 (4H 2 0) (all from Fisher Chemical Co.) were 
dissolved in one liter of glass-distilled water. 
2. Reagent _a 
5 g of CuS04 (5H 2 o) (Fisher Chemical Co.) were dissolved 
in one liter of water. 
3. Reagent ..Q 
Fifty parts of Reagent A and one part Reagent B were 
combined and used within hr. 
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E. ~ Yitro Cytosolic Protein Phosphorylation Assay 
The final concentration of the components 
constituting the phosphorylation incubation medium in a total 
volume of 0.25 ml were as follows: 0.1 M NaCl, 2 mM MgC1 2 , 50 
mM Tris-HCl, pH 7.5, and 6.7 x 10-9M [gamma-3 2 pJ ATP (3000 
Ci/mmol) obtained from Amersham Corp., Des Plaines, IL. The 
phosphotransferase reaction was started by the addition of an 
aliquot of a freshly prepared fraction of cytosolic protein 
(15 to 90 ug) which served as the source for endogenous 
protein kinases and phosphorylatable substrates. In some 
experiments the final concentrations of additional components 
were as follows: 1o-11 to 1o-9M and uM adenosine 3':5' 
cyclic monophosphate (cyclic AMP), 1 uM guanosine 3':5' eye 
lie monophosphate (cyclic GMP), 2.0 x 10-5 to 10-3 M CaC1 2 , 
mM znc1 2 , 65 mM (ethylenedinitrilo)tetra-acetic acid (EDTA), 
1 mM ethyleneglycol-bis-(beta-aminoethyl ether)N,N'-tetra-
acetic acid (EGTA) or 50 inhibitory units of cyclic AMP-
dependent protein kinase inhibitor from bovine heart muscle 
(Sigma Chemical Co., St. Louis, MO) which was further 
purified prior to use in some experiments essentially 
according to Kantor and Brunton (1981) as described below 
(refer to Method F). After incubation of the phosphotrans-
ferase medium for 5 min, the assay tubes (12 x 75 mm) were 
transferred to ice and the reaction was terminated first by 
the addition of 25 ul of 5 mM adenosine 5' triphosphate (ATP) 
and then 100 ul of 5 % sodium pyrophosphate (NaPPi). 
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Aliquots of 50 ul from the reaction mixture were transferred 
in duplicate to Millipore filters (type PH from Millipore 
corp., Bedford, 
5 mf-'i ATP for 
MA) which were pre-treated by placing them in 
hr prior to use. The radioactive Millipore 
filters were subsequently treated overnight by washing them 
with constant stirring in 5 % trichloroacetic acid (TCA) and 
1.5% NaPPi in a cold room. The TeA-precipitable, 32P-radio-
activity on each filter was quantitated with a Packard model 
3380 liquid scintillation spectrometer in a 7.5 ml toluene 
solution containing Permafluor I (Packard Instrument Co., 
Downers Grove, IL). Data obtained from liquid scintillation 
counting were converted from counts per minute to soluble 
cytosolic protein phosphorylation with the use of a computer 
program (Method 0). Soluble cytosolic protein phosphoryla-
tion for denervated and contralateral, sham-operated solei 
were reported as femtomoles 32P-phosphate incorporated per 
milligram of soluble cytosolic protein per 5 min incubation 
period. 
F. Partial Purification of Cyclic AMP-Dependent Protein 
linase Inhibitor 
One hundred milligrams of crude inhibitor (lyophi-
lized powder from bovine heart, Sigma Chemical Co., St. 
Louis, MO) were dissolved in a minimal volume (usually 10 ml) 
or 5 mM sodium acetate and 1 mM EDTA, pH 5.3. This solu-
tion of inhibitor was passed over a diethylaminoethyl (DEAE)-
Sephadex (Pharmacia Fine Chemicals, Piscataway, NJ) anion 
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exchange column (0.9 x 9.0 em) which was previously equili-
brated with the 5 ruM sodium acetate buffer, pH 5.3, described 
above. Protein was eluted from the column with a linear 
gradient of 5 to 300 mM sodium acetate and absorbance of the 
effluent was monitored at 280 nm with a Uvicord II model 8300 
(LKB Instruments, Stockholm, Sweden). Consecutive fractions 
of 4.0 ml were collected immediately after the gradient was 
started and the relative conductance of each fraction was 
recorded immediately after collection with an Industrial 
Instruments conductivity meter (Cedar Grove, NJ) in order to 
avoid errors in measurement due to carbon dioxide contamina-
tion. The protein kinase inhibitor activity (refer to defini-
tion below) of each fraction was assayed ~~ x~~£Q in the 
buffered phosphorylation incubation medium described above 
(Method E) with the addition of 200 ul of each DEAE fraction 
and also 0.25 mg of hydrolyzed and partially dephosphorylated 
casein (Sigma Chemic&.l Co., St. Louis, MO) and 1 ul-1 cyclic 
AMP. The reaction was started by the addition of 12 units 
(refer to definition below) of cyclic HlP-dependent protein 
kinase type II isozyme (Sigma Chemical Co.) and was allowed 
to proceed for 5 min before the assay tubes were transferred 
to ice. At this time the reaction was terminated with ATP 
and NaPPi as described in Method E. Aliquots of 50 ul were 
transferred in duplicate to ATP-treated Millipore filters. 
The filters were treated overnight by washing them with 
constant stirring in 5 % TCA and 1.5 % NaPPi and the TCA-
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precipitable, 32P-radioactivity was quantitated by liquic 
scintillation spectrometry. The DEAE fractions corresponding 
to inhibitor activity were pooled, lyophilized and then 
resuspended in a minimal volume of 5 mM sodium acetate and 1 
mM EDTA, pH 5.3. The chromatograph indicating relative 
protein absorbance, relative conductance and inhibitor 
activity is shown in Figure ~7 of the Appendix. 
J2_efinitions 
1 . !l1!ll .Qf_ I n hi b i t o r Mli..Y..il..Y 
The amount of cyclic AMP-dependent protein kinase 
inhibitor needed to inhibit one unit of cyclic AMP-dependent 
protein kinase phosphorylating activity. 
2.!ll!ll Qf CycliQ AMP-Dependent Protein Kinase Phosphoryl-
ating Activity 
At 37°C and pH 7.5, one unit will transfer 1.0 picomole: 
of phosphate from [gamma-32p]ATP to hydrolyzed and partially 
dephosphorylated casein per min. 
G. Adenosine Triphosphatase (ATPase) Assay 
Soluble cytosolic protein was prepared from rat 
solei and assayed for ATPase activity using the incubation 
medium described previously in Method E. The ATPase assay, 
Which monitored the conversion of [gamma-32p]ATP to 3 2 P-
inorganic phosphate, was started by the addition of aliquots 
or soluble cytosolic protein (between 20 and 130 ug) and 
incubated for 1, 2, 5, 10 or 20 min. The reaction was 
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terminated with 25 ul of 5 mM ATP and 100 ul of 5% NaPPi. 
Five microliters of the reaction products were quantitatively 
transferred by disposable glass pipet (Clay Adams, 
parsippany, NJ) to polyethyleneimine-impregnated cellulose 
thin layer chromatography paper (Brinkman Instuments, Inc., 
westbury, NY) which was cut into strips (1 em x 6.5 em). The 
5 ul of reaction product was spotted at a location 1 em from 
the bottom of the paper strip designated the origin. After 
spotting, the thin layer chromatography paper strips were 
air-dried and then developed by ascending chromatography for 
30 min in a glass chamber containing approximately 20 ml of 
0.3 M LiCl (Fisher Chemical Co). The paper strips were then 
allowed to dry overnight and the reaction products ([gamma-
32P]ATP and 32P-inorganic phosphate) were visualized under 
ultraviolet light, appropriately marked and then cut out. 
The 3 2 P-inorganic phosphate spot migrated from the origin 
while the [gamma-32p]ATP remained at the origin. 32P-radio-
activity associated with the UV-sensitive spots was measured 
by liquid scintillation spectrometry in a 7.5 ml toluene 
solution containing Permafluor I (Method 0). 
B. •Mixing• Experiments 
The effect of endogenous protein kinase modulators 
upon the soluble cytosolic protein phosphorylation in dener-
vated and sham-operated solei was evaluated by conducting 
"mixing" experiments. For these experiments, equal volumes 
(75 ul) of the cytosolic protein fractions from denervated 
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and sham-operated solei were added to the 1D vitro phosphory-
lation assay (Method E) as a combined sample. Cytosolic 
protein phosphorylation of the combined sample (150 ul) was 
compared quantitativelyandstatistically to that of each 
individual cytosolic protein fraction from denervated and 
sham-operated solei in a 150 ul aliquot. All samples of 150 
ul (combined or individual) were pre-incubated for 0, 10, 20 
or 30 min. 
1. Determination of Alkali-Labile Phosphate 
Protein-bound phosphate was determined as alkali-
labile phosphate according to Weller (1979) with minor modi-
fications. Soluble cytosolic protein phosphorylation was 
assayed ..in vitro in the standard phosphorylation incubation 
medium (Method E). After the 5 rr.in incubation, the 
phosphorylation reaction was terminated by adding 1.0 ml of 
"precipitating solution" (10 % TCA and 0.05 M ATP) and 0.1 rr.l 
of bovine serum albumin (Miles Laboratories, Inc., Elkhart, 
IN) prepared as a 20 mg/ml solution in glass distilled water. 
The assay tubes were immediately transferred to ice and were 
allowed to stand for 30 min. Then the incubation medium was 
centrifuged at 2000 r.p.m. and li°C for 20 min. The superna-
tant was discarded and the pellet was rinsed 8 to 10 times 
With 2 rnl of 5 % TCA and 0.01 M NaPPi. The precipitate was 
Pelleted each time by centrifugation at 2000 r.p.m. and lj°C 
for 10 min. 32P-phospholipid was extracted by treating the 
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p e 11 e t o n c e w i t h 1 • 0 m 1 e than o 1 : die thy 1 e the r ( 1 : 1 , vI v ) and 
once with 1.0 ml of chloroform:methanol (2:1, v/v). Again 
the precipitate was pelleted each time by centrifugation at 
2000 r.p.m. and 4°C for 10 min. The supernatant fractions 
from these two steps were combined and allowed to evaporate 
overnight. 3 2 P-phospholipid was quantitated by liquid 
scintillation spectrometry after resuspending the dried phos-
pholipid in 0.75 ml Soluene 350 (Packard Instrument Co., 
Downers Grove, IL) and 7.5 ml of a toluene solution 
containing Permafluor I. 32P-phospholipid was reported as 
percent of the total TeA-precipitable 32P-radioactivity 
(untreated sample). 
The pellet remaining after phospholipid extraction 
was then treated to remove acid-labile phosphate by heating 
in 1.0 ml of 10% TCA and 0.05 H ATP for 12 min at 100°C. 
The acid-treated protein was then centrifuged at 2000 r.p.m. 
and 4oc for 10 min. The supernatant was retained and 32p_ 
acid-labile phosphate was quantitated by liquid scintillation 
spectrometry in a 7.5 ml pre-mixed liquid scintillation 
cocktail (Phase Combining System, Amersham Corp., Des 
Plaines, IL). The 32P-acid-labile phosphate was reported as 
Percent of the total 32P-radioactivity. 
Free acid was removed from the remaining pellet by 
~xtracting in 1.0 ml ethanol:diethyl ether (1:1, v/v). 
Alkali-labile phosphate was determined by heating the lipid-
free, acid-treated pellet in 1.0 ml 1 M NaOH for 12 min at 
loooc. After treatment with base, protein was reprecipitated 
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with 1.0 ml of 30% TCA and centrifuged at 2000 r.p.m. and 
4oc for 20 min. The final resulting pellet was resuspended 
in 0.75 ml of Soluene 350 and the 32P-radioactivity was 
quantitated by liquid scintillation spectrometry in a 7.5 ml 
toluene solution containing Permafluor I. Acid-stable, 
alkali-labile 3 2 P-phosphoprotein was reported as percent of 
the total 32P-radioactivity of the untreated sample. 
J. Chro•atographic Methods 
1. Gel filtration 
A Sephadex G-150 Superfine (Pharmacia Fine Chemi-
cals) gel filtration column (1.5 x 90 em, Bio-Rad Laborato-
ries, Richmond, CA) was used to resolve 32P-phosphoproteins 
from the cytosols of both denervated and sham-operated solei. 
Soluble cytosolic protein fractions from denervated and sham-
operated solei were prepared and aliquots phosphorylated as 
previously described (Methods C and E). 32P-labeled soluble 
c Y t o s o 1 i c p r o t e i n f r o m t h e .i..n .Y.i.t...rQ a s s a y ( 6 0 t o 9 0 u g 
soluble cytosolic protein) was combined with unlabeled cyto-
solic protein (200 to 250 ug) in non-phosphorylated aliquots 
of the denervated and sham-operated cytosolic protein frac-
tions. The unlabeled cytosolic protein served as cold 
carrier protein. The combined samples were quantitatively 
transferred to membrane tubing (Spectrapor, Spectrum Medical 
·Industries, Los Angeles, CA) and then dialyzed overnight in a 
50 0-fold volume of 0.1 M NaCl, 2 mM MgC1 2 and 50 mM Tris-HCl 
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buffer, pH 7.5, at 4°C. The dialysis buffer was changed 
three times during this period. The Sephadex G-150 columns 
were equilibrated with this same buffer. Care was taken to 
apply equal aliquots of the dialyzed denervated and sham-
operated cytosolic protein to individual Sephadex G-150 
columns. After the protein had entered the column, elution 
was carried out under non-denaturing conditions with the same 
buffer used during dialysis at an approximate flow rate of 
0.1 ml/min. During the elution of protein, consecutive 1.5 
ml fractions were collected. The 32P-radioactivity in each 
fraction was quantitated in 200 ul aliquots by liquid 
scintillation spectrometry using a 7.5 ml pre-mixed scintil-
lation cocktail (Phase Combining System, PCS). The protein 
profiles from both denervated and sham-operated solei were 
obtained by recording the relative absorbance (280 nm) of 
each fraction using a Gilford model 250 spectrophotometer. 
These profiles were compared quantitatively and qualita-
tively. The relative molecular weie,ht range of various 
soluble cytosolic phosphoproteins was established after 
calibrating the Sephadex G-150 column. This was done by 
calculating the partition coefficient (defined below) of 
known molecular weight marker proteins (given in the legend 
to Figure 35 of the Appendix) and plotting this calculated 
value against the log molecular weight of these marker 
Proteins. A linear relationship was established and then 
used to estimate the relative molecular weight of specific 
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soluble cytosolic phosphoproteins from denervated and sham-
operated solei. 
..Q&finition: Partition Coefficient (Kav) 
Kav = Elution Volume (Ve) - Void Volume (V 0 ) 
Bed Volume (Vt) - Void Volume (V 0 ) 
2. High performance liquid chromatography 
Soluble proteins from the cytosolic fractions of 
denervated and sham-operated solei were resolved by high 
performance liquid chromatography (HPLC). One advantage of 
HPLC over more conventional liquid chromatographic systems is 
that it employs a high pressure pumping system which allows 
for a rapid separation of components. 
A Waters I-125 Protein Purification size exclusion 
column (30 em, Waters Associates, Inc., Milford, MA) was used 
to separate soluble cytosolic proteins prepared from dener-
vated and sham-operated solei (Method C). The soluble cyto-
solic protein fractions were phosphorylated ~D x~~~Q as 
previously described (Method E). An aliquot of the cytosolic 
fraction (30 to 50 ug of protein) was combined with unlabeled 
cytosolic protein (70 to 90 ug) which served as cold carrier 
Protein. The combined samples were quantitatively trans-
ferred to Spectrapor membrane tubing and then dialyzed over-
night against a 500-fold volume of 0.05 M sodium phosphate 
buffer , pH 7.4, The dialysis buffer was changed 
. three to four times during an 18 hr period. Care was taken 
to apply similar aliquots (approximately 80 ug) of both 
98 
denervated and sham-operated soluble cytosolic protein to 
individual HPLC columns. Immediately following application 
of the protein (via a syringe-type injection system of Waters 
Assoc.), elution was started under non-denaturing conditions 
using the 0.05 M sodium phosphate buffer described above. A 
constant flow rate of 2.0 ml/min was maintained using a 
single pump system (Waters Assoc.) and a constant pressure of 
1500 pounds per square inch (psi). Consecutive fractions of 
o.5 ml were collected immediately after elution was started. 
Protein was monitored continuously at 254 nm and recorded at 
a constant chart speed of 2.0 em/min using a Houston Instru-
ments (Houston, TX) chart recorder. 32P-radicactivity in 
each fraction was quantitated by liquid scintillation spec-
trornetry. This was done by combining each 0.5 ml fraction 
with 7,5 ml of a pre-mixed scintillation cocktail (Phase 
Combining System, PCS). The relative molecular weights of 
specific phosphoproteins from denervated and sham-operated 
soleus cytosols were obtained after calibrating the HPLC 
column using the calculated partition coefficients (K 8 v) cf 
molecular weight marker proteins (described in the legend to 
Figure 36 of the Appendix). 
3. Chromatofocusing 
The approximate isoelectric points of soluble 
cytosolic proteins from denervated and sham-operated solei 
"-'ere obtained by column chromatography under non-denaturing 
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condition~. A relatively new technique was used - chromate-
focusing (Sluyterman and Elgersma, 1978). Chromatofocusing 
is a technique which ideally combines the high resolution of 
isoelectric focusing with the high capacity of ion-exchange 
chromatography. 
Relatively small columns (15 to 30 ml bed volumes) 
are used which have the capacity to rapidly separate proteins 
on a preparative scale. A 1.5 x 90 em column (Bio-Rad) was 
packed with Polybuffer Exchanger (PBE 94, Pharmacia Fine 
Chemicals) and equipped with flow adaptors (Bio-Rad) to 
ensure even sample application. The bed volume of the column 
was 20 ml. PBE contains ion exchangers carrying basic 
buffering groups. The column was equilibrated with 0.025 H 
histidine-HCl buffer, pH 6.3. The pH of the eluting buffer, 
Poly buffer 
Polybuffer 74 
74 (Pharmacia), was adjusted to pH 4.0. 
contains a large number of differently charged 
ionic species the most acidic of which binds the basic anion 
exchanger (PBE 94) and elutes last. This automatically 
establishes an internal descending pH gradient which allows 
for the elution of proteins as sharply focused zones in the 
order of their isoelectric points. 
To resolve soluble phosphoproteins from the 
cytosolic fraction of rat solei, an aliquot of soluble cyto-
solic protein (approximately 0.5 ug) 32P-labeled ~ ~~~~ was 
combined with 10 to 15 mg of unlabeled protein from the same 
cytosolic fraction. The combined samples were quantitatively 
transferred to Spectrapor membrane tubing and then dialyzed 
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overnight at 4°C against a 500-fold volume of 0.025 M histi-
dine-HCl buffer, pH 6.3. The dialysis buffer was changed 
three to four times. The next day the protein was applied to 
the column and then eluted by passing 200 to 300 ml (10 to 1!1 
bed volumes) of elution buffer (PB 74) over the column. A 
constant flow rate was maintained during elution (1.0 ml/min) 
by a Technicon Auto Analyzer hi-pressure micro pump 
(Technicon Instrument Corp., Chauncey, NY) 
maximal output. Consecutive fractions 
operating at 
of 2.0 ml 
50 % 
were 
collected and protein was monitored at 280 nm with a Uvicord 
II 8300 (LKB Instruments, Stockholm, Sweden) and recorded 
with a LKB Chopper Bar Recorder model 6520. When protein 
elution with PB 74 was completed, the pH of each individual 
fraction was recorded immediately with a Markson pH meter and 
electrode (Markson Science Inc., Del Mar, CA) in order to 
avoid errors in measurement due to C0 2 contamination. 3 2 P-
radioactivity was quantitated in 200 ul aliquots of each 
fraction by liquid scintillation spectrometry in a 7.5 ml 
pre-mixed scintillation cocktail (PCS). 
4. Cyclic adenosine 3':5' monophosphate affinity 
chromatography 
a. synthesis of N6-(2-aminoethyl)-cyclic adenosine 
3':5' monophosphate 
The preparation of N6-(2-aminoethyl)-cyclic AMP was 
carried out essentially according to Dills et al. (1975, 
1 0 1 
1979). The procedure is based on the conversion of 6-chloro-
purine-riboside-3':5'-monophosphate (6-Cl-cPRMP) to the 
desired cyclic AMP-affinity ligand. 6-Cl-cPRMP (25 mg or 
o.067 mmoles) was added to 0.26 g (l-1.35 mmoles) of ethylene-
diamine free base in 5 ml of glass-distilled water. This 
solution was refluxed for 6 hr at 100°C. The incubation 
medium was allowed to cool to room temperature and was then 
applied to an anion exchange column (1.8 x 30 em). The anion 
exchange resin used was AG 1-X2 (Bio-Rad Laboratories) of 
100 to 200 mesh in the acetate form. The resin had been pre-
washed with glass-distilled water. After the sample was 
applied, the column was washed successively with 25 ml of 
glass-distilled water, 25 ml of 0.01 M NH4Cl and 25 ml of 
glass-distilled water. N6-(2-Aminoethyl) cyclic AMP was then 
eluted with a linear gradient of 0 to 0.5 N acetic acid 
(approximately 160 ml elution buffer or 4 column bed 
volumes). When the gradient was started, consecutive frac-
tions of 4.0 ml were collected and absorbance was monitored 
at 265 nm by reading each fraction with a Gilford model 250 
spectrophotometer. A 50 ul aliquot of each fraction was 
transferred to a sheet of Whatman #1 filter paper and the 
free amino group of the nucleotide was observed in a 
chromatic reaction after treating the spotted filter paper 
with ninhydrin (Spray-type reagent from Gelman Instument 
Co., Ann Arbor, MI). Ninhydrin is a strong oxidizing agent 
Which is commonly used as a qualitative identification of an 
amino acid or a free amino group. Ninhydrin brings about an 
oxidative deamination 
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of N6-(2-aminoethyl) cyclic A~lP 
(Figure 2). The ammonia and hydrindantin formed react with a 
second molecule of ninhydrin to yield a purple pigment. A 
purple color observed in the ninhydrin reaction served as a 
positive test for the presence of the free amino group of N6-
(2-aminoethyl) cyclic AMP. Those fractions which absorbed at 
265 nm and were ninhydrin positive were pooled, lyophilized 
overnight and then resuspended in a minimal volume (usually 
4.0 ml) of glass-distilled water. This nucleotide 
solution was diluted 1000 times in glass-distilled water 
adjusted to pH 1.0 with 12 N HCL Absorbance was recorded 
at 262 nm. Dills et al. (1975) reported that the nucleo-
tide showed maximum absorbances at 262 nm and at 267 nm 
in solutions of pH 1.0 and 11.0, respectively. The molar 
extinction coefficients are 16,000 at pH 1.0 and 11.0. Using 
this molar extinction coefficient, a 71.12 % (17.78 mg) yield 













N6 -(2-aminoethyl )cAMP ninhydrin 






Figure 2. Chromatic reaction to detect N6-(2-aminoethyl)cAMP 
With ninhydrin reagent. 
b. coupling of N6-(2-aminoethyl) cyclic AHP to 
Sepharose 4B 
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The protocol used to couple N6-(2-aminoethyl) cyclic 
AMP to Sepharose 4B was essentially according to Dills et al. 
(1975 and 1979) and the steps are illustrated in Figure 3. 
To prepare approximately 9.0 ml of gel, 2.5 gm of Cyanogen 
bromide-activated Sepharose 4E (CNBr-activated Sepharose) 
obtained from Sigma Chemicc.l Co. was washed with 5 ml of 1.0 
mM HCl. The washed gel was then suspended in an equal volume 
of 100 mM sodium bicarbonate buffer, 
of enough N6-(2-aminoethyl) cyclic 
pH 9.5, in the presence 
AMP to give a final 
concentration of 4 umoles of nucleotide per ml of washed gel. 
The coupling reaction was allowed to proceed for 2 hr at room 
temperature. At this time, an equal volume of 1 Methanol-
amine hydrochloride, pH 9.5, was added and the reaction was 
allowed to proceed overnight for 16 hr at 4°C. The gel was 
then filtered by vacuum filtration using a Millipore type 
NCWP filter (14 micron pore size and 47 mm diameter) and 
washed with 5 to 10 volumes of the bicarbonate buffer (pH 
9.5) followed by at least 5 volumes of glass-distilled water. 
The affinity gel was stored in 0.02 % sodium azide at 4°C. 
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Figure 3. Coupling rea.ction of N6-(2-aminoethyl) cyclic AMP 
to Sepharose ~B chromatography resin 
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c. adsorption of soluble cyclic AMP-binding proteins 
from cytosolic fractions of rat soleus muscle 
N6-(2-Aminoethyl) cyclic adenosine 3':5' monophosphate 
coupled to Sepharose 4B was used to adsorb cyclic AMP-
binding proteins from the cytosolic fractions of denervated 
and sham-operated solei. Approximately 2.0 ml of affinity 
gel were poured into a disposable polypropylene column (0.7 x 
4 em) from Bio-Rad Laboratories. A small piece of rubber 
tubing (approximately 2.0 em long) was at~ached to the outlet 
of the column and flow was regulated with a pinch clamp. The 
cyclic AMP affinity resin was equilibrated with 5 mM 2-(N-
morpholino) ethanesulfonic acid (MES) containing 0.1 mM EDTA, 
15 mM 2-mercaptoethanol and 100 mM NaCl, pH 6.8 (buffer A). 
32P-radiolabeled phosphoproteins from the cytosolic 
fractions of denervated and sham-operated solei were prepared 
as previously described (Method E). Approximately 200 ug of 
protein from both denervated and sham-operated solei were 
quantitatively transferred to Spectrapor membrane tubing and 
then dialyzed against a 500-fold volume of buffer A overnight 
at 4°c. The dialysis buffer was replaced three to four times 
during this per·iod. 32P-labeled soluble cytosolic protein 
from denervated and sham-operated solei were then passed over 
separate cyclic AMP affinity columns. The protein was 
applied to the column and was incubated with the resin for 2 
hr at 4°C in order to allow for the interaction of cyclic 
AMP-binding proteins with the cyclic AMP ligand. After 
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incubation, the cyclic AMP affinity resin was washed with 10 
ml of buffer A, then with 10 ml of buffer A containing 750 mM 
NaCl, and finally with 5 ml of buffer A. The washed column 
was then allowed to come to room temperature. 
d. elution of soluble cytosolic cyclic AHP-binding 
phosphoproteins 
Soluble cytosolic cyclic AMP-binding proteins from 
denervated and sham-operated solei were specifically eluted 
from the affinity gel essentially according to Dills et al. 
(1979). Proteins were eluted from the cyclic AMP affinity 
ligand by first washing the column with 5.0 ml of buffer 
A at room temperature and then two sequential 5.0 ml washes 
(1.5 hr elution time for each wash) with buffer A containing 
1.0 mM cyclic AMP. The cyclic AMP displacement wash was 
retained and concentrated by lyophilization overnight. The 
lyophilized protein was resuspended in a minimal volume 
(usually 0.5 ml) of dialysis buffer containing 0.065 H Tris-
HCl, pH 6.8, and 0.1 % sodium dodecyl sulfate (SDS). 2-
mercaptoethanol was then added at a final concentration of 5% 
immediately before use. The suspension was then heated for 
2 min at 100°C and dialyzed overnight at room temperature 
against a 500-fold volume of the dialysis buffer. The next 
day, 200 ul of the cyclic AMP-binding protein suspensions 
from denervated and sham-operated solei were electrophoret-
ically resolved on SDS polyacrylamide gradient slab gels and 
32 P-labeled soluble cytosolic cyclic AMP-binding proteins 
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were visualized by autoradiography of the dried slab gel. 
The gel electrophoresis and autoradiography protocol is 
described in detail in Method K. 
(. SDS-Polyacrylamide Gel Electrophoresis 
1. Rod gel protocol 
a. casting the polyacrylamide rod gels 
Soluble cytosolic proteins which had been phosphory-
lated .iJ1 vitro (Method E) were electrophoretically resolved 
in SDS-1 0% polyacrylamide rod gels (SDS rod gels) 
essentially according to Weber and Osborn (1969). Rod gels 
were cast in cylindrical glass rods 0.5 em in diameter and 
7.5 em in length. Usually 12 gels were cast at one time by 
setting the glass rods onto a plexiglass holder (Buchler 
Instruments, Fort Lee, NJ) equipped with a level to ensure 
even casting. A small piece of parafilm was used to seal the 
cylinder. To make the gel bottom opening of 
casting solution, 
the glass 
20 ml of a 10 % acrylamide solution 
containing 0.5 % N,N'-methylene-bis-acrylamide (filtered 
through Whatman #1 paper before using) was mixed with 15 ul 
of N,N,N',N'-tetramethylethylenediamine and 60 ul of 10 % 
ammonium persulfate. This gel solution (1.0 ml) is 
transferred into the glass cylinders and a few drops of 
glass-distilled water are carefully added to the top of the 
gel solution to eliminate the meniscus. The gels are allowed 
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to polymerize by exposing them to fluorescent light for 30 
min. 
b. electrophoretic separation of protein 
Twenty five microliters of 18% SDS was added to the 
terminated ~ vitro phosphorylation incubation medium (refer 
to Method E) and the SDS-treated samples were heated for 2 
The SDS- and heat-treated 3 2P-labeled cyto-
solic fractions from denervated and sham-operated solei were 
transferred to Spectrapor membrane tubing and then dialyzed 
overnight at room temperature against a 500-fold volume of 
electrophoresis buffer consisting of 0.01 M sodium phosphate 
buffer, pH 7.4, 0.1 % SDS and 0.14 M 2-mercaptoethanol. The 
dialysis buffer was changed three to four times during this 
period. In order to directly compare the 32P-labeling and 
electrophoretic patterns of soluble cytosolic protein from 
denervated and sham-operated solei, equivalent aliquots of 
dialyzed, cytosolic protein (usually 30 ug protein) were 
always taken and quantitatively transferred to the SDS-10% 
polyacrylamide rod gels. Electrophoretic separation in 
these gels was conducted at a constant current of 8 mA/gel 
for approximately 2 hr. The buffer used at the anode (upper 
reservoir) and cathode (lower reservoir) of the electropho-
resis cell (Buchler Instruments) was the same as that used 
for dialysis. When the tracking dye had migrated to within 
2 to 5 mm from the bottom of the gels, electrophoresis was 
terminated. 
1 1 0 
c. staining of resolved proteins 
Following electrophoresis, the gels were removed 
from the glass rods by carefully injecting water with a 
needle and syringe between the polyacrylamide rod gel and the 
wall of the glass tubes. The gels were then placed in a 
solution of methanol-acetic acid-water (5:1:5) for hr. 
Each gel was then stained for 2 hr at room temperature in a 
solution of 1.25 g of Coomassie brilliant blue R (Sigma 
Chemical Co.), 454 ml of 50% methanol and 46 ml of glacial 
acetic acid. The staining solution was filtered through 
Whatman #1 filter paper before using. After staining, the 
gels were rinsed with distilled water before being destained 
electrophoretically in 7 % acetic acid for approximately 2 hr 
using a Canalco gel destaining apparatus (Canalco, Rockville, 
MD). 
d. evaluation of resolved proteins 
The distribution of protein-stained bands was 
analyzed by scanning each gel at 600 nm using a Gilford model 
250 spectrophotometer equipped with a model 2410-S linear 
transport and a model 6050 recorder. 
(1) estimation of molecular weights 
The relative molecular weight (Mr) of the resolved 
Proteins was estimated after calibrating the electrophoresis 
system. This was done by plotting the relative mobility (Rr) 
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of the molecular weight marker proteins against the log of 
their molecular weights. SDS molecular weight marker 
proteins (bovine serum albumin, ovalbumin, trypsinogen and 
lysozyme from Sigma Chemical Co. and aldolase from Pharmacia 
Fine Chemicals) were heated at 10Q°C for 2 min in dialysis 
buffer (1 mg marker protein/ml buffer). The linear relation-
shiP established (example shown in Figure 13) was used to 
determine the relative molecular weights of specific soluble 
cytosolic phosphoproteins. Relative mobility was calculated 
as described by Weber and Osborn (1969) according to the 
following equatiou: 
(migration (mm) of protein) (length (mm) of gel) 
(length of gel (mm) after destaining)(migration (mm) of dye) 
(2) quantitation of 32P-labeling in gel slices 
The protein-stained gels were frozen with dry-ice 
and then sectioned into consecutive mm slices with a 
Brinkmann gel slicer (Brinkmann Instruments, Westbury, NY). 
The 32P-radiolabeling of each consecutive 1.0 mm gel slice 
was quantitated in a 7.5 ml toluene solution of Permafluor I 
by liquid scintillation spectrometry. The gels were also 
sliced longitudinally, sealed in Saran wrap and placed flat 
Side down on Kodak X-Omat film (Eastman Kodak Co., 
Rochester, NY) which was then kept in a lightproof box for 3 
to 7 days. After this exposure time, the film was developed 
and the resulting autoradiograph was used to qualitatively 
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detect the distribution of 32P-radiolabeling in the rod 
gels. 
2. Slab gel protocol 
a. casting the polyacrylamide slab gels 
Soluble cytosolic proteins which were phosphorylated 
in yitro using the assay protocol described in Method E were 
electrophoretically resolved in SDS-polyacrylamide gradient 
slab gels (SDS gradient slab gels) essentially according to 
Laemmli (1970) with a 5 to 15% exponential acrylarr.ide 
gradient. The 5% acrylamide gel was prepared with 3.5 ml of 
1.5 M Tris-HCl buffer (pH 8.8) containing 0.4% SDS (buffer 
L), 2.5 ml of 29.9% acrylamide containing 0.8% N, N'-
methylene-bis-acrylamide (solution N), 8.75 ml of glass-
distilled water, 17 ul of 10% ammonium persulfate and 5 ul 
N,N,N',N'-tetramethylethylenediamine (TEMED). The 1 5% 
acrylamide gel was prepared with 5.0 ml of buffer L, 10.0 ml 
of acrylamide solution N, 3.0 ml glass-distilled water, 2.0 
ml glycerol, 22 ul of 10% ammonium persulfate and 5 ul 
TEMED. The gel solutions were degassed by vacuum before 
being cast between two glass plates arranged in a plastic gel 
casting apparatus (Bio-Rad Laboratories) to give a polyacry-
lamide slab gel 1.5 mm thick with a 5 (top of the gel) to 15% 
(bottom of the gel) exponential acrylamide gradient. The 5 
to 15% polyacrylamide gradient was formed from the bottom to 
the top by layering the 15% gel solution under the 5% gel 
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solution using a pumping device to ensure an even flow rate. 
After the gradient slab gel had polymerized (usually after 
hr), the stacking gel was prepared. The stacking gel was a 
4.5% acrylamide gel prepared with 2.5 ml of 0.5 M Tris-HCl 
buffer (pH 6.8) containing 0.4% SDS, 1 .5 
solution N, 6.0 ml glass-distilled water, 
ammonium persulfate and 10 ul of TEMED. 
ml acrylamid€ 
30 ul of 10% 
A plastic well 
former was used during polymerization of the stacking gel to 
allow for application of 10 samples per gel. 
b. electrophoretic separation of proteins 
Fifty microliters of an "SDS-stop solution" (18% 
SDS, 12.5 mM EDTA, 3.0 mM EGTA, 30% 2-mercaptoethanol and 
0.375 M Tris-HCl buffer, pH 6.8) was added to assay tubes 
containing terminated phosphotransferase incubation medium 
f r o m t h e .i.n ..Y.i..t..r..2 a s s a y ( M e t h o d E ) a n d t h e c o v e r e d t u be s w e r e 
placed in a boiling water bath for 2 min. The SDS-treated, 
32P-labeled cytosolic protein was quantitatively transferred 
to membrane tubing (Spectrapor) and dialyzed overnight at 
room temperature against a 500-fold volume of buffer 
consisting of 0.0625 M Tris-HCl, pH 6.8, 0.1% SDS and 5% 2-
mercaptoethanol. The dialysis buffer was changed three to 
four times. The next day 32P-labeled protein was removed 
from the membrane tubing and transferred to graduated conical 
glass cylinders so that the sample volume in the membrane 
tube could be measured. The protein concentration ofthe 
dialysate was calculated with corrections made for changes in 
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sample volume which occurred during dialysis. In order to 
directly compare the 3 2P-labeling and electrophoretic pat-
terns of soluble cytosolic proteins from denervated and sham-
operated solei, equivalent aliquots of dialyzed, cytosolic 
protein (approximately 30 to 45 ug protein) were always taken 
and quantitatively transferred to individual sample wells of 
the gel. The maximum sample volume applied did not exceed 200 
ul. Along with the protein applied, 10 ul of 66% sucrose 
and 5 ul of tracking dye (0.04% bromophenol blue solution 
from Eastman Kodak) was also added to each sample well. The 
electrophoresis buffer at the anode (upper reservoir) and the 
cathode (lower reservoir) of the double slab electrophoresis 
cell (Bio-Rad Laboratories) was 0.025 M Tris (free base) 
buffer, pH 8.3, with 0.192 M glycine and 0.1% 
constant current of 20 mA/gel was used until the 
SD S. A 
protein 
entered the stacking gel. It was then increased to 30 mA/gel 
and later to 40 mA/gel when the protein entered the gradient 
gel (running gel). The current was kept at 40 mA/gel until 
the tracking dye had migrated approximately 110 mm. Electro-
Phoresis was then terminated and the slab gel was removed 
from between the glass plates and fixed in a solution of 
methanol-acetic acid-water (5:1 :5) overnight. 
c. staining of resolved proteins 
Gels were stained for 30 min with a solution 
containing 1.25 g Coomassie brilliant blue R, 454 ml of 50% 
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methanol and li6 ml glacial acetic acid. The staining solu-
tion was filtered with Whatmann #1 filter paper before using. 
The gels were destained successively with methanol-acetic 
acid-water solutions of 5:1:5 and 1:1:9 for 1 hr each. Then 
the gels were placed in 7% acetic acid with 5% glycerol 
overnight. The protein-stained gels were dried onto filter 
paper by applying vacuum and heat for 2 hr with a gel dryer 
( Bio-Rad). 
d. evaluation of resolved proteins 
(1) estimation of molecular weights 
The relative molecular weights of the resolved proteins 
were estimated after calibrating the electrophoresis system. 
This was done by plotting the relative mobility of the 
molecular weight marker proteins against the log of their 
molecular weights. 
Molecular weight marker proteins (Sigma Chemical 
Co.) were boiled for 2 min in 0.0625 M Tris-HCl, pH 6.8, 0.1% 
SDS and 5% 2-mercaptoethanol ( 1 1tg marker protein/ ml 
buffer). The linear relationship established was used to 
determine the relative molecular weights of specific soluble 
cytosolic phosphoproteins. The relative mobilities of the 
molecular weight marker proteir.s were calculated using the 
following equation: 
Relative Mobility (Rf) = migration (mm) of protein 
migration (mm) of tracking dye 
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(2) quantitation of 32P-labeling in gel slices 
The dried gel was placed on Kodak X-Omat AR film 
(Eastman Kodak) for 1 to 7 days. The film was placed in a 
lightproof film holder (Buck X-Ray Accessories, Cincinnati, 
OH) and stored at -20°C. The lightproof film carriage also 
housed a Cronex Intensifying Screen (DuPont Chemical Co., 
Cleveland, OH) which was used to shorten the exposure time 
needed to obtain an autoradiograph. The distribution of 32p_ 
radiolabeling was determined qualitatively from the auto-
radiograph and quantitatively by slicing the dried gel into 
consecutive gel slices of 2 mm which were placed in a 7.5 rul 
toluene solution containing Permafluor I. The 32p content of 
these slices was analyzed by liquid scintillation 
spectrometry. 
L. Immunological Methods 
1. Development of anti-RII (regulatory subunit of cyclic 
AMP-dependent protein kinase type II) antiserum 
Anti-RII antiserum was a generous gift from the 
Sigma Chemical Co., St. Louis, MO. The antiserum was raised 
by Sigma in New Zealand white rabbits by the subcutaneous 
(s.c.) injection of 500 ug of purified cyclic AMP-dependent 
Protein kinase regulatory subunit type II from bovine heart 
(Sigma Chemical Co.). Complete Freund's adjuvant accompanied 
the injection of protein kinase regulatory subunit. Booster 
injections (s.c.) of regulatory subunit (200 ug) were given 
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at 4, 8 and 10 weeks following the initial injection. The 
rabbits were bled through the ear vein 7 days following the 
final booster injection to harvest anti-RII antiserum. The 
rabbits continued to receive booster injections once every 
four weeks for three months and were bled three weeks after 
each of these injections. Antiserum was stored at 4°C in 0.1 
% sodium azide. 
2. Partial purification of RII antibody immunoglobulin G 
(IgG) fraction 
The IgG fraction of the anti-RII antiserum was 
purified using sodium sulfate fractionation and DEAE-Sephadex 
anion exchange chromatography. Crude antiserum (2 ml) 
donated by Sigma Chemical Co. was diluted with 2 ml of 
0.14 H NaCl, pH 7.2 (physiological saline). Solid sodium 
sulfate (Fisher Chemical Co., Fair Lawn, NJ) was added at a 
final concentration of 18% (0.72 g) and the solution was 
allowed to incubate at room temperature for 30 min. The 
precipitate formed was pelleted by centrifugation at 2000 x g 
and 4°C for 10 min. The pellet obtained was resuspended in 
ml of a 10 mM potassium phosphate buffer, pH 7.2, containing 
15 mM NaCl and then dialyzed overnight against a 100 to 200-
folc volume of this buffer at 4°C. The dialyzed antiserum 
was applied to a 5 ml DEAE-Sephadex (Pharmacia Fine 
Chemicals) column which had been previously equilibrated with 
the same buffer used for dialysis. The void volume was 
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collected and represented the partially purified IgG fraction 
of the anti-RII antiserum. 
3. Antibody specificity 
A double diffusion test was performed essentially 
according to Ouchterlony (1967) in 1% agar gels to test the 
specificity of the purified IgG fraction of the anti-RII 
antibody. The double diffusion protocol was also used to 
test the anti-RII antibody against 15 and 20 ug of the cyclic 
AMP-dependent protein kinase type I holoenzyme (Sigma 
Chemical Co.), 20 ug of the purified catalytic subunit of 
this enzyme (Sigma Chemical Co.) and 20 ul of 0.15 M NaCl. 
To prepare the double diffusion gel plates, 1 g of 
purified agar (Difco Laboratories, Detroit, MI) was dissolved 
in 100 ml of 0.05 M sodium borate, pH 7.2, by heating. After 
the solution cooled to room temperature, 10 ml was trans-
ferred to a 100 x 15 mm plastic petri dish (Falcon Plastics, 
Oxnard, CA) placed on a level surface to ensure even 
distribution of the agar gel. A 2 mm thick gel was formed. 
Four sample wells (4 rom diameter) were formed with a cork 
borer at an equal distance (5 mm) from the center antisera 
well (6 mm diameter) and equidistant from each other (10 mm). 
Purified IgG anti-RII antibody fraction (50 ul) was placed in 
the center well. Various aliquots of a mg/ml solution of 
PUrified RII protein (20, 15, 10 and 5 ul) were placed in 
the four sample wells. Diffusion was carried out for 24 hr 
at room temperature. 
~' 
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Non-precipitated protein was washed from the gel 
with 0.15 M NaCl twice for 24 hr and once with glass-
distilled water for 24 hr. Antibody-neutralized RII was 
visualized by staining the agar gel with a Coomassie bril-
liant blueR solution (1.25 g Coomassie brilliant blue R in 
451! ml 50% methanol and 46 ml glacial acetic acid) for 2 hr 
at room temperature and by destaining overnight in a solution 
of methanol:acetic acid: water (1:1:9) and then overnight 
again in 7% acetic acid. 
4. Immunoaffinity chromatography 
a. preparation of anti-RII-IgG affinity column 
Anti-RII antibody was coupled to Cyanogen bromide-
activated Sepharose 4B (Pharmacia Fine Chemicals). The acti-
vated Sepharose (2.9 g) was treated with 500 ml of 1 roM HCl 
(1 g is approximately equivalent to 3.5 ml of affinity gel). 
The treated gel was collected on a sintered glass filter 
and then washed with 15 ml of a coupling buffer consisting of 
0.1 M NaHC0 3 , pH 8.3, and 0.5 M NaCl. The purified IgG anti-
RII antiserum fraction was diluted to 10 ml with 0.15 M NaCl 
and this solution was mixed with 30.0 ml of the coupling 
buffer. The gel suspension was added to the antibody/coup-
ling buffer solution and allowed to incubate overnight at 
4 °c. The antibody affinity gel was then transferred to 1 0 .o 
ml Of 0.2 M NaHco 3 buffer, pH 8. 0' with 0.1 M NaCl and 1 M 
ethanolamine-HCl and incubated with this buffer for 2 hr at 
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room temperature to block remaining active groups. The 
excess of uncoupled antibodies and blocking agent were 
removed by washing the gel alternately with 10 ml of low pH 
buffer (0.1 M sodium acetate buffer, pH 4.0, with 0.5 M NaCl) 
and 10 ml high pH buffer (coupling buffer, pH 8.3, with 0.5 M 
NaCl). This process was repeated four to five times. 
b. adsorption of 32P-labeled soluble cytosolic protein 
Denervated and sham-operated soleus cytosolic 
fractions were prepared (Method C) and phosphorylated ~n 
y~..t...r.Q (Method E). Equal aliquots (approximately 200 ug 
protein) of 32P-labeled denervated and sham-operated cyto-
solic protein were quantitatively transferred to membrane 
dialysis tubing (Spectrapor) and dialyzed overnight against a 
500-fold volume of 50 mM sodium phosphate buffer, pH 7.0, 
with 1 mM EDTA at 4°C. The dialyzed 32P-labeled cytosolic 
protein from denervated and sham-operated solei was applied 
to separate 1.0 ml anti-RII-IgG affinity columns and 
incubated with the resin for 1.0 hr at 4°C in a disposable 
0.7 x 4.0 em polypropylene column (Bio-Rad Laboratories). 
The antibody affinity columns were washed initially with 2.0 
ml of 50 mM sodium phosphate buffer, pH 7.0. The eluate was 
saved and served as the unadsorbed fraction. Salts and non-
specifically bound proteins were removed from the columns by 
Washing with 10.0 ml of the sodium phosphate buffer 
containing 0.5 M NaCl and then with 2.0 rel of 10 mM Tris-HCl 
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buffer, pH 7.4 (Uno, 1980). 
c. elution of specifically-bound 32P-labeled protein 
32P-radiolabeled adsorbed antigens were eluted from 
the anti-RII IgG affinity columns with 0.5 ml of 0.2 M 
glycine buffer, pH 2.2, and the eluates were then neutralized 
with 1.0 M Tris base (Uno, 1980). Fifty microliters of SDS-
stoP solution (Method K) was added to each 200 ul aliquot of 
the eluates from the denervated and sham-operated solei. The 
SDS-treated eluates were heated for 2 min at 100°C, quantita-
tively transferred to Spectrapor membrane dialysis tubing, 
and then dialyzed overnight against a 500-fold volume of 
0.0625 M Tris-HCl, pH 6.8, with 0.1% SDS and 5% 2-mercapto-
ethanol. Also, the unadsorbed fractions collected 
previously (b) were concentrated overnight by lyophilization 
and resuspended with boiling in 0.5 ml of 0.0625 M Tris-HCl 
buffer, pH 6.8, with 0.1 % SDS and 5 % 2-mercaptoethanol. 
d. resolution of 32P-labeled eluates 
Aliquots (200 ul) of the unadsorbed protein frac-
tions from denervated and sham-operated solei were electro-
Phoresed on a SDS-polyacrylamide gradient slab gel (Method 
K). The dialyzed proteins eluted from the anti-RII affinity 
column were also electrophoretically separated in a SDS-
Polyacrylamide gradient slab gel (Method K). 32P-labeled 
soluble proteins from the cytosolic fractions of denervated 
and sham-operated solei (adsorbed and unadsorbed fractions) 
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were analyzed qualitatively by autoradiography of the slab 
gel and quantitatively in 2 mm gel slices by liquid scintil-
lation spectrometry (Method 0). Relative molecular weights of 
specifically-bound soluble cytosolic phosphoproteins were 
established by calibrating the SDS-polyacrylamide gradient 
slab gel using SDS molecular weight marker proteins (Method 
K). 
H. Peptide Mapping 
Peptide maps of a specific 56,000-dalton phospho-
protein resolved from the cytosolic fraction of denervated 
and sham-operated solei were obtained essentially according 
to the method of Cleveland et al. (1977). This method allows 
for a rapid and convenient analysis of the enzymatic proteo-
lytic fragments of specific proteins isolated in SDS gels. 
Cytosolic fractions were prepared from denervated 
and sham-operated rat solei (Method C). These fractions were 
Ph o s p h o r y 1 a t e d .i..n .Y..i..t.XQ ( M e t h o d E ) a n d t h e 3 2 P- 1 a b e 1 e d 
56,000-dalton phosphoprotein was resolved from these muscles 
by SDS gradient slab PAGE (Method K). After electropho-
resis, the gel was removed from between the glass plates and 
Placed in a solution of methanol: acetic acid: water 
(5:0.5:5) overnight. The next day the gel was transferred 
immediately to a staining solution 
Coomassie brilliant blue R in 454 ml 
consisting of 
50% methanol 
1. 2 5 g 
and 46 
m1 glacial acetic acid. The gel was stained for no longer 
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than 15 to 20 min. The gel was destained briefly (45 min to 
1 hr) in a methanol-acetic acid-water (5:0.5:5) solution and 
then in 5% acetic acid for 1 hr. The protein-stained gel 
was placed on a transparent plastic sheet and protein-
staining bands were visualized with a light box. The 
56 ,000-dal ton phosphoproteins were sliced from each sample 
column of the slab gel. Each gel slice was incubated for 
30 min in 10 ml of a 0.125 M Tris-HCl buffer, pH 6.8, with 
0.1% SDS and 1 mM EDTA with occasional stirring. 
While the gel slices were incubating, the polyacry-
lamide gel to be used for peptide mapping was cast. This gel 
(1.5 mm thick x 8.5 mm long) was cast between two glass 
plates as described for the SDS-polyacrylamide gradient slab 
gel (Method K). To make the 15% acrylamide gel casting 
solution, 20 ml of a 29.2% acrylamide solution containing 
0.8% N,N-methylene-bisacrylamide was combined with 10.0 ml 
of 1.5 M Tris-HCl buffer, pH 8.8, with 0.4% SDS, 6.0 ml 
glass-distilled water, 4.0 ml glycerol, 44 ul of 10.0% 
ammonium persulfate and 10.0 ul of TEMED. The 8.5 em peptide 
gel was also cast with a longer than usual stacking gel (5 
em). The stacking gel was cast by combining 3 ml of the 
acrylamide solution described above with 5.0 ml of 0. 5 t-1 
Tris-HCl buffer, pH 6.8, with 0.4% SDS, 12.0 ml of glass-
distilled water, 60.0 ul of 10.0% ammonium persulfate and 
20.0 ul TEMED. A Teflon well former was used when casting 
the stacking gel to allow for application of 10 samples. 
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The specific gel slices for peptide mapping were 
removed from the 0.125 M Tris-HCl incubation buffer and 
trimmed to 2 x 5 mm. Trimming was necessary in order to 
place these gel slices in the formed sample wells of the 15% 
polyacrylamide peptide mapping gel. Approximately 88.3 ± 
1.0% (mean± S.E.M. with n=4) of the total 32P-radioactivity 
in the whole gel slice (usually about 2 x 8 mm after incuba-
tion) was consistently and reproducibly recovered in the 2 x 
5 mm trimmed gel slice. The trimmed gel slices were placed 
in the formed sample wells. The outer two wells of the slab 
gel contained a mixture of standard known molecular weight 
marker proteins prepared for electrophoresis as previously 
described (Method K). Sample wells containing the gel slices 
were filled with 200 ul of 0.125 M Tris-HCl buffer, pH 6.8, 
with 0.1% SDS and 1 mM EDTA, 
of a 0.04% Bromophenol blue 
10.0 ul of glycerol and 10.0 ul 
tracking dye solution. The ge 1 
slices were pushed to the bottom of the sample wells with a 
spatula. Finally, 0.5, 1.0 or 10.0 ug of bovine pancreas 
trypsin (Sigma type III from Sigma Chemical Co.) was added to 
some sample wells. One microgram of trypsir. was added to 
only one of the side wells containing the marker proteins. 
Electrophoresis was conducted as described for the SDS-poly-
acrylamide gradient slab gel system (Method K) except that 
the current was turned off for 30 min when the tracking dye 
was 5 to 10 mm from the bottom of the stacking gel. 
Electrophoresis was terminated when the tracking dye had 
migrated to within 2 to 5 mm from the bottom of the gel. 
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After electrophoresis, the peptide gel was stained 
and destained (Method K). The gel was dried with a Bio-Rad 
gel dryer and the dried gel was placed on Kodak X-Omat AR 
film for 1 to 7 days. An autoradiograph was obtained with 
the aid of Cronex Intensifying screens. The autoradiograph 
was used to qualitatively compare the 32P-labeled tryptic 
peptides of the 56,000-dalton phosphoprotein from denervated 
and sham-operated solei. All molecular weights were 
determined after calibrating the gels as described in Method 
K. Quantitative analysis of the tryptic 32P-labeled phos-
phopeptides generated from the 32P-labeled 56,000-dalton 
phosphoprotein was carried out by sectioning the peptide gel 
into consecutive 2 mm gel slices and counting the radio-
activity of each slice by liquid scintillation spectrometry. 
It was determined that 66.li ± 7.6 % (mean ± S.E.M. with 
n=24) of the total 32P-radioactivity applied to the peptide 
gel (total radioactivity associated with the 56,000-dalton 
phosphoprotein in the trimmed gel slice) was consistently and 
reproducibly recovered in the peptide mapping gel. Also, by 
paired t-test the percentage of 32P-radioactivity recovered 
when the 56,000-dalton phosphoprotein from denervated muscle 
was applied was not significantly different from the 
Percentage recovered when the 56,000-dalton phosphoprotein 
from sham-operated, contralateral muscle was applied. 
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N. Phosphorylation of the Regulatory Subunit of Cyclic AMP-
Dependent Protein Kinase Type II 
The regulatory subunit of the type II cyclic AMP-
dependent protein kinase purified from bovine heart was 
obtained from Sigma Chemical Co. This protein was phosphory-
lated ~D x~~~Q using the phosphorylation assay protocol 
described in Method E. Four micrograms of purified cyclic 
AMP-dependent protein kinase catalytic subunit from bovine 
heart (Sigma Chemical Co.) was added to the phosphorylation 
incubation medium along with 0.13 ml of 0.32 M sucrose with 
3.0 mM MgC1 2 , pH 6.5. The phosphorylation reaction was 
started with the addition of ~.0 ug of regulatory subunit 
type II and terminated after a 5 min incubation period at 
37°C with 5 mM ATP and 1.5 % sodium pyrophosphate (Method E). 
0. Liquid Scintillation Spectrometry 
1. Instrument 
A Packard Tri-Carb model 3380 liquid scintillation 
spectrometer (Packard Instruments, Downers Grove, IL) was 
used for analysis of all 32P-labeled radioactive samples. 
The spectrometer was integrated with a teletype printer and a 
tape punch mechanism. All 32P-labeled radioactive samples 
were analyzed with a factory set 32P-channel which was 
optimized for counting of single-labeled 32P-samples. The 
Pre-set channel (X) had an amplification setting of 0.3% to 
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o.5% and a window of 20 divisions (lower limit discriminator, 
0.03 MeV) to 1000 divisions (upper limit discriminator, 1.7 
He V) • 
2. Sample preparation 
3 2 P-radioactivity of nitrocellulose Millipore 
filters, thin layer chromatography paper strips or SDS-poly-
acrylamide gel slices were analyzed by liquid scintillation 
spectrometry in a 7.5 ml liquid scintillant. A 1 liter stock 
solution of the liquid scintillant was prepared by combining 
960 ml of scintillation grade toluene (Research Products 
International Corp., Elk Grove Village, IL) with 40 ml of 
Permafluor I (scintillation grade, Packard Instrument Co.). 
The resulting "scintillation cocktail" contained 5.0 g of 
2,5-diphenyloxazole (PPO) and 0.1 g of 1,4-bis-2-(5-
phenyloxazolyl) benzene (POPOP). Samples (filters, gel 
slices or thin layer paper strips) were counted in 20 ml low-
phosphate borosilicate glass vials fitted with plastic screw 
caps. Filters, gel slices and thin layer paper strips were 
always placed at the bottom of the glass vials. 
32P-labeled soluble cytosolic protein in fractions 
collected during chromatographic separations were analyzed by 
liquid scintillation spectrometry using a liquid scintillant 
(Phase Combining System, Amersham Corp., Des Plaines, IL) 
especially suitable for use with aqueous solutions. 
Aliquots of these fractions were introduced into the fluor by 
Pipetting. Then the borosilicate glass vials were capped and 
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shaken vigorously to dissolve the test material. 
3. Counting accuracy 
The Packard model 3380 scintillation counter 
indicates the statistical counting accuracy for each sample 
counted as percent standard deviation. The percent standard 
deviation is the quotient of 100 and the square root of the 
gross counts in the 32p channel. This is expressed to the 
nearest of 12 values ranging from 9.5 to 0.1. All 3 2 P-
radioactive samples were counted for 10.0 min. Only those 
counts per minute that were within a percent standard devia-
tion range of 0.1 to 2.5 were considered for analysis of 
results. Thus, for example, if a sample had 200 counts per 
minute with a 2% counting accuracy this would indicate a 2% 
counting error associated with those 200 counts per minute at 
a 68.27% confidence level. 
4. Counting efficiency 
The efficiency of counting the 32p was determined 
by external standarization for the two liquid scintillants 
used. External standardization was carried out by counting a 
known amount (dpm) of [gamma-32p]ATP in 7.5 ml of either of 
the two scintillants using varying concentrations of quencher 
(O to 0.5 % chloroform). Chloroform is a chemical quencher 
Which competes with the scintillator for the energy being 
transferred from the sol vent. Counting efficiency correla-
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tion curves were obtained by plotting efficiency ratios (dpm 
obtained/known dpm) versus the automatic external standard 
ratio. The Packard model 3380 automatic external standard-
ization (AES) system uses a compound gamma source consisting 
of americium-241 and radium-226. These two sources are spaced 
apart so that americium-241 irradiates the sample near the 
top of the sample and radium-226 irradiates it near the 
bottom. Counts in the automatic external standard channel 
are accumulated during two automatic one-half min counting 
periods. The AES count ratio is obtained by division of the 
counts recorded in two fixed, internal AES counting channels. 
This ratio is calculated by the computer and is recorded for 
each sample counted. The correlation curves in Figure 48 I 
and II of the Appendix show that the counting efficiency was 
97 to 99% for both scintillants. This factor was not 
included in calculations of counting data. 
5. Conversion of 32P-cpm to cytosolic protein phosphoryla-
tion 
Counting data (32P-counts per minute) from the~~ 
~itrQ phosphorylation assay (Method E) was converted to cyto-
solic protein phosphorylation by a computer program. The 
Packard liquid scintillation spectrometer was integrated 
With a digital computer (Hewlett Packard model 9830 with tape 
reader model 2748B and printer model 9866A) so that counting 
data (cpm) could be entered into the computer via punched 
Paper tape. A teletype was used to punch tape automatically 
after each sample count. 
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A computer program which had been 
written in BASIC language was used to convert cpm to dpm. 
This program incorporated factors for 32P-decay, background 
counts per minute and the specific activity of the [gamma-
32p]ATP which was the phosphoryl donor in the ~D vitro phos-
phorylation assay. The computer program was also able to 
convert dpm/ug soluble cytosolic protein to cytosolic protein 
phosphorylation reported as femtomoles (1o-15 moles) of 32p_ 
phosphate incorporated per mg soluble cytosolic protein per 5 
min incubation period. 
P. Statisical Treatment of Data 
The statistical significance of differences between 
experimental and control measurements was determined using 
a two-sided Student's t-test. A paired t-test was used when 
comparing paired experimental and control samples. 
of p < 0.05 was accepted as minimally significant. 
A level 
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Ill· RESULTS 
A. Phosphorylation or Soluble Cytosolic Protein rrom Rat 
Soleus Muscle 
1. Requirements and characterization of the ~n y~~I~ 
phosphorylation reaction 
The phosphorylation of soluble protein from 
cytosolic fractions of rat soleus muscle was assayed ~ vitro 
using an incubation medium consisting of 0.1 M NaCl, 50 mt--1 
Tris-HCl buffer, pH 7.5, 2 mM MgC1 2 and 6.7 x 10-9M [gamma-
32p]ATP (3000 Ci/mM) as described in Method E. The soluble 
protein obtained after high speed centrifugation of the 
soleus muscle homogenate (Method C) included endogenous 
protein kinases and phosphorylatable protein substrates. 
Phosphorylation was determined as the femtomoles (1o-15 
moles) of 32p-phosphate incorporated into trichloroacetic 
acid precipitable material per mg of soluble cytosolic 
protein per incubation period. The phosphorylation of 
soluble cytosolic protein was found to be heat-labile (Table 
3). When Mg+2 was deleted from the phosphorylation assay, a 
Slight (22%) but significant (p < 0.05) reduction in 
cytosolic protein phosphorylation was observed (Table 3). The 
lack of a larger reduction in phosphorylation might be due to 
endogenous Mg+2 or the small amount of Mg+2 derived during 
homogenization of the muscles with 0.32 M sucrose and 3 mM 
Mgc1 2 , pH 6.5, since addition of 6.5 mM EDTA, a chelator of 
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TABLE 3. REQUIREMENTS FOR THE PHOSPHORYLATION OF SOLUBLE 
CYTOSOLIC PROTEIN FROM RAT SOLEUS MUSCLE 
.lncubg,t;i.on M~l!! Protein Phosphorylationa 
completeb 9.1 .± 0.7 
without Mg+2 7.1 .± 0.1 • 
with EDTA (6.5 mM) 0 
with ca+2 (0.2 mM) 9.0 .± 0.5 
with ca+ 2 ( 2. 0 mM) 9.7 .± 0.3 
with EGTA (1.0 mM) 9.9 ± 0.4 
with cyclic AMP (1o-11 to 1o-9 H) 1 0.4 .± 1.2 
with cyclic AMP (1o-6 M) 5. 7 ± 1 • 0 • 
with cyclic GHP (1o-6 M) 9. 3 .± 0. 2 
with protein kinase inhibitorc (40 ug) 4.6 .± 0.4 •• 
boiled cytosolic protein fraction 0 
a cytosolic protein phosphorylation (fmoles 32p_po4 ;incuba-
tion period (5 rnin)/mg protein) are the means ± S.E.M. from 3 
to 4 groups of 3 rats. * p < 0.05 and ** p < 0.01. 
b The complete incubation medium (Method E) consists of 0.1 
M NaCl, 50 mt-'1 Tris-HCl (pH 7.5), 2 mH MgC1 2 and 5 uCi [gamma-32p]ATP (3000 Ci/rnmole). The phosphorylation reaction was 
carried out as described in MethodE after the addition of 40 
to 45 ug of soluble cytosolic protein. 
0 Purchased from Sigma Chemical Co., St. Louis, MO, Type II 
from bovine heart fractionated essentially as described by 
Ashby and Walsh (1971) for the cyclic AMP-dependent protein 
kinase i nhi bi tor. 
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Mg+2, completely inhibited the phosphorylation reaction. 
These results are consistent with protein kinase catalyzed 
phosphotransferase reactions (EC 2.7.1.37-ATP:protein phos-
photransferases) which are dependent upon the presence of 
this divalent cation. ca+2, which serves as a modulator of 
other cytosolic protein kinases when combined in a ternary 
complex with calmodulin (Cheung, 1980), and EGTA, a strong 
chelator of ca+2 ions, had no effect upon this phospho-
transferase reaction. Also, no change in cytosolic protein 
phosphorylation was observed after the addition of 10-6 M 
cyclic GMP. This nucleotide stimulates a soluble cytosolic 
cyclic GMP-dependent protein kinase. A slight and 
statistically insignificant stimulation (14%) of the 
endogenous phosphorylation reaction was seen after the addi-
tion of exogenous concentrations of cyclic AMP in the range 
of 1o-11 to 1o-9 M, but a significant reduction (37%) occurs 
with n:;icromolar additions. Cyclic AMP activates cytosolic 
cyclic AMP-dependent protein kinases by binding to the 
regulatory subunit of the holoenzyme. This results in a 
dissociation of the regulatory and catalytic subunits and 
activation of the free catalytic subunit (Builder et al., 
1980). Addition of 40 ug of a specific inhibitor (commercial 
Preparation) of the free catalytic subunit of cyclic AMP-
dependent protein kinase, first identified by Ashby and Walsh 
(1972), significantly inhibited (49%) the cytosolic phos-
Phorylation reaction. 
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Protein phosphorylation was also studied in cyto-
solic fractions from rat solei denervated for 24 hr prior to 
sacrifice by cutting the soleus branch of the sciatic nerve 2 
mm before insertion into the muscle. Protein phosphorylation 
in these cytosolic fractions was compared to cytosolic 
protein phosphorylation in the contralateral, sham-operated 
muscles. After incubation of 15 to 90 ug of soluble cyto-
solic protein from either 24 hr denervated short nerve stump-
solei or contralateral, sham-operated solei, a direct 
relationship was observed between the concentration of 
soluble cytosolic protein added to the buffered (pH 7.5) 
phosphorylation incubation medium and the 32P-radiolabeling 
of the trichloroacetic acid precipitable material (Figure 4). 
Within this range, therefore, it was valid to compare the 
cytosolic protein phosphorylation from denervated and sham-
operated muscles. This protein range was used for all 
denervation studies. 
An incubation time-course study of the ~~ y~~IQ 
phosphorylation of soluble cytosolic protein shows that when 
the phosphotransferase reaction is terminated at 1 or 2 min 
instead of after 5 min (the incubation time used throughout), 
the phosphorylation of soluble protein from the cytosolic 
fractions of 24 hr denervated short nerve stump-solei is 
still consistently increased more than twofold relative tc 
the contralateral, sham-operated solei. Also, even though 
the rate of cytosolic protein phosphorylation declined after 
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Figure 4. The relationship of phosphorylation of soluble 
cytosolic protein in denervated ( ) and sham-operated 
(-----) solei of the rat to the concentration of soluble 
protein in the incubation medium. The left soleus was 
denervated 24 hr prior to sacrifice by cutting the soleus 
branch of the sciatic nerve 2 mm before insertion into the 
muscle. Control samples were from sham-operated, contra-
lateral muscles. Phosphorylation of soluble cytosolic 
protein was conducted in a phosphorylation reaction buffer 
containing 0.1 M NaClt 50 mM Tris-HCl, pH 7.5, 2 mM MgC1 2 and 6.7 x 1o-9 M [gamma-3'P]ATP (3000 Ci/mmole) in a total volume 
of 0.25 ml (Method E), but with several concentrations of 
soluble cytosolic protein. Values are reported as means and 
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Figure 5. Time course of phosphorylation of soluble 
cytosolic protein in denervated ( ) and sham-operated 
(----) solei of the rat. The left soleus was denervated 24 
hr prior to sacrifice by cutting the soleus branch of the 
sciatic nerve 2 mm before insertion into the muscle. Control 
samples were obtained from sham-operated, contralateral 
muscles. Phosphorylation of soluble cytosolic protein was 
conducted in a phosphorylation reaction buffer containing 0.1 
M NaCl, 50 mM Tris-HCl, pH 7.5, 2 mM MgC1 2 and 6.7 x 10-9M [gamma-32p]ATP (3000 Ci/mmole) in a total volume of 0.25 ml 
(Method E), but after incubation periods of 1, 2, 5 and 10 
min. Values are reported as means and ranges of duplicate 
assays at each time period. 
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phosphorylation of cytosolic protein is again approximately 
twofold greater in denervated solei relative to the contra-
lateral, sham-operated solei (Figure 5). 
Incorporation of the ~~ X~~IQ 32P-radiolabel into 
trichloroacetic acid precipitable soluble cytosolic material 
was determined as alkali-labile, acid-stabile protein-bound 
phosphate (Method I). Table 4 shows that most of the 3 2 p-
label associated with the soluble cytosolic substrates from 
both 24 hr denervated short nerve stump-solei (85.6 ± 1.7%, 
mean ± S.E.M. with n=3) and contralateral, sham-operated 
solei (84.1 ± 2.0%, mean± S.E.M with n=3) is incorporated 
into protein as alkali-labile, acid-stable phosphate probably 
linked to serine or threonine residues. Also, the percentage 
of the total 32P-label incorporated into protein asalkali-
labile phosphate is not statistically different in denervated 
solei (by paired t-test) relative to contralateral, sham-
opera ted solei. 
2. Conversion of [gamma-32p]ATP to 32P-inorganic phosphate 
by endogenous adenosine triphosphatase (ATPase) 
The conversion of [gamma-32p]ATP to 32P-inorganic 
phosphate by endogenous ATPase was assessed for varying 
concentrations of soluble cytosolic protein under the ~~ 
vitro phosphorylation conditions described previously (Method 
E). The separation of these two 32P-radiolabeled components 




PERCENTAGE OF 32P-PHOSPHATE AS PHOSPHOLIPID, ACID-
LABILE AND ALKALI-LABILE PHOSPHATE IN CYTOSOLIC 
FRACTIONS OF DENERVATED AND CONTRALATERAL, SHAM-
OPERATED RAT SOLEI AFTER ~ VITRO PHOSPHORYLATIONa 
% of Total 32P-Radioactivityb 
-------------------------------------------------------------
Denervated Sham-operated 
Phospholipid 2.4 ±0.5 1.8 .±0-3 
Acid-labile Phosphate 10.2 .±0.8 1 2. 7 .±0. 6 
Alkali-labile Phosphate 85.6±1-7 84.1 .±2.0 
aphosphorylation of soluble cytosolic protein from 
denervated and sham-operated solei was determined as 
described in Method I. Cytosolic fractions were prepared 
from rat solei denervated with a short (< 2 mm) distal nerve 
stump for 24 hr prior to sacrifice and from contralateral, 
sham-operated muscles. 
b Percentages were calculated from the ratios of 32P-radio-
activity in the form of phospholipid, acid-labile phosphate 
and alkali-labile phosphate to the total 32P-radioactivity 
determined in TCA-precipitable soluble cytcsolic protein 
essentially according to Weller (1979) as described in Method 
I. Percentages are reported as means .± S.E.M with n=3· 
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B. Effect of Denervation and Nerve Stump Length Upon the 
Phosphorylation of Soluble Cytosolic Protein froa Rat 
Soleus Muscle 
A comparison of the phosphorylation of soluble 
protein from the cytosolic fractions of denervated and 
contralateral, sham-operated rat solei is shown in Figure 8. 
Cytosolic protein phosphorylation was determined as the 
femtomoles of 3 2 P-phosphate incorporated into trichloroacetic 
acid-precipitable material per mg soluble cytosolic protein 
in the buffered phosphorylation incubation medium (pH 7.5) 
per incubation period (Method E). 
Rat solei were denervated for 1, 3, and 6 hr 
and also at 6 hr intervals to a maximum of 78 hr by cutting 
the left sciatic nerve or one of its branches so that either 
a short nerve stump of 2 mm or less, an intermediate nerve 
stump of 17 to 20 mm, or a long nerve stump of 32 to 35 mm 
was left attached to the muscle (illustrated in Figure 1). 
With distal nerve stumps of short and intermediate lengths, 
the sciatic nerve was cut in the midthigh region leaving a 32 
to 35 mm distal nerve stump. The midthigh cut denervates 
all the muscles of the lower hindlimb eliminating the pos-
sibility of passive stretching of the soleus by contraction 
of neighboring muscles. 
The level of cytosolic protein phosphorylation of 
denervated muscles was compared to that of the corresponding 
sham-operated muscle from the contralateral hindlimb. A 
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Figure 6. Relationship of ATPase activity in the soluble 
cytosolic fraction from unoperated rat soleus muscle to the 
concentration of soluble cytosolic protein in the incubation 
medium. The 32P-radioactivity associated with ATP and 
inorganic phosphate was determined in cytosolic fractions 
pooled from three muscles by thin layer chromatography and 
liquid scintillation spectrometry as described in Method G 
with aliquots of the 100,000 x g supernatant fraction 
containing 20 to 130 ue; of protein. Values are reported as 
means ± S.E.M. of triplicate assays for each level of 
protein. 
Figure 7. Time course of the appearance of 32P-inorganic 
phosphate in the soluble cytosolic protein fraction from 
three pooled unoperated rat solei. The percentage of 32p_ 
radioactivity in the form of inorganic phosphate was 
calculated by determining the ratio of 32P-inorganic phos-
phate to 32P-ATP. Separation of radiolabeled components from 
the incubation medium was carried out by thin layer chromato-
graphy as described in Method G. Incubation of protein 
(87.5 ug) was for 1, 2, 5, 10, 15 or 20 minutes. Values are 
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paired Student's t-test was used to determine statistical 
significance. With this statistical evaluation, therefore, 
each animal served as its own control. 
Cytosolic protein phosphorylation was significantly 
increased approximately twofold in the denervated muscles 
whether a short, intermediate or long nerve stump was left 
attached to the soleus muscle (Figure 8). Additionally, the 
elapsed time during which cytosolic protein phosphorylation 
was significantly stimulated in the denervated muscles (24 to 
33 hr) was also the same for each of the three nerve stump 
lengths. The lag period, however, which was observed after 
denervation of the soleus muscle before the phosphorylation 
of cytosolic protein was significantly increased, was 
different for each of the three distal nerve stumps. 
Specifically, with the short 2 mm nerve stump a significant 
increase in cytosolic protein phosphorylation was observed as 
early as 3 hr (p < 0.02) after denervation. However, a 
significant increase was not observed until 30 hr (p < 0.05) 
and 48 hr (p < 0.02) for the intermediate (17 to 20 mm) and 
long (32 to 35 mm) nerve stumps, respectively. At the early 
periods of 3, 12 and 24 hr, a significant increase in cyto-
solic protein phosphorylation was observed with the short 2 
mm nerve stump. However, no significant change in phos-
Phorylation occurs at these times or at 24 hr when an inter-
mediate (17 to 20 mm) nerve stump is left attached to the 
muscle. Also, no change is observed in cytosolic protein 
Figure 8. Temporal dependency of cytosolic protein 
phosphorylation of denervated rat solei upon the length of 
distal nerve stump remaining attached to the muscle. The 
left soleus muscle of the rat hindlimb was denervated for the 
given pericds prior to sacrifice by transecting the sciatic 
nerve or its branches so that the distal nerve stumps were 
short < 2 mm (A), intermediate 17-20 mm (B) or long 32-35 mm 
(C). A sham-operation was performed on the contralateral 
hindlimb. Unoperated muscles were obtained from separate 
groups of animal~. Phosphorylation of soluble cytosolic 
protein was conducted as described in Method E ir. a 
phosphorylation reaction buffer containing 0.1 M NaCl, 50 mM 
Tris-HCl, pH 7.5, 2 mM HgC1 2 and 6.7 x 10-9 M [gamma-3 2 P]ATP (3000 Ci/mmole) in a total volume of 0.25 ml. The re~ults 
are means ± S.E.M. for the number of groups of 3 rats 
indicated in the parentheses. * p < 0.05, ** p < 0.02 and 
*** p < 0.01 based upon paired t-tests. 
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phosphorylation at 3, 12, 24, 36 and 42 hr when the long (32 
to 35 mm) nerve stump is left attached to the muscle. 
However, a significant increase in phosphorylation is 
observed at 3, 12 and 24 hr and at 36 and 42 hr for the short 
and intermediate nerve stump-solei, respectively. 
The denervation period corresponding to the maximum 
increase in cytosolic protein phosphorylation was observed 
was also different for the three distal nerve stump lengths. 
For example, with the short nerve stump-solei the maximal 
increase was observed at 24 hr. However, with the inter-
mediate and long nerve stump solei the maximal increase in 
cytosolic protein phosphorylation was observed at 54 and 66 
hr, respectively. 
Cytosolic protein phosphorylation was not signifi-
cantly increased in denervated muscles relative to contra-
lateral sham-operated muscles at longer denervation periods. 
This was observed at 48 and 72 hr with the short 2 mm nerve 
stump muscles, 66 and 72 hr with the 17 to 20 mm intermediate 
nerve stump muscles and 78 hr with the long 32 to 35 mm nerve 
stump muscles. 
Protein phosphorylation in the cytosolic fractions 
of muscles from unoperated animals did not differ signifi-
cantly from sham-operated muscles. Also, cytosolic protein 
Phosphorylation in sham-operated muscles did not differ 
significantly from each other. 
In a separate group of animals the left soleus 
muscle was denervated by cutting the soleus branch of the 
1 ll5 
sciatic nerve to leave a 2 mm nerve stump while the right 
soleus muscle was also denervated by cutting the sciatic 
nerve at a distance of 32 to 35 mm from its insertion into 
the muscle. On the left side the proximal cut (32 to 35 mm 
from insertion) was also made and preceded the distal dener-
vation. Twenty four hours after these surgical procedures 
soluble cytosolic protein phosphorylation in the right versus 
left solei was compared. For this "double denervation" 
protocol, therefore, cytosolic protein phosphorylation was 
compared in two denervated muscles (right and left solei) 
that differed only in the length of the distal nerve stump 
left attached to these muscles. With previous animal 
groups, denervated solei was always compared to contra-
lateral, sham-operated solei. 
When both the left and right solei were electrically 
silenced for 24 hr as described above, a significant 
increase (162.8 .±. 17.3%, mean ± S.E.M. with n=4 and p < 
0.02 by paired t-test) in cytosolic protein phosphorylation 
was observed in the left denervated short nerve stump-solei 
when compared to the contralateral, ~~D~£X~~~~ long nerve 
stump-solei (Table 5). Also, this increase (162.8 ± 17.3%) 
in cytosolic protein phosphorylation in the "double denerva-
tion" group was not significantly different (by Student's t-
test) from the increase in cytosolic protein phosphorylation 
in 24 hr short nerve stump solei versus contralateral, ~m= 
.2.ll~.r..a~~~ s o 1 e i ( 1 9 9 • 8 ± 3 • 4 , m e a n ± S • E • M • , n = 1 2 , F i g u r e 8 ) • 
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TABLE 5. COMPARISON OF THE EFFECT OF "DOUBLE DENERVATION" 
AND DENERVATION UPON THE PHOSPHORYLATION OF 
SOLUBLE CYTOSOLIC PROTEIN FROM RAT SOLEUS MUSCLE 
------------------------------------------------------------
Denervation Protocol % ChangeC (Left/Right x 100) 
-----------------------------------------------------------~ 
Double Denervationa (4) 162.8 ± 17.3 ** 
Denervationb (12) 199.8 ± 3.4 *** 
------------------------------------------------------------
a The left soleus was denervated for 24 hr prier to sacri-
fice by cutting the soleus branch of the sciatic nerve 2 mm 
before its insertion into the muscle. This surgical 
procedure was immediately preceded by cutting the left 
sciatic nerve 32 to 35 mm before insertion into the muscle. 
The right contralateral soleus was also denervated by cutting 
the right sciatic nerve 32 to 35 mm before insertion into the 
muscle. However, the more distal cut (< 2 mm distal nerve 
stump) was not made on the right side. 
b In this group of rats the left soleus muscle was 
denervated for 24 hr prior to sacrifice by cutting the soleus 
branch of the sciatic nerve 2 mm before insertion into the 
muscle (Figure 1C). The sciatic nerve was also cut at a 
distance of 32 to 35 mm from insertion into the left soleus 
(Figure 1A). The right contralateral soleus muscle was sham-
operated. 
0 The percent changes are determined by dividing the cyto-
solic protein phosphorylation in the left soleus by the 
cytosolic protein phosphorylation in the right soleus muscle 
and are reported in the Table as means± S.E.M. ** p < 0.02 
and *** p < 0.01. Statisitical differences were evaluated by 
paired t-tests. The number of groups of three rats at the 24 
hr denervation period is given in the parentheses. Cytosolic 
protein phosphorylation (femtomoles 32po 4 incorporated/ mg 
soluble cytosolic protein/ incubation period) was determined 
as described in Method E. 
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A direct relationship between the earliest denerva-
tion period with a significant increase in cytosolic protein 
phosphorylation (onset period) and the length of the distal 
nerve stump left attached to the muscle was found based upon 
these nerve stump lengths (Figure 9). The onset periods from 
Figure 8 are 3 hr (p < 0.02) for the short (2 mm) nerve 
stump, 30 hr (p < 0.05) for the intermediate (17 to 20 mm) 
nerve stump and 48 hr (p <0.02) for the long (32 to 35 mm) 
nerve stump. The slope of the solid linear regression line 
in Figure 9 indicates that the onset period is delayed 1.4 
hr for every millimeter of distal nerve stump remaining 
attached to the muscle. 
The dashed linear regression line in Figure 9 which 
is based upon the denervation period corresponding to the 
maximum increase in cytosolic protein phosphorylation 
relative to sham-operated muscles also indicates that this 
change is directly related to nerve stump length. The lag 
period derived from the slope of the line is 1.3 hr for every 
millimeter of distal nerve stump remaining attached to the 
muscle and is similar to the delay (1.4 hr/mm nerve) prior to 
onset. The pericds corresponding to the maximal increase in 
cytosolic protein phosphorylation (see Figure 8) are 24, 54 
and 66 hr for muscles with short, intermediate and long nerve 
stumps, respectively. 
The development of muscle atrophy was assessed for 
each denervation period with each nerve stump length 
indicated in Figure 8 by comparing the wet weights of 
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Figure g. The relationship of the times of onset and of 
maximal increase of cytosolic protein phosphorylation in 
denervated solei to the length of the nerve stump remaining 
attached to the muscle. Time of onset was defined as the 
period of the first statistically significant increase in 
cytosolic protein phosphorylation (p < 0.05). As shown in 
Figure 8, this occurred at 3, 30 and 48 hr for solei with 
distal nerve stumps of < 2 mm, 17-20 mm and 32-35 mm, 
respectively. The slope of the solid linear regression line 
derived from these points indicates that the onset of 
increased protein phosphorylation is delayed 1.4 hr for each 
mm of nerve left attached to the muscle. The time of maximal 
increase in cytosolic protein phosphorylation as shown in 
Figure 8 occurred at 24, 54 and 66 hr for muscles with distal 
nerve stumps of < 2 mm, 17-20 mm and 32-35 mm, respectively. 
The dotted linear regression line derived from these points 
indicates that the maximal increase is delayed 1.3 hr for 
each mm of distal nerve remaining attached to the muscle. 
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denervated versus contralateral, sham-operated solei. 
During the denervation periods of 3, 6, 12, 18, 24, 30 and 
36 hr when a significant increase in cytosolic protein phos-
phorylation in short nerve stump muscles is observed (Figure 
8), muscle weight is not affected by denervation (Table 6). 
Also, no muscle weight change is observed during denervation 
periods corresponding to a significant increase in cytosolic 
protein phosphorylation (30, 36, 42, 48, 54 and 60 hr) with 
the intermediate nerve stump length and most of the periods 
corresponding to a significant increase in cytosolic protein 
phosphorylation (48, 54 and 60 hr) with the long nerve stump 
(Figure 8 and U in Table 6). In addition, although there is 
significant weight loss (p < 0.01) observed during the 66 hr 
denervation time period for the intermediate nerve stump 
muscles and 60 and 66 hr with long nerve stump muscles, still 
cytosolic protein phosphorylation is significantly increased 
for these groups. 
C. Resolution or Denervation Period and Herve Stuap 
Length-Dependent Soluble Cytosolic Phosphoproteins 
rroa Rat Soleus Muscle 
1. Resolution of proteins under non-denaturing conditions 
a. gel filtration chromatography 
Gel filtration chromatography was chosen as a first 
step in resolving soluble protein substrates for the denerva-
1 50 
TABLE 6. COMPARISON OF DENERVATED AND CONTRALATERAL, SHAM-
OPERATED SOLEUS MUSCLE WEIGHTSa 
------------------------------------------------------------
Period (hr) Short 










3 0.40 0.39# 
6 0.43 0.42# 
1 2 0. 4 9 0.4911 
1 8 0.37 0.4011 
24 0. 4 9 0. 4 9# 
30 0.50 0. 51# 
36 0.39 0.4211 
42 




72 0.44 0.45 
78 
+ + 
0.42 0.43 0.45 0.44 
0. 4 8 0.47 0. 4 1 0.42 
0.42 0.43 0.40 0.46 
0.44 0. 41 
0.46 0.4511 0.44 0.45 
0.45 0.44/1 0.46 0.40 
0.43 0.44// 0.47 0.471/ 
0.42 0.42# 0.39 0.42/fo 
0.38 0.3911 0.36 0.41//* 
0.40* 0.40 0.43/1* 
0.40 0. 4 1 o.46 o.491J 
0.38 0.45* 
1 51 
tion period and nerve stump length-dependent cytosolic phos-
phosphorylation reaction due to its reliability and simpli-
city. Separation of components by gel filtration chromato-
graphy is related to the capacities of the various components 
to enter pores of the stationary phase. Smaller molecules 
which can enter the gel pores move much slower than large 
molecules which cannot enter the pores. Components are, 
therefore, eluted in order of decreasing molecular size. 
Samples of 32P-labeled soluble cytosolic protein 
fractions from 24 hr denervated short nerve stump-solei and 
contralateral, sham-operated solei were dialyzed separately 
overnight in ice-cold buffer (50 mH Tris-HCl, pH 7.5, 0.1 M 
NaCl and 2 mM MgC1 2 ) and then quantitatively applied to a 
Sephadex G-150 gel filtration column (1.5 x 90 em) which was 
equilibrated prior to use with the same buffer (Method J). 
A similar amount of dialyzed protein from denervated (275 ug) 
and sham-operated (286 ug) cytosols was applied to individual 
columns. Protein was eluted under non-denaturing conditions 
using the dialysis buffer. The relative absorbance profile 
at 280 nm generated during elution of soluble protein from 
the cytosolic fractions of denervated and sham-operated 
muscles is shown in Figure 10-I and II, respectively (refer 
to solid lines). No striking quantitative or qualitative 
differences were observed when comparing 24 hr denervated 
short nerve stump-solei to contralateral, sham-operated 
solei. Along with the absorbance profiles, the distribution 
of 32P-radioactivity quantitated in consecutive 1.5 ml 
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fractions is shown in Figure 10 (dotted line). Approximately 
60 to 75% of the total 32P-radioactivity eluted from columns 
to which denervated (Figure 10-I) or sham-operated (Figure 
10-II) cytosolic fractions were applied was localized in four 
consecutive 1.5 ml fractions corresponding to a total elution 
volume of 96.0 to 102.0 ml. The level of 3 2 P-radioactivity 
recovered in these four consecutive fractions, however, is 
2.5 fold greater in the cytosolic fraction from denervated 
solei relative to a similar sample from the cytosolic 
fraction of the contralateral, sham-operated solei. Also, 
the four consecutive fractions from both muscle cytosols 
correspond to a region of very low protein absorbance in a 
relative molecular weight range of Mr = 58,000 to 45,000. 
Tbe approximate molecular weight range under this four 
fraction peak was determined from the partition coefficients 
of the first and last 1.5 ml fraction of the peak and the 
molecular weight calibration curve shown in Figure 35 of the 
Appendix. The calibration curve is based upon the partition 
coefficients of known molecular weight marker proteins. 
Additionally, when the four consecutive major 32P-labeled 
fractions were pooled, resolved by SDS gradient slab PAGE and 
then 32P-labeled proteins were visualized by autoradiography, 
only a 56,000-dalton radiolabeled phosphoprotein was apparent 
(data not shown). 
1 54 
b. high pressure liquid chromatography (HPLC) 
HPLC was chosen as an alternate method to conven-
tional gel filtration chromatography to shorten the time 
needed for separation of soluble cytosolic proteins and to 
achieve greater resolution of components. Conventional 
sephadex gel filtration was found to be extremely time 
consuming, often taking 18 hr. 
3 2P-labeled soluble phosphoproteins from the cyto-
solic fractions of 24 hr denervated short nerve stump-solei 
and contralateral, sham-operated solei were resolved under 
non-denaturing conditions by HPLC using a 0.05 M sodium 
phosphate buffer, pH 7.4, and a Waters I-125 protein purifi-
cation size exclusion HPLC column. Cytosolic protein applied 
to the column from denervated (76.0 ug) and sham-operated 
muscles (81.5 ug) were eluted under non-denaturing conditions 
with the sodium phosphate buffer. The relative absorbance 
profiles (254 nm) for denervated and contralateral, sham-
operated muscles are essentially identical (compare 
continuous solid lines in Figure 11-I and II). 
The distribution of 32P-radioactivity in consecutive 
0.5 ml fractions from denervated and sham-operated solei 
indicated that the majority (85 to 90%) of the total 3 2 P-
radioactivity eluted is localized in five consecutive frac-
tions corresponding to a total elution volume of 7.5 to 9.5 
ml. The level of 32P-radioactivity of this region was 
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relative to a similar sample from the contralateral, sham-
operated muscle (Figure 11-I vs. 11-II). Also, the five 
consecutive fractions from both muscles corresponded to a 
region of low protein absorbance in a broad molecular weight 
range of Hr = 58,000 to 35,000. The approximate molecular 
weight range of this peak was determined from the partition 
coefficients of the first and last 0.5 ml fraction of the 
peak and the molecular weight calibration curve shown in 
Figure 36 of the Appendix. The calibration curve is based on 
the partition coefficients of known molecular weight marker 
proteins. The approximate molecular weight of each peak was 
calculated and is indicated in the molecular weight scale 
presented at the top of Figure 11-I and II. The HPLC 
chromatographic procedure resolved cytosolic proteins more 
rapidly (approximately 9 min for separation of cytosol 
proteir.s) than the conventional Sephadex gel filtration 
chromatography (approximately 18 hr). However, neither 
method of protein separation yielded a good resolution of 
soluble cytosolic proteins. 
2. Resolution of proteins under denaturing conditions 
a. rod gel electrophoresis 
The soluble proteins in cytosolic fractions from2~ 
hr denervated short nerve stump-solei and contralateral, 
sham-operated solei of the rat were phosphorylated ..i.D vitro 
in a buffered incubation medium containing [gamma-32p]ATP as 
1 57 
the phosphoryl donor (Method E). Aliquots of these 
phosphorylated cytosolic fractions were heat- and SDS-
treated, dialyzed and then subjected to SDS-10% polyacry-
lamide rod gel electrophoresis (SDS rod PAGE) in a phosphate 
buffered (pH 7.4) system (Method L). The absorbance profiles 
of Coomassie blue protein-stained gels at 600 nm obtained 
with equivalent amounts of soluble cytosolic protein (30 ug) 
from denervated and sham-operated solei were qualitatively 
comparable as shown in Figure 12A and B, respectively. Also, 
only minor quantitative differences between denervated and 
were observed. When the distribution sham-operated muscles 
of the 32P-radiolabel on the Coomassie blue protein-stained 
gels was analyzed by autoradiography of longitudinally sliced 
gels, the obviously overexposed film was darkened only in the 
region of lightly stained protein bands (refer to double 
arrows in Figure 12A and B). Four consecutive mm gel 
slices from the 32P-labeled region of the gel contained 70 ± 
2% (mean ±. S.E.M. with n=8) of the 32P-radioactivity 
recovered after electrophoresis (i.e., 61 ± 6% of applied 
radioactivity; mean ± S.E.M. with n=4). This distribution of 
the 32P-labeling was found for cytosolic protein from both 
denervated and sham-operated muscles. The 32P-radioactivity 
associated with the relatively minor polypeptide band(s) was 
186 ± 18% (mean± S.E.M with n=5) higher when resolved from 
~~ x~~£Q phosphorylated soluble protein in cytosolic frac-
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Figure 12. Resolution of a phosphorylated polypeptide from 
the cytosolic fractions of denervated and sham-operated solei 
of the rat in SDS-10% polyacrylamide rod gels. The left 
soleus was denervated 24 hr prior to sacrifice by cuttingthe 
soleus branch of the sciatic nerve 2 mm before insertion into 
the muscle. Control samples were obtained from shan:-
operated, contralateral muscles. Cytosolic fractions were 
incubo.ted in the phosphorylation medium (Method E) and then 
Prepared for SDS rod gel electrophoresis (Method K) . 
Densitometric tracings recorded at 600 nm ( ..... ) of 
Coomassie blue-stained rod gels are shown along with 3 2 P-
radioactivity ( ) quantitated in consecutive 1 mm gel 
Slices by liquid scintillation spectrometry. An equivalent 
amount of soluble cytosolic protein (30 ug) was applied in 
(A) and (B). Photographs of these protein-stained gels and 
autoradiographs of longitudinally sliced gels are shown at 
the bottom of the Figure. 
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sbort (< 2 mm) nerve stump (Figure 12A) than when resolved 
from contralateral, sham-operated muscles (Figure 12B). 
Based upon the relative electrophoretic mobilities 
of molecular weight marker proteins (i.e., albumin-66,000; 
ovalbumin-45,000; pepsin-34,700; trypsinogen-24,000 and beta-
lactoglobulin-18,400) in SDS-10% polyacrylamide rod gels 
(Figure 13), the relative molecular weight of the 
ctenervation-dependent phosphopolypeptide is 40,400 ± 800 
(mean± S.E.M. with n=8). The distance (in mm) migrated by 
tbe polypeptide was taken as the distance of the gel slice 
from the origin which was the most radioactive (e.g., the 
peak at 15 mm in Figure 12A and B). All measurements were 
corrected for differences and changes in the lengths of the 
rod gels due to the staining and destaining procedures 
according to the equation given by Weber and Osborn (1969) 
(Method K). 
The relationship of the 40,400-dalton denervation-
dependent soluble cytosolic phosphoprotein to the catalytic 
subunit of the cyclic AMP-dependent protein kinase was also 
examined using the SDS rod PAGE system. This comparison was 
significant in that the catalytic subunit of cyclic AMP-
dependent protein kinase has reported molcular weights of Mr 
= 37,000 to 41,300 (Kinzel and Kubler, 1976; Bechtel et al., 
1977) and undergoes autocatalytic self-phosphorylation (Chiu 
and Tao, 1978) under reaction conditions similar to those 
employed in the ~~ y~~~Q cytosolic phosphorylation assay 


















,.....- .. / 3~P-LABELED SOLUBLE PROTEIN 
,.. .. / /" ... PROTEIN KINASE CATALYTIC SUBUNIT 
... " .. ········ PEPSIN 
... ·· .... ············· 
TRYPSINOGEN 




Figure 13. Estimation of the relative molecular weight of a 
32P-labeled soluble cytosolic phosphoprotein from rat soleus 
muscle and the protein kinase catalytic subunit by SDS-10% 
Polyacrylamide rod gel electrophoresis. The protein 
standards of known molecular weight (i.e., albumin-66,000; 
ovalbumin-45,000; pepsin-34,700, trypsinogen-24,000 and beta-
lactoglobulin-18,400) used for the calibration and the 
catalytic subunit (from bovine heart muscle) were obtained 
from Sigma Chemical Co., St. Louis, MO. The molecular weight 
marker proteins were prepared for electrophoresis as 
described in Method K. Relative mobilities were determined 
according to Weber and Osborn (1969) and are shown as means±. 
S.E.M. with n=8 for the 32P-labeled soluble protein and n=3 
for all other proteins. 
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dependent protein kinase catalytic subunit from bovine heart 
(commercial preparation) was determined to be 38,000 ± 580 
(mean ± S.E.M. with n=3) as demonstrated in Figure 13. 
Additionally, after coelectrophoresis with 32P-labeled 
soluble cytosolic protein from rat soleus muscle, this 
commercially purified catalytic subunit was distinctly 
separated from the 40,400-dalton major soluble phosphoprotein 
resolved from the cytosol of rat soleus muscle (Figure 14). 
b. slab gel electrophoresis 
Aliquotsof phosphorylated soluble proteins which 
were denatured (heat- and SDS-treated) and dialyzed were 
also subjected to SDS polyacrylamide gradient slab gel 
electrophoresis (SDS slab PAGE) using a 5 to 15% exponential 
gradient according to Laemmli (1970) (Method K). This gel 
system was used to achieve a better resolution of cytosolic 
proteins from rat soleus muscle. With this gel system, 
approximately 45 to 50 Coomassie blue protein-staining bands 
were reproducibly resolved (Figure 15B). 
Autoradiography of the dried slab gels indicates 
that 8 to 11 soluble cytosolic proteins were phosphorylated 
during the ..in ..YJ,llQ assay (Figure 15C-H). Based upon liquid 
scintillation counting of consecutive 2 mm gel slices, 
76.5 ± 2.8% (mean± S.E.M. with n=6) of the total 32p_ 
radioactivity applied to the gel was recovered after electro-
Phoresis when soluble cytosolic proteins were resolved from 
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denervated solei. When soluble proteins were resolved from 
contralateral, sham-operated solei, 77.8 ± 2.8 % (mean ± 
s.E.M. with n=6) of the total 32P-radioactivity applied to 
the gel was recovered after electrophoresis. However, 67.5 
± 5.1 % (mean ± S.E.M. with n=6) of the 32P-radioactivity 
recovered after electrophoresis of soluble cytosolic proteins 
from denervated solei was associated with two consecutive 2 
rom gel slices corresponding to a lightly stained protein band 
(Figure 15C, E and G). Similarly, 69.9 ± 4.3% (mean± 
s.E.M. with n=6) of the 32P-radioactivity recovered after 
electrophoresis of soluble cytosolic proteins from contra-
lateral, sham-operated solei was also associated with two 
consecutive 2 mm gel slices corresponding to a lightly 
stained protein band (Figure 150, F and H). The low levels 
of 32P-radioactivity associated with the other phosphopro-
teins (100 cpm or less) detected by autoradiography prevented 
their reliable quantitative assessment by liquid scintilla-
tion spectrometry. 
The predominant soluble cytosolic phosphoprotein 
from the cytosolic fractions of both denervated and sham-
operated solei has a relative molecular weight of Mr = 56,000 
±. 400 (mean± S.E.M. with n=12). The distance migrated by 
the predominant soluble phosphoprotein was taken as the most 
radioactive gel slice from the origin (top) of the SDS 
gradient slab gel. The relative molecular weight of this 
Predominant phosphoprotein was estimated from the molecular 
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Figure 16. Estimation of the relative molecular weight of 
the denervation period and nerve stump length-dependent 
soluble cytosolic phosphoprotein from rat soleus muscle by 
SDS gradient slab PAGE. The protein standards of known 
molecular weight described in Figure 15 were purchased from 
Sigma Chemical Co. with the exception of aldolase which was 
purchased from Pharmacia Chemical Co. The standard proteins 
were prepared as solutions of 1 mg protein/ml of a 0.0625 M 
Tris-HCl buffer, pH 6.8, with 0.1% SDS and 5% 2-mercapto-
ethanol. The protein solutions were boiled for 2 min prior 
to electrophoresis to denature the proteins. An equal 
aliquot (10 ug) of each·protein was applied to the gradient 
slab gel. Relative mobilities were calculated according to 
the equation given in Method K and are shown as means ± 
S.E.M. for 12 electrophoretic separations. 
1 6 6 
tion curve was derived by calculating the relative electro-
phoretic mobilities of the known molecular weight standard 
marker proteins shown in Figure 15A. 
An increased phosphorylation of the predominant 
56,000-dalton phosphoprotein was observed when 32P-labeled 
soluble proteins were resolved from the cytosolic fractions 
of rat solei denervated for 24, 54 and 66 hr with the three 
nerve stump lengths of 2, 17-20 and 32-35 mm, respectively. 
These are the denervation periods at which a maximal increase 
in cytosolic protein phosphorylation was found (Figure 8). 
The marked increase in the 32P-labeling of the major 56,000-
dalton soluble cytosolic phosphoprotein from denervated 
muscles can be observed in Figure 15 by comparing the auto-
radiographic density of 
(C), intermediate nerve 
this protein in short nerve stump 
stump (E) and long nerve stump (G) 
solei relative to their respective, sham-operated (D, F and 
H) muscles. Similar amounts of soluble protein from the 
cytosolic fractions of denervated and contralateral, sham-
operated muscles were applied to the gel. Denervation had no 
effect on synthesis of soluble cytosolic proteins as judged 
from the Coomassie staining pattern. It is pertinent to note 
that the density of the autoradiographs of one pair of 
samples cannot be compared with another pair (e.g., C-D vs E-
F or G-H) since the half-life of 32p is relatively short 
(14.2 days) and the samples for the three pairs of denervated 
and sham-operated muscles were not available for electro-
167 
phoresis simultaneously. 
Due to the discrepancy in apparent molecular weight 
of the predominant soluble phosphoprotein observed when 32p_ 
labeled cytosolic proteins were resolved by SDS rod PAGE and 
SDS gradient slab PAGE, an experiment was conducted to 
directly compare the relative molecular weight of 
protein by SDS rod PAGE and SDS gradient slab PAGE. 
this 
3 2 P-
labeled soluble cytosolic proteins were resolved initially by 
SDS rod PAGE. After electrophoresis the rod gels were sliced 
into five consecutive 10 mm segments and the radiolabeled 
segment was detected with a Geiger counter (ElScint Ltd., 
Israel). The radiolabeled segment was prepared for re-
electrophoresis by hand homogenizing the 10 mm segment and 
resuspending the radiolabeled protein in the electrophoresis 
buffer used during SDS gradient slab 
consisted of 0.0625 M Tris-HCl, pH 6.8, 
PAGE. The buffer 
0.1% SDS and 5% 2-
mercaptoethanol. It can be seen from the autoradiograph 
shown in Figure 17B that the major radiolabeled protei~ 
resolved initially by SDS rod PAGE and re-electrophoresed on 
SDS gradient slab gels had a molecular weight similar to the 
major 32P-labeled protein of Mr = 56,000-daltons also 
resolved by SDS gradient slab PAGE (17A). 
During the denervation periods corresponding to a 
significant increase in cytosolic protein phosphorylation 
ttlith a short nerve stump (3, 6, 12, 18 and 24 hr), a similar 
Percentage increase in the 32p-radiolabeling of the 56,000-





Figure 17. Molecular weight determination of the denervation 
period and nerve stump length-dependent soluble cytosolic 
phosphoprotein from rat soleus muscle by SDS rod PAGE and SDS 
gradient slab PAGE. 32P-labeled cytosol samples of 3 pooled 
unoperated rat solei were prepared for electrophoresis in SDS 
rod gels and SDS gradient slab gels as described in Method K. 
Autoradiographs of the 32P-labeled cytosolic samples resolved 
by SDS gradient slab PAGE (A) and of the major 32P-radio-
1abeled soluble cytosolic phosphoprotein (40,000-daltons) 
Which was sliced from an SDS rod gel and then re-electro-
Phoresed in an SDS gradient slab gel (B) are shown. 
Molecular weight of the major radiolabeled protein band was 
determined relative to the electrophoretic mobilities of 
Proteins of known molecular weight and the calibration curve 
shown in Figure 16. 
16 9 
denervated solei relative to sham-operated solei (Figure 18). 
Where no significant change in cytosolic protein phosphoryla-
tion was observed at 1 hr, no significant increase in phos-
phorylation of the 56,000-dalton protein was observed. 
Relative phosphorylation of the 56,000-dalton phosphoprotein 
was determined by dividing the total 32P-radioactivity 
(counts per minute in two consecutive 2 mm gel slices) 
associated with this protein band by the total amount of 
soluble cytosolic protein (usually between 30 and 50 ug) from 
denervated or sham-operated samples applied to corresponding 
individual sample wells of the gel. Histograms showing the 
quantitative distribution of 32P-radioactivity in SDS 
gradient slab gels for 1, 3, 6, 12, 18 and 24 hr denervated 
and sham-operated solei can be found in Figures 41 to 46 of 
the Appendix. 
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D. Modulators of the Denervation Period and Nerve Stump 
Length-Dependent Phosphorylation of Cytosolic Protein(s) 
1. Effect of exogenous modulators and protein substrates 
a. cyclic AMP 
The Coomassie blue protein-staining pattern (Figure 
19-I) indicates that the addition of cyclic AMP and also 
other exogenous modulators to the ~n x~~~Q assay had no 
qualitative effect upon the soluble cytosolic protein pattern 
of rat soleus muscle. However, the autoradiograph of the 
dried slab gel shows that the level of 32P-labeling of the 
56,000-dalton protein band from both denervated and sham-
operated cytosolic fractions is markedly inhibited by the 
a d d i t i o n of 1 u M c y c 1 i c A M P t o t h e .in x.i~..rQ p h o s p h o r y 1 a t i o n 
assay (Figure 19-II). Quantitatively, the 32P-radiolabeling 
of the two consecutive gel slices (2 mm) corresponding to the 
56,000-dalton protein band was significantly reduced (p < 
0.01 by paired t-test) 77.93 ± 3.37% (mean ± S.E.M. with 
n=5) in the denervated sample and 76.12 ± 3.77% (mean ± 
S.E.M. with n=5) in the contralateral, sham-operated sample 
(Table 7). These results were obtained after determining the 
relative phosphorylation of the 56,000-dalton cytosolic phos-
Phoprotein. This was calculated as the 32P-radiolabeling of 
the 56,000-dalton protein relative to the total amount of 
soluble protein in cytosolic fractions of denervated or sha~­
operated solei applied to corresponding individual sample 
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EFFECT OF CERTAIN MODULATORS UPON THE PHOSPHORY-
LATION OF THE SOLUBLE 56,000-DALTON PHOSPHOPROTEIN 
FROM THE CYTOSOLIC FRACTION OF DENERVATED AND 
SHAM-OPERATED RAT SOLEUS MUSCLE 
Modulatora % Change in Phosphorylation of the 
56,000-Dalton Phosphoproteinb 
uM cyclic AMP ( 5) 
uM cyclic GMP ( 3) 
2.0 mM C a 2 + ( 3) 
mM Z n2+ ( 5) 
50 units PKid ( 5) 
Denervatedc 
Soleus 
-11 • 9 3 .±3 • 37 I I I 
+ 1 .4 6 .±6. 9 9 
-2.3 2 .±5. 27 




( 5) -76.12 .±3 .77 I** 
( 3) -0.01 .±9. 37 
( 3) -6.43 .±2.80 
( 5) -4.90 .±4. 1 2 
( 5) -1.10 ±5. 2 3 
asoluble cytosolic protein in cytosolic fractions of 
denervated and contralateral, sham-operated rat solei. was 
phosphorylated j_n vitro (Method E) with the addition of 1 mH 
zn2+ (replacing Mg2+), 1 uM cyclic AMP, 1 uM cyclic GMP, 2.0 
mM ca2+ and 50 units of the protein kinase inhibitor (see d 
below). The 56,000-dalton phosphoprotein was resolved from 
these fractions by SDS gradient slab PAGE (Method K). 
bPhosphorylation of the 56,000-dalton phosphoprotein 
resolved by SDS gradient slab gel electrophoresis was calcu-
lated by dividing the total cpm in 2 consecutive gel slices 
corresponding to the region of the gel containing the 56,000-
dalton protein by the amount of soluble protein (ug) applied 
to individual sample wells of the slab gel. Percent changes 
in phosphorylation with the addition of certain modulators 
to the j_n vitro phosphorylation assay are presented as means 
± S.E.M. for the number of groups of three rats indicated in 
the parentheses. Ill p < 0.01 by paired t-test. + indicates 
an increase in phosphorylation and - indicates a decrease i~ 
Phosphorylation relative to phosphorylation without the addi-
tion of modulators. 
cExperimental muscles were denervated unilaterally to leave 
a short (< 2 mm) distal nerve stump 24 hr prior to sacrifice. 
Sham-operated, contralateral muscles served as controls. 
dProtein kinase inhibitor purchased from Sigma Chemical Co., 
St. Louis, MO was fractionated from bovine heart. The 
inhibitor was purified further (Method F). 
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wells of the SDS polyacrylamide gradient slab gel. Also, 
note in Figure 19-II the increase in the phosphorylation of a 
47,000-dalton and an 18,000-dalton protein when cyclic ANP 
was added to the ~ vitro assay system. Quantitative changes 
in the phosphorylation of these soluble proteins (47,000 and 
18,000-dalton proteins) could not be accurately assessed, 
however, due to the low level of counts (< 100 cpm) asso-
ciated with these bands when cytosolic protein phosphoryla-
tion is assayed without cyclic AMP. Molecular weights 
indicated in Figure 19-I and II were calculated relative to 
the electrophoretic mobilities of known molecular weight 
marker proteins (Figure 37 of the Appendix). 
b. protein kinase inhibitor 
The specific inhibitor of the free catalytic subunit 
of cyclic AMP-dependent protein kinase had only a slight 
(statistically insignificant) effect upon the phosphorylation 
of the predominant 56,000-dalton phosphoprotein resolved from 
denervated (5.74 ± 4.59% inhibition, mean± S.E.M. with n=5) 
and contralateral, sham-operated solei (7.70 ± 5.23% 
inhibition, mean ± S.E.M. with n=5) (Table 7). However, 
addition of 50 units of the specific inhibitor reduced the 
Phosphorylation of the cyclic AMP-stimulated 47,000-dalton 
Phosphoprotein in both denervated and sham-operated solei 
( 1 an e s D a n d H in F i g u r e 1 9 - I I) . 
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W h e n 1 IL M Z n 2 + w a s u s e d i n t h e J...n .Y.1..1I.2 p h o s p h o r y 1 a -
tion assay instead of 2 mM Mg2 +, only a slight (statistically 
insignificant) inhibitory effect upon the phosphorylation of 
the predominant 56,000-dalton phosphoprotein resolved by SDS 
gradient slab PAGE from denervated solei (7.34 ± 3.98% 
inhibition, mean± S.E.M with n=5) and contralateral, sham-
operated solei (4.90 ± 4.12% inhibition, mean± S.E.M. with 
n=5) was observed (Table 7). However, zn2+ had an effect 
similar to the proteir. kinase inhibitor in reducing the 
phosphorylation of the cyclic AMP-stimulated 47,000-dalton 
phosphoprotein in both denervated and sham-operated solei 
(lanes E and I in Figure 19-II). 
Also, Figure 20 shows that the increase in the 
phosphorylative modification of the 56,000-dalton cytosolic 
protein from 24 hr denervated short nerve stump-solei in the 
presence of either the specific cyclic AMP-dependent protein 
kinase inhibitor or zn2+ is comparable (not statistically 
different by paired t-test) to the overall increase in total 
cytosolic protein phosphorylation in these muscles; i.e. the 
percentage change in the phosphorylation of the 56,000-dalton 
Protein in denervated solei under the two conditions shown in 
Figure 20 (abscissa) relative to their corresponding, sham-
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In Figure 21-I, the photograph of the Coomassie blue 
stained proteins from 24 hr denervated short nerve stump-
solei and contralateral, sham-operated solei shows that 
neither 0.2 nor 2.0 mM ca 2 + had any qualitative effect upon 
soluble proteins resolved from the cytosolic fractions of 
these muscles. ca2+ (0.2 and 2.0 mM) also had no qualita-
tive (Figure 21-II) or quantitative (Table 7) effect upon the 
phosphorylation of the predominant 56,000-dalton phosphopro-
tein. 
e. cyclic GMP 
Like ca2+, uM cyclic GMP had no qualitative 
(Figure 21-II) or quantitative (Table 7) effect upon the 
phosphorylation of the predominant 56,000-dalton phosphopro-
tein resolved from the cytosolic fractions of 24 hr 
denervated short nerve stump solei and their sham-operated, 
contralateral muscles. Molecular weights indicated in Figure 
21-II were determined relative to the electrophoretic mobili-
ties of standard known molecular weight marker proteins 
(Figure 38 of the Appendix). 
f. histone 
Cytosolic protein phosphorylation was determined in 
24 hr denervated short nerve stump-solei relative to sham-
operated solei with or without histone added to the ~ vitro 
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phosphorylation assay. Histone is a natural substrate for 
the cytosolic cyclic AMP-dependent protein kinase (Weller, 
1979). Without histone added to the incubation medium, 
cytosolic protein phosphorylation was increased in the dener-
vated muscle 172.5 ± 3.2% (mean± S.E.M. with n=5). With 50 
ug of a commercial preparation of calf thymus histone added 
to the ~D x~~£Q assay, cytosolic protein phosphorylation 
(determined as femtomoles 32po 4 incorporated/ mg soluble 
cytosolic protein/ incubation time period) increased 369.3 ± 
5.9% (mean ± S.E.M. with n=5) in the denervated sample 
relative to cytosolic protein phosphorylation in denervated 
solei assayed without histone (Table 8). However, cytosolic 
protein phosphorylation in sham-operated solei assayed with 
histone was increased 88ll.7 ± 7.3% (mean± S.E.M. with n=5) 
relative to cytosolic protein phosphorylation in sham-
operated solei assayed without histone (Table 8). Also, when 
exogenous histone was added to the phosphorylation reaction, 
cytosolic protein phosphorylation in denervated solei was 72% 
that of the sham-operated solei. 
2. Effect of endogenous modulators 
The relationship between the stimulation of the 
cytosolic protein phosphorylation in denervated rat solei and 
a change in the concentration of an endogenous modulator of 
Protein phosphorylation was studied in "mixing" experin:ents 
in which protein phosphorylation in a sample containing equal 
1 80 
TABLE 8. ENDOGENOUS VS. EXOGENOUS PROTEIN PHOSPHORYLATION BY 
CYTOSOLIC FRACTIONS FROM DENERVATED AND CONTRA-
LATERAL, SHAM-OPERATED RAT SOLEI 
Substratea DEN SOLb SHAM-OPER SOL DEN/SHAM x 100 
------------------------------------------------------------cppc %increase CPP %increase 
Sol~;.ble 1 9. 3 .±.2. 0 11.2 .±.1.7 172.5** 
Cytosolic 
Protein 
Histone 7 1.1 .±.5 . 1 369** 9 8.8 .±.5. 5 884 ** 7 2.0 • 
aThe phosphorylation of cytosolic protein (40 to 45 ug) was 
assayed~ vitro with the phosphorylation medium described in 
Method E. Histone (50 ug, from Sigma Chemical Co., St. 
Louis, MO) was also added to some assays as exogenous 
substrate. 
bThe left soleus muscle was denervated 24 hr prior to 
sacrifice by cutting the soleus branch of the sciatic nerve 2 
miL before insertion into the muscle. Sham-operated, contra-
lateral muscles served as controls. 
cCPP - Cytosolic protein phosphorylation (fmoles 32po 
incorporated/mg soluble protein/incubation period (5 min)~ 
are the means .±. S.E.M. from 5 groups of 3 rats. * p < 0.05 
and** p < 0.01 by Student's t-test. 
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aliquots of cytosolic fractions from both 24 hr denervatec 
short nerve stump-solei and contralateral, sham-operated 
solei was compared to protein phosphorylation in these 
individual fractions alone. If the concentration of an 
endogenous modu~ator of the cytosolic protein phosphorylation 
reaction in either denervated or sham-operated cytosolic 
fractions is altered, then protein phosphorylation of the 
combined aliquots of these samples will deviate from the 
expected additive value derived from the results of assays of 
these samples separately. When equal aliquots of cytosolic 
fractions from 24 hr denervated short nerve stump-solei and 
sham-operated solei were combined and assayed ~~ ~~~~Q, 
cytosolic protein phosphorylation was significantly (p < 0.01 
by paired t-test) decreased by g.4 ± 2.1% (mean ± S.E.M., 
n=8) from the expected value (Figure 22, refer to 0 min pre-
incubation period). It is significant to note that phcs-
phorylation of cytosolic protein in denervated solei is 
consistently increased (1.6 to 2.0 fold) compared to that of 
the contralateral, sham-operated solei over the entire 
incubation time course. Pre-incubation, however, results in 
the formation of less phosphorylated product than that formed 
without pre-incubation. Also, longer pre-incubation of the 
combined sample resulted in an even greater and significant 
decrease in protein phosphorylation from the expected value. 
For example, a 10.4 ± 1.7% (mean± S.E.M. with n=8; p < 
0.02) decrease from the expected value was observed with the 
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Figure 22. Effect of endogenous soluble modulators upon 
cytosolic protein phosphorylation in rat solei. Combined 
aliquots from the cytosolic fractions of 24 hr denervated 
short (< 2 mm) nerve stump-solei and contralateral, sham-
operated solei were assayed and cytosolic protein phosphory-
lation (fmoles 32P-phosphosphate incorporated/ mg soluble 
cytosolic protein/ incubation period) was determined in these 
combined samples as described in Method E varying only the 
time of pre-incubation. These results were compared to those 
obtained from assays of each sample separately. Each point 
represents the mean of eight determinations obtained from 
eight separate experiments. Statistical analyses were 
Performed by paired t-test to examine differences between 
experimentally determined cytosolic protein phosphorylation 
( ) and expected values (-----) for combined samples. 
1 P S. 0.05, •• p S. 0.02 and ••• p S. 0.01. 
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with n=8; p < 0.05) decrease from the expected value was 
observed with the 20 min pre-incubation period and an 18.7 ± 
1.6% (mean± S.E.M. with n=8; p < 0.01) decrease was observed 
with the 30 min pre-incubation period. 
3. Effect of endogenous divalent cation-dependent and 
independent protein phosphatase activity 
Soluble proteins from the cytosolic fractions of 
denervated and sham-operated solei were phosphorylated ~~ 
.Y.i.t.£Q in a buffered ( pH 7 • 5) phosphor y 1 at ion medium 
containing Mg2+ and [gamma-32p]ATP (Method E). The 
phosphorylation reaction was terminated after 1, 2, 5, 10, 20 
and 30 min. Under these reaction conditions, cation-
dependent dephosphorylation of 32P-labeled soluble proteins 
was examined. 32P-labeled .soluble proteins were resolved by 
SDS gradient slab PAGE (Figure 23-I) and visualized by auto-
radiography (Figure 23-II). Similar amounts of 32P-labeled 
soluble protein from the cytosolic fractions of denervated 
(30.77 ug) and sham-operated solei (30.44 ug) were applied to 
the SD~ gradient slab gel. The Coomassie blue protein 
staining patterns for denervated samples were essentially 
identical to the protein pattern obtained with sham-operated 
solei (Figure 23-I). Autoradiography of the dried slab gel 
shows an increase in the 32P-labeling associated with the 
major 56,000-dalton phosphoprotein with longer incubation 
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Figure 23. The effect of incubation time on the phosphory-
lation and cation-dependent dephosphorylation of the major 
56,000-dalton soluble phosphoprotein in denervated and sham-
operated cytosolic fractions of rat solei. Cytosol samples 
from solei denervated for 24 hr with a short (< 2 mm) di~tal 
nerve stump (+) and the contralateral, sham-operated muscles 
(-) were radiolabeled in x~~£Q as in Method E except that 
times of incubation were 1, 2, 5, 10, 20 and 30 min. 3 2 P-
radiolabeled reaction products were resolved by SDS gradient 
slab PAGE. A photograph of the Coomassie blue protein 
staining pattern from the cytosolic fractions of denervated 
and sham-operated muscles is shown in I. The autoradiograph 
or the dried slab gel is also shown (II). Molecular weights 
indicated were determined relative to the electrophoretic 
mobilities of known molecular weight marker proteins. These 
Proteins were used to derive the calibration curve shown in 
Figure 39 of the Appendix. 
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of this protein occurs in both denervated and sham-operated 
samples. Also, a marked increase in the phosphorylation of 
the 56,000-dalton phosphoprotein in denervated compared to 
sham-operated muscles was observed for all incubation 
periods. However, a cation-dependent dephosphorylation of 
the 56,000-dalton phosphoprotein in either denervated or 
sham-operated solei was not observed over the incubation time 
course studied. 
The effect of a cation-independent dephosphorylation 
of the predominant 56,000-dalton soluble phosphoprotein was 
examined in the cytosolic fractions of 24 hr denervated short 
nerve stump-solei and contralateral, sham-operated solei. To 
specifically study the cation-independent dephosphorylation 
of the major 56,000-dalton phosphoprotein, soluble cytosolic 
protein from denervated and sham-operated solei were 
incubated for 5 min in the buffered phosphorylation reaction 
system (Method E). After the 5 min incubation period, 6.5 mM 
EDTA was added to the assay to terminate phosphorylation and 
to inhibit any cation-dependent phosphatase activity. The 
dephosphorylation reaction catalyzed by the cation-indepen-
dent protein phosphatase was allowed to proceed for another 
0, 5, 1 5, and 2 5 min. The reaction products were resolved by 
SDS gradient PAGE (Figure 24-I) and visualized by autoradio-
graphy of the dried slab gel (Figure 24-II). Similar amounts 
or soluble protein from denervated (30.77 ug) and sham-
operated (30.44 ug) soleus cytosolic fractions were applied 
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Figure 2~. Effect of cation-independent protein phosphatase 
activity upon the 32P-labeling of the major soluble 56,0 00 -
dalton phosphoprotein in the cytosolic fractions of 
denervated and sham-operated solei. Cytosol samples from rat 
solei denervated for 2~ hr with a short(< 2 mm) distal nerve 
stump(+) and contralateral, sham-operated solei(-) were 
32P-labeled ..i.n vitro with a 5 min incubation period (Method 
E). After the 5 min incubation period, 6.5 mM EDTA was 
added to the incubation medium and the dephosphorylation 
reaction catalyzed by a cation-independent phosphoprotein 
phosphatase was allowed to proceed for another 0, 5, 15 or 25 
min. 32P-radiolabeled reaction products were resolved by SDS 
gradient slab PAGE. A photogr·aph of the Coomassie blue 
Protein staining pattern from the cytosolic fractions of 
denervated and sham-operated muscles is shown in I. The 
autoradiograph of the dried slab gel is also shown (II). 
Molecular weights indicated were determined relative to the 
electrophoretic mobilities of known molecular weight marker 
Proteins. These proteins were used to derive the calibration 
curve shown in Figure 39 of the Appendix. 
1 87 
phosphorylation of the 56,000-dalton phosphoprotein was 
observed in denervated samples compared to sham-operated 
samples and appears to be consistent for each incubation 
period. Little change in the 32P-radiolabeling of the 
56,000-dalton protein from either denervated or sham-operated 
solei occurred at either the 5 or 15 min incubation periods. 
A slight dephosphorylation of the 56,000-dalton protein from 
the cytosolic fraction of sham-operated solei occurs after 25 
min. These results indicate that both denervated and sham-
operated solei have a similar low level of cation-independent 
protein phosphatase activity. The molecular weights of 
proteins indicated in Figures 23 and 2~ were calculated 
relative to the electrophoretic mobilities of standard known 
molecular weight marker proteins. The molecular weight cali-
bration curve for these gels is shown in Figure 39 of the 
Appendix. 
E. Identification o~ the 56,000-Dalton Denervation Period 
and Nerve Stump Length-Dependent Cytosolic Phospho-
protein ~rom Rat Soleus Muscle 
1. Chromatofocusing 
Soluble proteins from the cytosolic fraction of 
unoperated rat solei were phosphorylated ~ vitro (Method E) 
and were prepared for chromatofocusing by dialyzing aliquots 
overnight against a buffer of 0.025 M histidine-HCl, pH 6.~, 
at ~°C (Method J). An aliquot of unlabeled soluble cytosolic 
188 
protein (12.75 mg) was combined with an another aliquot of 
soluble protein (43.0 ug) which was 32P-labeled .i.n vitro and 
the combined sample was applied to a pH-equilibrated (pH 6.4) 
chromatofocusing column. Unlabeled soluble cytosolic protein 
was used as cold carrier protein. The majority of the 
soluble cytosolic protein elutes in the void volume corres-
ponding to a pH of 6.4 or higher (Figure 25-I). The 32p_ 
radioactivity determined in 250 ul aliquots of consecutive 
5.0 ml fractions by liquid scintillation spectrometry shows 
that the majority (55%) of the recovered 3 2 P-radioactivity 
(i.e., 68.3% of the radioactivity applied to the column) is 
localized in four consecutive fractions eluting within a pH 
range of 5.9 to 5.6. When these four fractions were pooled, 
concentrated by lyophilization, resuspended in a buffer 
containing SDS, dialyzed overnight in the buffer containing 
SDS and then resolved by SDS gradient slab PAGE, the major 
cytosolic 32P-labeled phosphoprotein observed in this pH 
range (5.9 to 5.6) was a 56 ,000-dal ton phosphoprotein (lane C 
in Figure 25-II). The molecular weight of this protein was 
determined relative to the molecular weight marker proteir.s 
shown in Figure 25. Therefore, this protein has the same 
electrophoretic mobility on the SDS slab gel system as the 
56,000-dalton denervation period and nerve stump length-
dependent phosphoprotein (Figure 15). Also, the less intense 
32P-labeled 39,000-dalton band probably represents a proteo-
lytic fragment of the 56,000-dalton phosphoprotein because it 
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iS not observed when total phosphorylated soluble cytosolic 
proteins are resolved by SDS gradient slab PAGE and 
visualized by autoradiography of the dried slab gel (Figure 
1 5 ) • 
2. Cyclic AMP-affinity chromatography 
The possible identity of the 56,000-dalton denerva-
tion period and nerve stump length-dependent phosphoprotein 
from rat soleus muscle as the type II regulatory subunit of 
cyclic AMP-dependent protein kinase (RII) was studied by 
examining the specific binding of 32P-labeled soluble cyto-
solic phosphoproteins from 24 hr denervated short stump-solei 
and contralateral, sham-operated solei onto N6-(2-
aminoethyl)-cyclic AMP-Sepharose. Binding and non-binding 
phosphoproteins were resolved by SDS gradient slab PAGE and 
visualized by autoradiography (Figure 26). The Coomassie 
blue protein-staining patterns obtained when soluble 
proteins from the cytosolic fractions of denervated (176 ug) 
and sham-operated solei (188 ug) were applied to the affinity 
column are shown in lanes A and E of Figure 26-I. Most of the 
soluble cytosolic proteins from denervated and sham-operated 
solei applied to the cyclic AMP affinity column did not bind 
to the resin and appeared in the void volume (lanes B and F 
of Figure 26-I). A small amount of non-specifically bound 
Protein was eluted from the cyclic AMP affinity resin with 
750 mM NaCl when soluble cytosolic protein from either 
denervated or sham-operated solei was applied to the column 
I. STAINED PROTEINS 
n. 32P-LABELED PROTEINS 
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(lanes C and G of Figure 26-I). Some protein from denervated 
and sham-operated solei appeared to be specifically bound to 
the cyclic AMP affinity resin and was displaced from these 
columns with high concentrations (1 mM) of cyclic AMP (lanes 
D and H of Figure 26-I). This protein{s) was not visualized 
with the Coomassie stain, but was detected by autoradiography 
(lanes D and H of Figure 26-II). 
The specificity of the N6-(2-aminoethyl)-cyclic AMP-
Sepharose in retaining 32P-labeled soluble cytosolic phosphc-
proteins from 2l! hr denervated short stump-solei and sham-
operated solei is illustrated in the autoradiograph (Figure 
26-II) derived from the dried slab gel shown in Figure 26-I. 
A single 32P-labeled soluble cytosolic phosphoprotein was 
specifically adsorbed by the cyclic AMP affinity resin when 
soluble protein from either the cytosolic fractions of 
denervated solei (Figure 26 II-lane D) or contralateral, 
sham-operated solei (Figure 26 II-lane H) was applied to 
separate cyclic AMP affinity columns. This 32P-radiolabeled 
phosphoprotein was eluted from these columns with 1 mM cyclic 
AMP. The relative molecular weight of the cyclic AMP-binding 
phosphoprotein resolved from the cytosolic fractions of 
denervated and sham-operated rat solei was determined to be 
56,000. This relative molecular weight was determined by 
comparing its relative electrophoretic mobility to the 
electrophoretic mobilities of known molecular weight marker 
Proteins which were used to establish the molecular weight 
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calibration curve shown in Figure 40 of the Appendix. The 
32 P-labeling of the 56,000-dalton cyclic AMP-binding protein 
resolved from denervated solei is greater relative to sham-
operated, contralateral solei. Also, the electrophoretic 
mobility determined on SDS gradient slab gels of the 56,000-
dalton cyclic AMP-binding phosphoprotein from rat solei is 
the same as the electrophoretic mobility of the 56,000-dalton 
denervation period and nerve stump length-dependent phospho-
protein from rat solei. 
3. Anti-RII (regulatory subunit of cyclic AMP-dependent 
protein kinase type II) immunoaffinity chromatography 
Antiserum was raised by Sigma Chemical Company (St. 
Louis, MO) as described in Method L against a commercial 
preparation of the cyclic AMP-dependent protein kinase type 
II regulatory subunit (RII) derived from bovine heart muscle. 
The immunoglobulin G (IgG) component of the crude antiserum 
was partially purified by sodium sulfate fractionation and 
ion exchange chromatography and then tested for its specifi-
city by the Ouchterlony double diffusion method (Ouchterlony, 
1967). The partially purified IgG fraction of the anti-RII 
antiserum immunoprecipitates commercially purified bovine 
heart RII (Figure 27-I). The antigenic response was weak 
(faint immunoprecipitin line) when the reaction was carried 
out against 5, 10, 15 and 20 ug of RII. However, only one 
immunoprecipitin line was observed which is characteristic of 
a monospecific, antibody/antigen conjugation. Also the IgG 
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fraction of the anti-RII antiserum did not cross react with a 
commercial preparation of cyclic AMP-dependent protein kinase 
type I holoenzyme (15 and 20 ug), a commercial preparation of 
cyclic AMP-dependent protein kinase catalytic subunit (20 
ug), or saline (Figure 27-II). 
An anti-RII immunoaffinity column was prepared by 
conjugating the partially purified IgG fraction of the anti-
RII antiserum to CNBr-activated Sepharose 4B (Method L). 
Soluble proteins from the cytosolic fractions of 24 hr 
denervated short nerve stump-solei and contralateral, sham-
operated solei were 32P-labeled ~ vitro (Method E) and then 
prepared for immunoaffinity chromatography (Method L). 
Similar amounts of soluble cytosolic protein from denervated 
and sham-operated solei (approximately 200 ug) were applied 
to separate immunoaffinity chromatography columns. Non-
adsorbing proteins collected in the column void volume, non-
specifically bound proteins eluting with NaCl, and those 
proteins eluting with low pH (2.2) glycine buffer were then 
concentrated by lyophilization, resuspended in 200 ~1 of "SDS 
stop solution" and resolved by SDS gradient slab PAGE. Also, 
a separate 200 ul aliquot of soluble cytosolic protein from 
denervated and sham-operated solei was not subjected to 
immunoaffinity chromatography, but was concentrated by 
lyophilization, resuspended in an "SDS stop solution" and 
resolved by SDS gradient slab PAGE. This procedure made it 
Possible to quantitate and statistically compare the 
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adsorption of specific soluble phosphoproteins from both 
denervated and sham-operated cytosols on an anti-RII immuno-
affinity resin. The 56,000-dalton phosphoprotein in each of 
these fractions resolved on SDS gradient slab gels was 
located by staining the gel with Coomassie brilliant blue. 
The Commassie blue stained band corresponding to the 56,000-
dalton protein was cut from the gel (2 mm slice) and 3 2 P-
radioactivity in this 2 mm gel slice was quantitated by 
liquid scintillation spectrometry. 
Quantitatively, 80.4 ± 2.8% (mean± S.E.M. with n=3) 
of the 32P-radioactivity specifically associated with the 
56,000-dalton phosphoprotein from the cytosolic fraction of 
denervated solei (total cpm in 2 mm gel slice) does not bind 
to the affinity resin and can be accounted for in the void 
fraction (Table 9). Similarly, 75.9 ± 5.6% (mean± S.E.M. 
with n=3) of the 32P-radioactivity associated with the 
56,000-dalton phosphoprotein from the cytosolic fraction of 
contralateral, sham-operated soleidoesnotbind to the 
affinity resin and appears in the void fraction (Table 9). 
Only 2.1 ± 0.7% (mean ± S.E.M. with n=3) of the total 3 2 P-
radioactivity associated with the 56,000-dalton protein from 
the cytosolic fraction of denervated solei was eluted from 
the affinity column with 0.5 M NaCl followed by 10 mM Tris-
HCl, pH 7.4 (Table 9). Also, only 1.5 ± 1.0% (mean± S.E.M. 
With n=3) was eluted from immunoaffinity columns to which 
cytosolic fractions of contralateral, sham-operated solei 
were applied (Table 9). However, 12.0 ± 1.7% (mean ± 
TABLE 9. 
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ADSORPTION OF THE 56,000-DALTON PHOSPHOPROTEIN 
FROM THE CYTOSOLIC FRACTIONS OF DENERVATED AND 




------------------------------------------------------------Sourcea %Total CPM %Total CPM 
of 56K 
Cytosol 100 100 
Void Vol. 80.4 ± 2.8 7 5. 9 ± 5.6 
~aCl Elution 2. 1 .± 0.7 1.5 .± 1.0 
Low pH ( 2. 2) Elution 1 2. 0 
.± 1 • 7 16. 2 .± 3. 9 
a Soluble protein from the cytosolic fractions of denervated 
and contralateral, sham-oprated rat solei was phosphorylated 
.i.n .Y.i..t.£..Q ( M e t h o d E ) • 3 2 P- 1 a b e 1 e d r e a c t i o n p r o d u c t s ( 2 0 0 u 1 
aliquot of the incubation medium) were resolved by SDS 
gradient slab PAGE (Method K). The 200 ul aliquot from the 
cytosclic fractions of denervated cytosol contained 188.7 ug 
of protein and the 200 ul aliquot from sham-operated cytosol 
contained 195.6 ug of protein. The region of the gel (2 mm 
gel slice) containing the the 32P-labeled 56,000-protein was 
visualized after Coomassie staining and located by examining 
consecutive 2 mm gel slices with a Geiger counter. Another 
aliquot from the phosphorylation assay containing a similar 
amount of soluble 32P-labeled protein from denervated 
cytosols ( 188.7 ug) and sham-operated cytosols ( 195.6) were 
applied to separate immunoaffinity columns. Non-binding 
proteins eluting in the void volume, non-specifically bound 
proteins eluting with NaCl and those eluted specifically with 
low pH (2.2) buffer were concentrated by lyophilization and 
applied to the SDS gel. The 32P-labeling of the 56,000-
dalton protein was quantitated by liquid scintillation 
spectrometry of 2 mm gel slices. Percentages are reported in 
the Table as means ± S.E.M for three groups of three animals. 
bThe left soleus was denervated 24 hr prior to sacrifice by 
cutting the soleus branch of the sciatic nerve leaving a 2 mm 
distal nerve stump left attached to the muscle. Sham-
operated, contralateral muscles served as controls. 
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s.E.M. with n=3) of the 32P-radioactivity associated with the 
56,000-dalton protein from the cytosolic fractions of 
denervated solei and 16.2 ± 3.9% (mean + S.E.M. with n=3) 
from sham-operated solei bound to anti-RII immunoaffinity 
columns and was displaced only after treating these columns 
with low pH (2.2) 0.2 M glycine buffer (Table 9). Also, the 
32p-radiolabeling associated with the 56,000-dalton soluble 
cytosolic phosphoprotein resolved by anti-RII immunoaffinity 
chromatography from denervated solei was significantly (p < 
0.05) greater (160.6 ± 27.5%; mean± S.E.M. with n=3) than 
the 32P-labeling associated with the 56,000-dalton protein 
resolved from contralateral, sham-operated solei. 
Since the percentage of 56,000-dalton phosphoprotein 
bound to the anti-RII immunoaffinity resin was low when 
either denervated (12.0%) or sham-operated (16.2%) sample was 
applied to individual columns, the ability of the immune-
affinity column to bind a commercial preparation of RII, 
phosphorylated .i...n vitro (Method N), was examined. Anti-RII 
immunoaffinity columns were prepared by conjugating either a 
commercial preparation of anti-RII to Sepharose ~B or by 
conjugating purified anti-RII (gift from the laboratory of 
Dr. Richard Jungmann, Department of Molecular Biology, 
Northwestern University Medical School, Chicago, 11.) to the 
Sepharose resin (Method L). Binding and non-binding 32p_ 
labeled RII protein were identified by SDS gradient slab 
PAGE. It is important to point out that purified 56,000-
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dalton RII protein obtained from commercial sources shows 
several contaminating proteins when resolved by SDS gradient 
slab PAGE (not shown). When equivalent amounts of 
phosphorylated bovine heart RII (16 ug) were passed over 
these two iromunoaffinity columns, only 23.4% of the total 
32p-radioactivity associated with the 56,000-dalton RII 
protein was retained by the iromunoaffinity column prepared 
with commercially produced anti-RII antiserum. Also, only 
17.6% was bound to the immunoaffinity column prepared with 
purified anti-RII antiserum (Table 10). 
4. 32P-Phosphopeptide mapping 
Limited tryptic digestion of proteins carried out in 
SDS polacrylamide slab gels (15%) according to Cleveland et 
al. (1977) provides a convenient method for analyzing peptide 
maps generated from the proteolytic fragmentation of specific 
proteins purified by SDS gradient slab PAGE. Cytosolic 
fractions from rat solei were incubated in the phosphoryla-
tion medium containing 2 mM MgC1 2 and [gamma-32p]ATP (Method 
E). The 32P-radiolabeled 56,000-dalton soluble phospho-
protein was resolved from the cytosolic fractions of these 
muscles by SDS gradient slab PAGE, sliced from the slab gel 
(2 x 5 mm gel slice) and prepared for tryptic peptide mapping 
(Method M) . Phosphopeptides generated by proteolysis of the 
56,000-dalton phosphoprotein with bovine pancreas trypsin for 
30 min were resolved by SDS slab PAGE (15% polyacrylamide 
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TABLE 10. ADSORPTION OF RII BY ANTI-RIIIMMUNOAFFINITY 
CHROMATOGRAPHY AFTER ~ VITRO PHOSPHORYLATION 
--------------------------------------------------------------




a Assay 94712 100 
Void Vol. 66541 70.3 
NaCl Elution 3080 3.3 
Low pH ( 2 . 2 ) Elution 22142 23.4 
b Assay 100113 100 
Void Vol. 71292 7 1 • 2 
NaCl Elution 803 0.8 
Low pH ( 2. 2) Elution 17538 17 . 5 
-------------------------------------------------------------
aAntiserum against commercially prepared RII subunit of 
cyclic AMP-dependent protein kinase type II was supplied by 
Sigwa Chemical Co., St. Louis, MO. The IgG fraction from 
this antiserum was partially purified and coupled to CNBr-
activated Sepharose 4B (Method L). 
bAntiserum raised against RII protein was a gift from the 
laboratory of Dr. Richard Jungmann. This antiserum was also 
prepared for use in immunoaffinty chromatography by the 
protocol described in Method L. 
ccommercially available RII protein (Sigma Chemical Co.) was 
phosphorylated~ vitro (Method N) and prepared for immunoaf-
finity chromatography (Method L). An equivalent amount of 
32P-labeled RII protein (16 ug) was applied to individual 
immunoaffinity chromatograph~ columns prepared with either 
antisera a or b. Non-binding 3 P-labeled RII protein eluting 
in the void volume, non-specifically bound RII protein 
eluting with NaCl and those eluting with 0.2 M glycine (pH 
2.2) were concentrated by lyophilization and applied to the 
SDS gel. The region of the gel containing the 56,000 -dalton 
RII protein (2 mm gel slice) was detected by cutting the gel 
into consecutive 2 mm gel slices and examing each slice with 
a Geiger counter. The 32P-labeling of the 56,000-dalton RII 
Protein was quantitated by liquid scintillation spectrometry. 
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gel) and visualized by autoradiography (Figure 28). Re-
electrophoresis of the 32P-labeled 56,000-dalton phosphopro-
tein by SDS slab PAGE resolved the 56,000-dalton phosphopro-
tein, another major 52,000-dalton phosphopeptide and a 
minor 39,000-dalton phosphopeptide (Figure 28A). These 
phosphopeptides probably represent proteolytic fragments 
generated from the 56,000-dalton protein during the prepara-
tion of the protein for re-electrophoresis (30 min 
incubation). Proteolytic fragments of 52,000 and 39,000-
daltons have been previously reported for the 56,000-dalton 
regulatory subunit of cyclic AMP-dependent protein kinase 
type II (Rangel-Aldao et al., 1979). When the 32P-labeled 
56,000-dalton phosphoprotein is treated with 0.5 ug of 
trypsin, much of the protein is digested to minor 32P-labeled 
phosphopeptides of Mr=52,000, 31,000, 24,000 and 12,000 and 
major phosphopeptides of 39,000 and 16,500 (Figure 28B). 
Increasing the amount of trypsin to 1.0 ug results in an 
apparent increase in the 32P-labeled 16,500-dalton and 
12,000-dalton 
3 2 P-labeled 
phosphopeptides and a slight decrease in the 
39,000-dalton phosphopeptide (Figure 28C). 
Complete digestion of the 56,000-dalton phosphoprotein with 
10.0 ug of trypsin yields phosphopeptides of 16,500-daltons 
and 12,000-daltons (Figure 28D). Holecular weights were esti-
mated after establishing a molecular weight calibration curve 
for this SDS slab gel using known molecular weight marker 
proteins (Figure 28). 
In order to determine whether the low molecular 
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Figure 28. 32P-phosphopeptide map obtained after tryptic 
digestion of the 56,000-dalton phosphoprotein from unoper a ted 
rat soleus muscle. The 56,000-dalton soluble phosphoprotein 
was 32P-radiolabeled in vitro using a phosphorylation incuba-
tion media containing 2 mM MgC1 2 and [gamma-32p]ATP. The 
phosphorylated 56,000-dalton protein was resolved by SDS 
gradient slab PAGE. The Coomassie blue stained band 
containing the 56,000-dalton phosphoprotein was sliced from 
the gel and prepared for peptide mapping (Method M). The 
56,000-dalton phosphoprotein was re-electrophoresed on an SDS 
15% polyacrylamide slab gel. The autoradiograph of the 
peptide mapping gel is shown. The 56,000-dalton phosphopro-
tein was treated as follows: (A) no trypsin; (B) + 0.5 ug 
trypsin; (C) + 1.0 ug trypsin; (D) + 10 ug trypsin. The 
molecular weights of radiolabeled phosphopeptides are 
indicated and were established relative to the electro-
phoretic mobilities of standard known molecular weight 
marker proteins. The protein standards (i.e., bovine serum 
albumin (BSA)-66,000; ovalbumin (OVAL)-45,000; aldolase 
(ALD)-40,000; trypsinogen (TRYP)-24,000; lysozyme (LYS)-
14,300) were obtained from commercial sources. Standard 
Proteins were prepared as solutions of 1 mg protein/n::l of 
buffer (0.0625 M Tr· is-HCl, pH 6.8, 0.1% SDS and 5% 2-
mercaptoethanol) and were denatured by boiling for 2 min 
Prior to electrophoresis. Ten micrograms of each standard 
Protein were applied to the peptide mapping gel. Relative 
mobilities (Rr) are the values obtained from a si n gle 
electrophoretic separation. 
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weight phosphopeptides observed in Figure 28 (16,500 and 
12,000-daltons) represented further proteolytic digestion of 
the 39,000-dalton phosphopeptide, the 32P-labeled 39,000-
dalton phosphopeptide obtained from the limited tryptic 
digestion of the 56,000-dalton phosphoprotein (lane B of 
Figure 28) was subjected to further proteolysis with 10.0 ug 
trypsin. The generated 32P-labeled peptides were resolved by 
SDS slab PAGE (15% gel). The 32P-cpm of consecutive 2 mm gel 
slices was determined by liquid scintillation spectrometry. 
Tryptic proteolysis of the 39,000-dalton phosphopeptide 
generated only 2~,000, 16,500 and 12,000-dalton phospho-
peptides (Figure 29). Also, the total 32P-cpm associated 
with these tryptic products (1069 ± 262 cpm; mean± S.E.M. 
with n=3 sum of solid bars in the inset of Figure 29) is 
not statistically different by paired t-test to the total 
32P-cpm associated with the 39,000, 16,500 and 12,000-dalton 
phosphopeptides observed before tryptic digestion (1208 ± 
228 cpm; mean± S.E.M. with n=3 sum of open bars in the 
inset of Figure 29). The relative molecular weights of these 
peptides were estimated after establishing a calibration 
curve using known molecular weight marker proteins as 
described for Figure 28. 
The phosphopeptide map of the 32P-labeled 56,000-
dalton phosphoprotein from rat soleus muscle was compared to 
the 32P-phosphopeptide map of a commercial preparation of 
bovine heart cyclic AMP-dependent protein kinase type II 
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regulatory subunit (RII). 
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The 56,000-dalton RII protein was 
autophosphorylated ~ vitro with the protein kinase catalytic 
subunit using [gamma-32p]ATP as the phosphoryl donor (Method 
N). The reaction products were resolved by SDS gradient slab 
PAGE. The 32P-labeled 56,000-dalton RII protein was sliced 
from the gel and digested with trypsin. Then the generated 
32P-phosphopeptides were resolved by SDS slab PAGE (Figure 
30-I). Like the 56,000-dalton phosphoprotein from rat soleus 
muscle, limited tryptic proteolysis of the 56,000-dalton RII 
protein with 0.1 ug trypsin generated major phosphopeptides 
of 52,000, 39,000, 31,000, 18,000 and 16,500-daltons (lane B 
of Figure 30-I). Also, like the 56,000-dalton soleus 
phosphoprotein, the 56,000-dalton RII protein was completely 
digested to phosphopeptides of 16,500 and 12,000-daltons 
(lane C of Figure 30-I). 
One of the tryptic phosphopeptides of the 56,000-
dalton RII protein, the 39,000-dalton phosphopeptide, has 
been reported to contain the autophosphorylation site (Potter 
and Taylor, 1979; Rangel-Aldao et al., 1979; \oleber and Hilz, 
1979; Takio et al., 1980). This 39,000-dalton autophosphory-
lation peptide generated from the limited tryptic digestion 
of the 56,000-dalton RII protein (lane B of Figure 30-I) was 
digested further with 2.0 ug trypsin and its proteolytic 
Products were also resolved by SDS slab PAGE. Only the 
39,000-dalton phosphopeptide was observed following re-
electrophoresis of this phosphopeptide by SDS slab PAGE 
Without trypsin present (lane A of Figure 30-II). However, 
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the 39,000-dalton autophosphorylation peptide generated the 
same low molecular weight proteolytic products as the 56,000-
dalton RII protein and the 56,000-dalton soleus phospho-
protein. These include the 31,000, 24,000, 16,500 and 
12,000-dalton tryptic fragments (lane B of Figure 30-II). 
Cytosolic fractions from 24 hr denervated short (< 2 
mm) nerve stump-solei and their contralateral, sham-operc.ted 
solei were 32P-labeled ~ ~~ and the radiolabeled 56,000-
dalton phosphoprotein was resolved from these fractions by 
SDS gradient slab PAGE. Then phosphopeptides generated by 
proteolysis (0.5 ug trypsin) of the 56,000-dalton phospho-
proteins from both denervated and sham-operated muscles were 
resolved by SDS slab PAGE and visualized by autoradiography 
(Figure 31). He-electrophoresis of the 56 ,000-dal ton phos-
phoprotein from both denervated (Figure 31A) and sham-
operated solei (Figure 31B) by SDS slab PAGE generated the 
56,000-dalton phosphoprotein and a 52,000-dalton phospho-
peptide. Tryptic proteolysis of the 32P-labeled 56,000-
dalton phosphoprotein from either denervated (Figure 31C) or 
sham-operated muscles (Figure 31D) generated major 39,000-
dalton phosphopeptide and a minor phosphopeptide of Hr 
=16,500. The phosphorylation of the 56,000-dalton phospho-
protein and also the 39,000-dalton fragment is increased in 
the denervated compared to the sham-operated muscle. 
Molecular weights were estimated after establishing a cali-















Figure 31. 32P-phosphopeptides generated frorr. the tryptic 
proteolysis of the 32P-labeled 56,000-dalton phosphoprotein 
from the cytosolic fractions of denervated and sham-operated 
rat solei. The 56,000-dalton soluble phosphoproteins from 
the cytosolic fractions of solei denervated for 24 hr with a 
short (< 2 mm) distal nerve stump and their contralateral, 
s h a m - o p e r a t e d m u s c l e s w e r e p h o s p h o r y l a t e d i.n _yj__k.r_Q a n d 
resolved by SDS gradient slab PAGE. Equal aliquots of 
denervated and sham-operated soluble cytosolic protein (35 
ug) were applied to individual sample wells of the slab gel. 
The 56,000-dalton 32P-labeled phosphoproteins were sliced 
fr· om the gel (2 mm gel slice) and prepared for peptide 
mapping. An autoradiograph of the resolved 32P-labeled phcs-
phopeptides derived from the 56,000-dalton phosphoproteins 
from denervated and sham-operated solei and resolved in an 
SDS 15% polyacrylamide slab gel is shown. The 56,000-dalton 
protein from the cytosolic fractions of denervated solei was 
treated as follows: (A) no trypsin; (C) + 0.5 ug trypsin. 
The 56,000-dalton proteins from the cytosolic fractions of 
sham-operated solei were treated as follows: (B) no trypsin ; 
(D) + 0.5 ug trypsin. Relative molecular weights of the 
tryptic phosphopeptides are shown and were established 
relative to the known standard molecular weight marker 
Proteins shown in Figure 28. 
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described for Figure 28. 
The 3 2 P-cpm of each phosphoprotein and phospho-
peptide shown in Figure 31 (A-D) was determined in consecu-
tive 2 mm gel slices by liquid scintillation spectrometry. 
The data shown in Figure 32 were derived from three 
individual gels of which a representative example is shown in 
Figure 31. The quantitative result shown in Figure 32 
supports the qualitative result shown in Figure 31. The 
phosphorylation of the 56,000-dalton protein and also the 
39,000-dalton fragment is increased in denervated (Figure 32 
lanes A and C) compared to sham-operated muscles (Figure 32 
lanes B and D). 
Cytosolic fractions from 66 hr denervated long (32 
to 35 mm) nerve stump-solei and their contralateral, sham-
operated muscles were 32P-labeled ~ x~~XQ and the radio-
labeled 56,000-dalton phosphoprotein was resolved from these 
fractions by SDS gradient PAGE. Then phosphopeptides 
generated by proteolysis (0.5 ug trypsin) of the 56,000-
dalton phosphoproteins from both denervated and sham-operated 
muscles were resolved by SDS slab PAGE and visualized by 
autoradiography (Figure 33). Tryptic proteolysis of the 
56,000-dalton phosphoprotein from both denervated and sham-
operated solei generated major phosphopeptides of 50,000, 
39,000 and 16,500-daltons. Minor phosphopeptides of 31,000, 
24,000 and 12,000 were also resolved. The 32P-cpm associated 
With each of the major phosphopeptides was determined by 
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Figure 32. The distribution of 32P-radioactivity associated 
with phosphopeptides derived from the 32P-labeled 56,000-
dalton soluble protein resolved from the cytosolic fractions 
of denervated and sham-operated solei. The left soleus was 
denervated 24 hr prior to sacrifice by cutting the soleus 
branch of the sciatic nerve 2 mm before its insertion into 
the muscle. Control samples were obtained from sham-
operated, contralateral solei. Cytosolic fractions were 
incubated in a phosphorylation media containing [gamma-
32P]ATP and the soluble 32P-labeled 56,000-dalton protein was 
resolved by SDS gradient slab PAGE, sliced from the gel and 
prepared for tryptic proteolysis and peptide mapping in an 
SDS 15% polyacrylamide slab gel. 32P-radioactivity was 
quantitated in consecutive 2 mm gel slices by liquid scintil-
lation spectrometry. The source of the 56,000-dalton protein 
in these samples was as follows: A) 24 hr denervated short (< 
2 mm) distal nerve stump-solei; B) contralateral, sham-
operated solei; C) denervated solei + 0.5 ug trypsin; D) 
sham-operated solei + 0.5 ug trypsin. Values for each bar 
represent the means ± S.E.M. with n=3· Molecular weights 
indicated at the top of each quadrant (A-D) were estimated 
relative to the electrophoretic mobilities of known molecular 
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Figure 33. 32P-phosphopeptides generated from the tryptic 
proteolysis of the 32P-labeled 56,000-dalton phosphoprotein 
resolved from the cytosolic fractions of denervated (long 
nerve stump) and sham-operated solei. The left soleus was 
denervated 66 hr prier to sacrifice by cutting the soleus 
branch of the sciatic nerve 32 to 35 mm before its insertion 
into the muscle. Control samples were obtained from sham-
operated, contralateral solei. Cytosolic fractions were 
incubated in the phosphorylation medium containing [gamma-
32p]ATP. A similar aliquot of radiolabeled cytosol protein 
from denervated (30.2 ug) and sham-operated (29.6 ug) solei 
was applied to an SDS gradient slab gel. The soluble radio-
labeled 56,000-dalton protein was resolved by SDS gradient 
slab PAGE, sliced from the gel and prepared for tryptic 
proteolysis and peptide mapping in an SDS 15% polyacrylamide 
slab gel. An autoradiograph of the resolved 3 2 P-labeled 
phosphopeptides derived from the tryptic digest (0.5 ug 
trypsin) of the radiolabeled 56,000-dalton protein fr om 
denervated and sham-operated solei is shown. The distribution 
of 32P-radioactivity was quantitated in consecutive gel 
slices of 2 mm by liquid scintillation spectrometry. The 
percentage of the total radioactivity recovered in the gel 
(cpm) repesented by each phosphopeptide is shown. Relative 
molecular weights of the tryptic phosphopeptides are also 
shown and were established relative to the electrophoretic 
mobilities of the known molecular weight marker proteins 
s hown i n Figure 28. 
each slice by liquid scintillation spectrometry. 
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By these 
procedures, it was determined that the percentage of the 
total 32P-cpm recovered in each of the major phosphopeptides 
was similar when the 56,000-dalton 32P-labeled phosphoprotein 
was derived from 66 hr denervated long nerve stump solei or 
the contralateral, sham-operated solei. Also, with the 
exception of the 50,000-dalton phosphopeptide, the phos-
phopeptides generated are the same as those generated from 
the 56,000-dalton RII protein and the 56,000-dalton protein 
from 24 hr denervated short nerve stump-solei and their 
contralateral, sham-operated muscles. Finally, the phos-
phorylation of the 56,000-dalton phosphoprotein and also the 
39,000-dalton fragment is increased in denervated (Figure 
3 3 A) compared to the sham-operated muscle (Figure 33B). 
The quantitative increase in cytosolic protein phos-
phorylation was determined in denervated solei (24 hr short 
nerve stump and 66 hr long nerve stump) relative to contra-
lateral, sham-operated solei as described for Figure 8 and is 
shown as the percentage of 32P-radioactivity in the 
denervated versus sham-operated solei (Figure 34). The quan-
titative increase in the phosphorylation of the radiolabeled 
56,000-dalton phosphoprotein was also determined in these 
samples using the gel slice data from Figure 32 (for 24 hr 
denervated muscles) and Figure 33 (for 66 hr denervated 
muscles). The quantitative increase in the phosphorylation 
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56,000-dalton phosphoprotein was determined in the same 
manner. When cytosolic protein phosphorylation is increased 
in 24 hr denervated short nerve stump-solei compared to sham-
operated solei (171.0 .± 13.4%, mean±. S.E.M. with n=3), a 
comparable increase is observed in the phosphorylation of the 
56,000-dalton phosphoprotein resolved from these muscles 
(160.6 .± 10.1%, mean±. S.E.H. with n=3) and also in the 
39,000-dalton tryptic phosphopeptide derived from the 56,000-
dalton phosphoprotein (157.1 .± 7.3%, mean±. with n=3) (Figure 
34). Additionally, when cytosolic protein phosphorylation 
is increased in 66 hr denervated long nerve stump-solei 
compared to sham-operated solei (148.9%), a comparable 
increase is observed in the phosphorylation of the 56,000-
dalton phosphoprotein resolved from these muscles (157.7%) 
and also in the 39,000-dalton tryptic phosphopeptide derived 
from the 56,000-dalton phosphoprotein (168.9%). 
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IV. DISCUSSION OF RESULTS 
A denervation-induced alteration of cytosolic 
protein phosphorylation in rat soleus muscle was found to be 
directly related to the denervation period and the length of 
the distal nerve stump. The phosphorylative changes observed 
in denervated solei were reported relative to contralateral, 
sham-operated solei. When the branch of the sciatic nerve 
innervating the soleus muscle was cut leaving a distal, short 
nerve stump of 2 mm or less, a significant increase in the 
phosphorylation of soluble cytosolic protein was first 
observed as early as 3 hr after denervation. The maximal 
increase of cytosolic protein phosphorylation in this short 
nerve stump-muscle occurred at 24 hr and a significant 
increase was still observed at 30 and 36 hr after denerva-
ti on. A significant increase in cytosolic protein phos-
phorylation was not observed, however, at the early denerva-
tion periods (i.e., 3, 12 or 24 hr) when an intermediate (17 
to 20 mm) or long (32 to 35 mm) nerve stump was left attached 
to the muscle. Additionally, a significant increase in the 
phosphorylation of soluble cytosolic protein was not 
observed until 30 hr after denervation when a distal, inter-
mediate nerve stump was left attached to the soleus muscle 
and 48 hr after denervation when a distal, long nerve stump 
stump was left attached to the muscle. A significant 
increase in the phosphorylation of cytosolic proteir, in the 
"double denervation" group (short nerve stump-solei dener-
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vated for 24 hr relative to contralateral, solei denervated 
for 24 hr with a distal, long nerve stump) was also found. 
All these denervation period and nerve stump length-dependent 
changes suggest that the neuroregulation of cytosolic protein 
phosphorylation is related to a trophic influence of the 
motoneuron and is not simply a consequence of muscle disuse. 
Additionally, the "double denervation" results suggest that 
cytosolic protein phosphorylation is not related to an 
alteration in the supply of blood-borne humoral factors due 
to a denervation-induced change in blood flow. 
Additionally, when a significant loss in muscle 
weight was observed in long nerve stump solei at 66 hr after 
denervation, the phosphorylation of soluble cytosolic protein 
was still significantly increased relative to contralateral, 
sham-operated muscles. This indicates that denervation 
atrophy (as evidenced by a significant decrease in muscle wet 
weight) also does not contribute to the alteration in protein 
phosphorylation within the denervation periods of to 66 hr. 
The delay in the times of onset and also of maximal 
increase in cytosolic protein phosphorylation were found to 
be directly related to the three lengths of distal nerve 
stumps left attached to denervated solei. The delay in the 
onset of increased cytosolic protein phosphorylation of 1.4 
hr/mm distal nerve stump and the comparable delay of 1.3 
hr/mm distal nerve stump based upon the denervation periods 
at which a maximal increase was observed indicate that the 
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rate of change in the phosphorylation event during the 21 hr 
interval from onset to peak is the same for the three nerve 
.stump-muscles. Also, the comparable rates suggest that the 
three nerve stump-~uscles are undergoing similar changes 
which lead to the appearance and development of the 
phosphorylative modification of soluble cytosolic proteir •• 
However, the return of cytosolic protein phosphorylation to 
the levels of the contralateral, sham-operated solei which 
was observed after long periods of denervation with short, 
intermediate and long nerve stump-muscles may not be related 
to neurotrophic effects, but rather to the many metabolic 
changes occurring as the ~uscle becomes increasingly 
atrophic. 
The onset of biochemical and physiological changes 
in muscle which can be related to the length of the distal 
nerve stump remaining attached to the muscle have been inter-
preted as neurotrophic events regulated by a function of the 
nerve independent of the impulse-directed release of acetyl-
choline (reviewed in Lubinska, 1975; Grafstein and Forman, 
1980). The impulse-directed release of acetylcholine at the 
neuromuscular junction will cease immediately in the distal 
nerve stump of any length as a consequence of nerve transec-
tion. Axoplasmic transport, however, has been shown to 
continue in isolated segments of peripheral nerve (Ochs and 
Ranish, 1969). The supply of axonally transported trophic 
substances to the neuromuscular junction ~n ~~~~ will be 
limited quantitatively and temporally by the length of distal 
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nerve stump left attached to the muscle. Therefore, denerva-
tion period and nerve stump length-dependent alterations in 
cytosolic protein phosphorylation may be related to a gradual 
depletion in the supply of an axonally transported neuro-
trophic factor(s). 
Elimination of the impulse-directed contractile 
activity of soleus muscle may also affect the utilization and 
supply of energy in the tissue. Speculatively, therefore, 
energy changes in muscle may contribute to the altered phos-
phorylative modification of soluble cytosolic proteir. 
observed in the denervated muscle. However, early denerva-
tion effects are apparently not energy related. A decrease 
in tigh energy phosphate has been observed in denerv~ted 
muscle and is apparently related to the reduction in 
metabolic rate observed in denervated slow-twitch and fast-
twitch skeletal muscle (Hogan et al., 1965; Kauffman and 
Albuquerque, 1970). These changes may be related to the 
reported denervation-induced decrease in the activities of 
key metabolic enzymes such as glycogen phosphorylase and 
glycogen synthetase (Pichey and Smith, 1979; Moruzi and 
Bergamini, 1983) and the decreased levels of lactate, phos-
phocreatine, inorganic phosphate and ATP (Kauffman and Albu-
querque, 1970). Changes in these energy-related parameters 
~ere studied in skeletal muscle denervated for two to nine 
days. However, alterations in these parameters reportedly do 
not appear until five to nine da~s after denervation of the 
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slow-twitch soleus muscle. Additionally, it is unlikely that 
the twofold increase in cytosolic protein phosphorylation 
observed in denervated solei compared to sham-operated solei 
is related to a change in endogenous ATPase since my results 
show that the conversion of 32P-ATP to 32P-inorganic phos-
phate during the 5 min incubation pericd was relatively 
limited (i.e., - 10 tc 15%). 
As mitochondria play a major role in energy produc-
tion and utilization in mammalian muscle cells, it seems 
likely that alterations in their functioning might also be 
observed in denervated muscles. In fact, an impairment in 
the first two energy coupling regions of the respiratory 
chain have been observed in denervated rat hindlimb muscle, 
but not before 28 days after denervation (Joffe et al., 
1981). DuBois and Max (1983) studied the oxidation of 6-14c-
glucose to 14co 2 in fast-twitch extensor digitorum longus 
muscles denervated for 1 to 60 days with a distal, short 
nerve stump. They found that the oxidation of glucose was 
not affected by denervation until 6 days after denervation. 
A decreased oxidation of specific substrates of the Krebs 
cycle (Kark et al., 1974; Nemeth et al., 1980) as well as a 
decrease in respiratory control and mitochondrial ATPase 
activity (Joffe et al., 1981) have also been observed in 28 
day-denervated muscle, but not in 14 day-denervated muscle. 
The denervation-induced decrease in respiratory control and 
mitochondrial ATPase activity are especially interesting in 
that they are apparently not affected during disuse atrophy 
r 
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(Max, 1972). In the disuse atrophy model the muscle is 
physically innervated, but mechanical contraction is experi-
mentally prevented. This suggests that energy-relc.ted 
alterations, while not contributing to the early denervation 
effect on cytosolic protein phosphorylation, may be affected 
by some neural message independent of impulse-related muscle 
activity. 
Although the nerve stump length protocol has been 
used to demonstrate a trophic function of the motor nerve, 
some investigators have argued that products of nerve 
terminal degeneration may contribute to the denervation-
induced effects observed in muscle. Nerve stump length-
related degeneration of distal nerve stumps has been reported 
for transected peripheral nerves (Miledi and Slater, 1970; 
Card, 1977; Pulliam and April, 1979a and b). It has been 
suggested that the products of nerve terminal degeneration 
may have a direct effect on muscle by exacerbating or 
accelerating the effects of inactivity on changes in some 
nerve stump length-related electrophysiological parameters 
such as the muscle resting membrane potential and extra-
junctional acetylcholine sensitivity. Evidence for ttis 
hypothesis is supported by the findings that partial denerva-
tion of the fast-twitch extensor digitorum longus muscle of 
the rat with tetrodotoxin (TTX) produced denervation changes 
in the TTX sensitivity of both denervated fibers and 
adjacent innervated fibers (Cangiano and Lutzemberger, 1980). 
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However, a more comprehensive study suggested that degenera-
ting nerve fibers did not affect the muscle resting membrane 
potential, extrajunctional acetylcholine sensitivity or TTX 
sensitivity of the adjacent innervated fibers (Teidt et al., 
1977). These authors (Teidt et al., 1977) also suggested that 
the conclusions of Cangiano and Lutzemberger (1977) may have 
been related to the inability of these investigators to 
accurately record changes in the electrophysiological 
parameters of the innervated adjacent fibers. The role of 
degenerating nerve products has also been supported by the 
findings that silastic cuffs impregated with variou~ 
substances such as nerve extract and trypsin caused the 
development of extrajunctional acetylcholine sensitivity when 
placed on the surface of the extensor digitorum longus muscle 
(Jones and Vrbova, 197l!; Jones and Vyskocil, 1975; Vyskocil 
and Syrovy, 1975). A similar effect was observed when a 
graft of peripheral nerve or a piece of suture material was 
placed on the muscle surface (Jones and Vrbova, 197l!). When 
these studies were repeated, marked histopathological 
abnormalities were observed on the muscle surface along with 
a decline in the resting membrane potential and development 
of extrajunctional acetylcholine sensitivity. These studies 
do not support the hypothesis that products of the degenera-
ting nerve are important in the effect of denervation upon 
acetylcholine sensitivity and the resting membrane potential 
since this histopathology was not found concomitantly with 
these electrophysiological changes in a denervated muscle 
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(Bray et al., 1979; Guth and Albuquerque, 1979; Guth et al., 
1980; Oh et al., 1980). Also, extracts of degenerating 
peripheral nerve stumps are able to sustain the development 
of embryonic muscle cells in culture presumably through the 
release of some viable trophic substance (Oh et al., 1980). 
Endplate potentials and muscle contraction which are 
dependent upon impulse-dependent acetylcholine transmission 
are immediately eliminated after transection of the 
peripheral nerve. However, muscle fibrillation has been 
reported to. occur at ~2 and ~8 hr after the sciatic nerve is 
sectioned 5 mm or 30 mm, respectively, from its insertion 
into the soleus muscle of the rat (Salafsky et al., 1968). 
The early onset of increased phosphorylation of cytosolic 
protein occurring at 3 hr and 30 hr for the short and inter-
mediate nerve stump solei, if not at 48 hr for the long nerve 
stump muscle, therefore, precedes the development of fibril-
latory potentials. 
It has been reported recently that spontaneous 
transmission of acetylcholine may be the neural element 
involved in the denervation period and nerve stump length-
dependent neurotrophic regulation of both the resting 
membrane potential and extrajunctional acetylcholine receptor 
sensitivity of muscle (Drachman et al., 1982; reviewed in 
section II). This conclusion was based upon the finding 
that alpha-bungarotoxin blockade of acetylcholine transmis-
sion (both quantal and nonquantal) and denervation have a 
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quantitatively similar effect on the decline in resting 
membrane potential and the increase in extrajunctional 
acetylcholine receptor number of muscle. Alpha-bungarotoxin 
binds specifically and irreversibly to the postsynaptic 
acetylcholine receptor. Blockage of impulse-dependent 
quantal acetylcholine release alone with TTX did not have as 
great an effect on changes in these muscle parameters. This 
result strongly supports a role for the acetylcholine 
receptor in the neural regulation of these parameters and 
implies a role for spontaneous 
choline transmission. Also, 
quantal or nonquantal acetyl-
since much more acetylcholine 
is released from the nerve terminal by nonquantal leakage 
than by spontaneous quantal release (Katz and Miledi, 1977), 
Drachman et al. (1982) also suggested that nonquantal acetyl-
choline release is most important in the neuroregulation of 
the resting membrane potential. However, whether other 
specific muscle properties are regulated entirely by an 
alteration in the spontaneous quantal or nonquantal transmis-
sion of acetylcholine has not been determined. It has been 
reported that the spontaneous, quantal release of acetyl-
choline will continue for no longer than 12 to 14 hr after 
denervation of solei when a short nerve stump is left 
attached to the muscle. These findings are based on the 
recording of miniature endplate potentials .1..n .Y.i.Y..Q in these 
denervated muscles for up to 14 hr after nerve transection 
(Deshpande et al., 1976; Stanley and Drachman, 1980). Non-
quantal spontaneous acetylcholine transmission is reportedly 
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eliminated within a few hr in a short nerve stump muscle 
(Stanley and Drachman, 1980). A significant increase of 
cytosolic protein phosphorylation in the short nerve stump-
solei occurred as early as 3 hr, reached a peak at 24 hr, and 
remained significantly increased for another 12 hr. Whether 
this temporal pattern would correlate with a nerve stump-
related cessation of quantal or nonquantal spontaneously 
released acetylcholine is not clear and would provide an 
interesting topic for future research. 
The specific role of spontaneously released acetyl-
choline in the neuroregulation of skeletal muscle parameters 
has been a controversial issue. The controversy has evolved 
from apparently conflicting results for the 
membrane depolarization (decline in resting 
time course of 
membrane poten-
tial) and the disappearance of miniature end plate potentials 
(mepps) which are the product of the spontaneous quantal 
release of acetylcholine. Alterations in both of these 
electrophysiological parameters have been found to be related 
to the length of distal nerve stump left attached to the 
muscle (reviewed in section II). Deshpande et al. (1976 and 
1980) reported that the decline in resting membrane potential 
cf rat soleus muscle was related to nerve stump length and 
that the change in potential, which occurred within 6 hr 
after denervation with a distal, short (2 mm) nerve stump, 
Preceded the disappearance of mepps measured . .in vitro. These 
results suggested that the denervation period and nerve stump 
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length dependent change in the resting membrane potential was 
not regulated by the spontaneous quantal release of acetyl-
choline and, therefore, might be regulated by an axonally 
transported trophic factor(s). However, Stanley and Drachman 
(1980) confirmed the nerve stump length effect on membrane 
depolarization, but reported that the change was not observed 
~D X~XQ until 18 hr after denervation of rat soleus muscle 
with a distal, short(< 2 mm) nerve stump and followed the 
elimination of mepps. These results are in close agreement 
with the findings of Linden et al. (1983) who assessed nerve 
stump length-dependent changes in resting membrane potential 
and mepps (recorded in vivo) in rat extensor digitorum longus 
muscle. Although it is not clear which changes occur first, 
the decline in resting membrane potential, elimination of 
mepps and the increase in cytosolic protein phosphorylation 
reportedly represent the earliest changes associated with 
denervated muscle and each of these are related to der:erva-
tion period and nerve stump length. Speculatively, therefore, 
these events may represent those muscle changes most closely 
regulated by non-impulse mediated communication between nerve 
and muscle. 
Additionally, another mode of regulation has been 
s u g g e s t e df o r t h e r e s t i n g m e m b r a n e p o t e n t i a 1 i n t h a t i t h a s 
been recently reported that the nerve stump length decline in 
this parameter is dependent upon protein synthesis in the 
target muscle cell (Komatsu et al., 1983). Earlier studies 
also showed that blocking RNA synthesis prevented the 
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denervation-dependent decline in the resting membrane 
potential (Grampp et al., 1972). Also of interest is the 
finding that newly synthesized extrajunctional acetylcholine 
receptors appear very early (within hours) after denervation 
(Olek and Robbins, 1983). However, it is not yet clear 
whether the neural regulation of either mepps, the resting 
membrane potential or cytosolic protein phosphorylation are 
related to the induction of acetylcholine receptor synthesis. 
Relatively few bioche~ical parameters have been 
reported to be related to the length of the distal nerve 
stump left attached to the muscle. Those reported are listed 
in Table 1 (Section II). It can be seen from this Table 
that before changes in these events occurred a latent period 
of 12 to 72 hr was required. This is much longer than the 3 
hr required before a significant increase in cytosolio 
protein phosphorylation is observed ir: short nerve stump-
solei. To my knowledge, a denervation period and nerve stump 
length-dependent increase in cytosolic protein phosphoryla-
tion has not been reported by other investigators. 
The requirements for the phosphorylation of cyto-
solic protein were determined in the cytosolic fractions of 
unoperated rat soleus muscle. The phosphotransferase 
reaction was found to be heat-labile, dependent upon Mg 2 ;. 
and cyclic AMP, but not ca2+ or cyclic GMP, and directly 
related to the amount of cytosolic protein which provides the 
endogenous source of the protein kinase enzyme (EC 2.7.1.37-
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ATP:protein phosphotransferases), ATP, cyclic AMP and phos-
phorylatable protei~ substrate. Also, cytosolic protein 
phosphorylation in unoperated solei did not differ from cyto-
solic protein phosphorylation in sham-operated solei. 
The results of these studies in unoperated muscle 
suggested that the ..1.n vitro phosphotransferase reaction was 
dependent upon endogenous cyclic AMP in the cytosol (Squinto 
et al., 1980). This is based upon the findings of a slight 
increase in cytosolic protein phosphorylation with additions 
of exogenous cyclic AMP in the range of 1o-11 to 10-9 M, but 
a significant reduction in phosphorylation with micromolar 
additions of cyclic AMP. Other investigators have found that 
while low concentrations of cyclic AMP are stimulatory to 
some purified protein kinases, higher levels were inhibitory 
(Kuo and Greengard, 1970). Also, although exogenous cyclic 
AMP only slightly stimulates the phosphorylation of cytosolic 
protein, the specific inhibitor of Ashby and Walsh (1972) for 
cyclic AMP-dependent protein kinase markedly reduces 
cytosolic protein phosphorylation. However, these results 
were obtained with a crude commercial preparation of the 
inhibitor which reportedly may contain other enzymes that 
affect protein phosphorylation (Kantor and Brunton, 1981 ). 
An evaluation of the substrates for the neurally 
regulated cytosolic phosphorylation reaction initially 
involved the biochemical resolution of 3 2 P-labeled soluble 
cytosolic proteins from rat soleus muscle by gel filtration 
chromatography and HPLC size exclusion chromatography. 
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Radiolabeled phosphate was incorporated predominantly into a 
minor protein or group of proteins within a molecular wei~ht 
range of Mr = 58,000 to 35,000. In the denervated solei, the 
3 2 P-radiolabeling of the minor protein(s) was increased 
approximately 2.5-fold when resolved by gel filtration 
chromatography and 2.0-fold when resolved by HPLC. There-
fore, the increase in cytosolic protein phosphorylation 
during the period of maximal stimulation for the short nerve 
stump muscles (24 hr) was comparable to the increased 32p_ 
labeling of a minor protein or group of proteins between 
Mr.=58,000 and 35,000. 
Evaluation of the substrates of the denervation 
period and nerve stump length-dependent cytosolic phosphory-
lation reaction also involved the resolution of in vitro 32p_ 
labeled soluble cytosolic proteins by SDS gradient slab PAGE. 
A minor protein with a relative molecular weight of Mr=56,000 
was immediately apparent as the predominant substrate and 
quantitatively contained approximately 70% of the 32P-label 
i n c o r p o r a t e d .i.n .Y.i.1.r.Q i n t o s o 1 u b 1 e c y t o s o 1 i c p r o t e i n. A 1 s o , 
-85% of the ~.n .Y.i.1.r_Q label was incorporated into alkali-
labile phosphate probably linked, therefore, to serine or 
threonine residues . Mastri et al. (1982) reported the ~.n 
.Y.i.1.r_Q phosphorylation of a 54,000-dalton soluble protein 
resolved from the cytosolic fractions of both the slow-twitch 
soleus and fast-twitch extensor digitorum longus muscles by 
SDS slab PAGE. These authors showed that the phosphorylative 
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modification of this protein was increased after chronic low 
frequency stimulation of the fast-twitch muscle but not the 
slow-twitch soleus muscle. These results suggest a neural 
regulation of this phosphorylation. However, unlike the 
56,000-dalton phosphoprotein reported here, the 54,000-dalton 
protein was a minor cytosolic phosphoprotein and phosphoryla-
tion of this protein was stimulated by cyclic AMP. 
Neuroregulation of the phosphorylative modification 
of the 56,000-dalton protein was established by two criteria. 
First, phosphorylation of the major soluble 56,000-dalton 
phosphoprotein was consistently and predominantly increased 
in the three nerve stump length-solei relative to sham-
operated solei at each of the denervation periods 
corresponding to a maximal increase in cytosolic protei~ 
phosphorylation. Secondly, denervation period and nerve 
stump length-dependent changes in both cytosolic protein 
phosphorylation and phosphorylation of the 56,000-dalton 
proteir, were similar during the course of development of 
these changes in a short nerve stump-muscle. The quantita-
tive assessment of the denervation period and nerve stump 
length-dependent alteration in the phosphorylation of soluble 
cytosolic proteins was only possible for the 56,000-dalton 
protein due to the low level of counts associated with the 
other minor phosphoproteins. The 56,000-dalton protein was 
also identified as having a molecular weight of Mr=40,000 in 
a SDS rod PAGE system (Squinto et al., 1981). The apparent 
discrepancy in molecular weight of the neurally regulated 
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phosphoprotein was resolved by determining that the 32p_ 
labeled, rod gel slice corresponding to a protein of Mr = 
40,000 was 56,000 after re-electrophoresis and improved 
resolution in the SDS gradient slab PAGE system. 
The 56,000-dalton predominant substrate for the 
neurally regulated cytosolic phosphorylation reaction is 
probably not a subunit tightly associated with a larger 
protein complex. This is based upon the findings of a 
similar relative size of the protein when resolved under both 
non-denaturing (gel filtration chromatography and HPLC) and 
denaturing conditions of SDS gradient slab PAGE. 
Several phosphorylatable cytosolic phosphoproteins 
have been identified in skeletal muscle and are listed in 
Table 11. The phosphorylative modification of these proteins 
has been described in section II. However, the molecular 
weight of the denervation pericd and nerve stump length-
dependent phosphoprotein (56,000) and its localization in the 
soluble cytosclic fraction rule out a number of these 
substrates which are found associated with mitochondria, 
myofibrils or glycogen particles. Even if trace amounts of 
certain particulate phosphoproteins should be present, the 
molecul~r weights of their subunits would be either 
considerably lower or higher than 56,000. For example, the 
molecular weights of the phosphorylated light chains of 
myosin are less than 29,000 while the subunits of myosin 
light chain kinase, glycogen phosphorylase, phosphorylase 
TABLE 11. 
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glycogen phosphorylase 4 beta subunits 
phosphorylase kinase alpha and beta 
subunits 
glycogen synthetase 4 subunits 
phosphofructokinase subunit 
cyclic GMP-dependent 2 subunits 
protein kinase 
vi~entin ? 
cyclic AMP-dependent regulatory 







Type I and II 
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white muscle 
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1 of 4 types 





















A listing of reported phosphorylatable cytosolic proteins 
from skeletal muscle, their site(s) of phosphorylation and 
their approximate molecular weights. 
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kinase, glycogen synthetase and phosphofructokinase all have 
molecular weights reportedly greater than 75,000 (Weller, 
1979; Stull, 1980). The molecular weight of the muscle 
phosphoprotein vimentin (57,000) is close to that of the 
56,000-dalton neurally regulated phosphoprotein from the 
cytosolic fraction of soleus muscle. However, vimentin, 
unlike the 56,000-dalton soleus phosphoprotein, can only be 
extracted from muscle with high concentration of nonionic 
detergent and salt and is solubilized with urea (Browning and 
Sanders, 1981 ). 
The relative size (Mr 
isoelectric point (pi of 5.6 
= 56,000) and approximate 
to 5.9 as determined by 
chromatofocusing) of the denervation period and nerve stump 
length-dependent soluble cytosolic phosphoprotein indicated 
that it might be the regulatory subunit of the soluble cyclic 
AMP-dependent pr~tein kinase type II (RII). The relative 
molecular weight of RII by SDS gradient slab PAGE is also 
56,000 (Table 11 and Zoller et al., 1979; Rangel-Aldao et 
al., 1979) and the phosphorylated RII protein has an iso-
electric point between 5.3 and 5.1! determined by isoelectric 
focusing on polyacrylamide gels (Rangel-Aldao et al., 1979). 
The reported pi of phospho-RII indicated that it is slightly 
more acidic than the minor 56,000-dalton phosphoprotein (5.6 
to 5.9). However, the slightly higher isoelectric point 
reported here is not surprising because with the chromate-
focusing method an internal descending pH gradient is esto.-
blished in the chromatography column; therefore, proteius 
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will elute in a pH range slightly more basic than their true 
pi. 
RII is reported to be a cyclic AMP binding proteir. 
and accounts for approximately 30% of the total cyclic Ati,P 
binding activity of skeletal muscle cytosol (Corbin et al., 
1975; Hofmann et al., 1975; Taylor and Stafford, 1978). The 
cyclic AMP-binding property has aided in the isolation, puri-
fication and identification of the types I and II regulatory 
subunits of cyclic AMP-dependent protein kinase by cyclic 
AMP-affinity chromatography (Ramseyer et al., 1974; Dills et 
al., 1975; Dills et al., 1976 and 1976a; Corbin et al., 1978; 
Dills et al., 1979). My preliminary approach toward identi-
fication of the 56,000-dalton denervation and nerve stump 
length-dependent phosphoprotein as RII was based upon the 
biospecific interaction of the 32P-labeled 56,000-dalton 
protein from 24 hr denervated short nerve stump-solei and 
contralateral, sham-operated solei with N6-(2-aminoethyl)-
cyclic AMP coupled to Sepharose 4B. The type II regulatory 
subunit isolated by this affinity chromatography protocol has 
a relative molecular weight of Mr=56,000 when resolved by SDS 
gradient slab PAGE (Liu et al., 1981). 
The 56,000-dalton phosphoprotein was the only 3 2 P-
labeled phosphoprotein bound to the cyclic AMP-affinity resin 
that was eluted specifically witha highconcentration of 
cyclic AMP. However, since only a small amount of thiE 
protein bound to the affinity resin, it cannot be 
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unequivocally established from this result that the 56,000-
dalton phosphoprotein is a soluble cyclic AMP-binding protein 
in the cytosolic fraction of denervated and sham-operated 
solei. The low level of specific binding can be explained if 
most of the 32P-labeled 56,000-dalton protein is already 
bound to endogenous cyclic AMP which would interfere with 
specific binding to the immobilized cyclic AMP affinity 
ligand. 
The identification and purification of cyclic AMP-
dependent protein kinase regulatory subunits (types I and II) 
using type specific antibodies and immunoaffinity chromato-
graphy has been employed less frequently than cyclic AMP 
affinity chromatography. For the type II regulatory subunit, 
this may be due to its poor antigenic properties (Weber et 
al., 1981). Antiserum raised against the type II regulatory 
subunit of cyclic AMP-dependent protein kinase from bovine 
heart (RII antigen and antiserum were commercial prepara-
tions) and coupled to CNBr-activated Sepharose 4B was used to 
identify the neurally regulated 56,000-dalton phosphoproteir: 
as RII. But less than 20% of the total phosphorylated 
56,000-dalton protein recovered from the cytosolic fraction 
of either denervated or contralateral, sham-operated solei 
appeared in the fraction corresponding to specifically bound 
RII antigen. However, the anti-RII immunoaffinity column was 
approximately as efficient in adsorbing (< 20% specifically 
bound) purified and ~~ x~~IQ phosphorylated RII antigen. 
The specific reason for the poor quantitative adsorption of 
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either the soluble cytosolic 56,000-dalton phosphoprotein or 
purified RII protein with the anti-RII immunoaffinity resin 
is not clear, but may be attributable to several factors: 1) 
a poor preparation of RII antigen leading to development cf 
non-specific antibodies exhibiting a low titer; 2) poor anti-
genic properties of the RII protein; 3) the possibility of 
proteolytic activity associated with the purified antibody 
(personal communication from Bio-R&d Laboratories, Richmond, 
CA); 4) an inefficient coupling of antibody to the resin; or 
5) a lack of cross-reactivity between bovine anti-RII 
antiserum and r~t muscle RII. 
The RII subunit of cyclic AMP-dependent protein 
kinase can be phosphorylated ~~ y~~£Q and ~~ Y~YQ by an 
autophosphorylation reaction in which the catalytic subunit 
of the soluble holoenzyme catalyzes the intramolecular 
transfer of the gamma phosphate of ATP to serine residue 95 
(Erlichman et al., 1974; Hofmann et al., 1975; Rangel-Aldao 
and Rosen, 1977; Geahlen et al., 1982). An inhibitory effect 
of cyclic AHP is consistent with the intramolecular autophos-
phorylation of the RII protein because cyclic AMP dissociates 
the regulatory and catalytic subunits and thus prevents the 
intramolecular autophosphorylc.tion reaction. This property 
(autophosphorylation) has been used by several investigators 
as a means of identifying 56,000-dalton phosphoproteins from 
various tissues as RII (DeLorenzo and Greengard, 1973; Maeno 
et al., 1974; Liu et al., 1981). Therefore, the inhibitory 
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effect of cyclic AMP upon the phosphorylation of the 56,000-
d a 1 t o n p r o t e i n w h e n ad de d t o t h e .i.D .Y.i.t..r.Q as s a y w i t h e i t h e r 
cytosolic fractions from 24 hr denervated short nerve stump-
solei or contralateral, sham-operated solei can be taken as 
evidence for an autophosphorylation phenomenon. Also, the 
lack of effect upon the phosphorylation of the 56,000-dalton 
protein when a specific inhibitor of the free catalytic 
subunit of cyclic AMP-dependent protein kinase (Ashby and 
Walsh, 1972) was added to the assay is also consistent with 
an intramolecular autophosphorylation of RII. 
Addition of cyclic AMP to the assay, however, 
markedly increased the phosphorylation of a 47,000-dalton 
phosphoprotein. The phosphorylation of this protein was 
markedly inhibited by the addition of the specific inhibitor 
of the free catalytic subunit of cyclic AMP-dependent protein 
kinase to the ~.D .Y.i.t..r.Q assay. Also, the phosphorylation of 
other minor proteins was markedly increased by cyclic AMP and 
reduced by the addition of the protein kinase inhibitor. The 
identity of this 47,000 cyclic AMP-dependent cytosolic phos-
phoprotein is currently unknown. It is possible, however, 
that this protein is the cyclic AMP-dependent protein kinase 
regulatory subunit type I. This regulatory subunit has a 
relative molecular weight of approximately 47,000 to 49,000 
when resolved by SDS slab PAGE (Hofmann et al., 1975) and can 
be phosphorylated by the catalytic subunit of cyclic AMP-
dependent protein kinase in an intermolecular autophos-
phorylation reaction (Huang et al., 1983). 
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Other subunits of cyclic nucleotide-dependent 
protein kinases are also involved in autophosphorylation 
reactions and are dissociated from the holoenzyme upon 
binding cyclic AMP or cyclic GMP. However, it is not likely 
that they represent the 56,000-dalton substrate of the 
neurally regulated phosphotransferase reaction due to the 
dissimilarity in their molecular weights and their 
phosphorylation properties. The autophosphorylatable 
catalytic subunits of cyclic AHP-dependent protein kinases 
type I and II have molecular weights of approximately 40,000 
(Sharma, 1982 and Table 11). They were also experimentally 
ruled out by comparing the electrophoretic mobilities of the 
major soluble cytosolic phosphoprotein to that of a commer-
cial preparation of the protein kinase catalytic subunit by 
SDS rod PAGE. The molecular weights of the autophosphory-
latable regulatory subunits of cyclic Gl·1P-dependent protein 
kinases are reported to be approximately 75,000 (Geahlen and 
Krebs, 1980 and Table 11). Also, unlike the 56 ,000-dal ton 
p h o s p h o p r o t e i n , t h e p h o s p h o r y 1 a t i o n o f t h e c y c 1 i c G ~: P -
dependent protein kinase regulatory subunits are not affected 
by cyclic AMP. 
Previous studies have indicated that high concentra-
tions of zn2+ (1 to 5 mM) inhibit both protein phosphatase 
activity and cyclic AMP-dependent protein kinase activity 
(DeLorenzo and Greengard, 
trations of Zn 2+ have 





phorylation of RII (Maeno et al., 1971!; Liu and Greengard, 
1976; Liu et al., 1981). When zn2+ was added to the ~ vitro 
phosphorylation reaction, it inhibited the phosphorylation of 
several minor phosphoproteins without affecting the 32p_ 
labeling of the predominant 56,000-dalton phosphoprotein. 
This lack of effect upon the phosphorylation of the 56,000-
daltcn protein in the presence of zn2+ was also observed with 
the cytosolic fractions from 21! hr denervated short nerve 
stump-solei and sham-operated, contralateral solei. Also, 
the cyclic AMP-dependent protein kinase inhibitor did not 
affect the phosphorylation of the 56,000-dalton phosphopro-
tein. Interestingly, the increase cf cytosolic protein phos-
phorylation in 21! hr denervated short nerve stump-solei 
relative to sham-operated solei evaluated ~n y~~IQ in the 
presence of zn+2 or cyclic AMP-dependent protein kinase 
inhibitor was not statistically different from the increase 
in the phosphorylation of the 56,000-dalton protein resolved 
in an aliquot of these samples by SDS gradient slab PAGE. 
This indicates that the denervation-induced increase in the 
phosphorylative modification of a 56,000-dalton soluble cyto-
solic protein may involve predominantly the autophosphoryla-
tion of RII. 
In order to substantiate the evidence suggesting 
that the 56,000-dalton phosphoprotein is the autophosphory-
latable RII protein, the phosphopeptide map of a purified RII 
(commercial preparation resolved by SDS gradient slab PAGE) 
was compared to the phosphopeptide map of the predominant 
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soluble cytosolic 56,000-dalton phosphoprotein from rat 
soleus muscle which was also resolved by SDS gradient slab 
PAGE. Similar to the purified type II regulatory subunit from 
bovine heart, the 56,000-dalton phosphoprotein yielded phos-
phopeptides of Mr = 52,000, 39,000, 31,000, 24,000, 16,500 
and 12,000 after partial tryptic proteolysis. Also, both the 
56,000-dalton soleus phosphoprotein and purified RII could be 
completely digested to phosphopeptides of 16,500 and 12,000-
daltons. These phosphopeptides have also been previously 
described by others for a partial tryptic digest of purified 
RII (Rangel-Aldao et al., 1979, Rannels and Corbin, 1979; 
Potter and Tayler, 1979; Takio et al., 1980; Corbin and 
Rannels, 1981; Hemrr:ings et al, 1982). 
Tt.e 39,000-dalton tryptic phcsphopeptide common to 
both the 56,000-dalton phosphoprotein and purified RII is the 
autophosphorylation peptide (Potter and Taylor, 1979; Rangel-
Aldao et al., 1979; Flockhart and Corbin, 1982). Amino acid 
sequencing and phosphoamino acid analysis of the 39,000-
dalton tryptic fragment of the 56,000-dalton RII protein, 
autophosphorylated .i..n ..YJ,llQ with the free catalytic subunit 
of cyclic AMP-dependent protein kinase, has shown that serine 
95 is the autophosphorylation site (Weber and Hilz, 1979; 
Takio et al., 1980). 
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When cytosolic protein phosphorylation was increased 
in a denervated muscle (24 hr short nerve stump and 66 hr 
long nerve stump) relative to its sham-operated, contra-
lateral muscle, a comparable increase was observed in the 
phosphorylative modification of the 56,000-dalton protein 
resolved from the cytosolic fractions of these muscles and 
the 39,000-dalton phosphopeptide derived from the tryptic 
proteolysis of the 56,000-dalton phosphoprotein. Other lcwer 
molecular weight phosphopeptides (Mr = 16,500 and 12,000) 
also appeared to show a denervation-induced increased phos-
phorylation. However, these low molecular weight tryptic 
fragments were shown to be derived from the major 39,000-
dalton peptide. These results rule out the possibility that 
the increased phosphorylation of the low molecular weight 
phosphopeptides (16,500 and 12,000) derived from the 39,000-
dalton phosphopeptide are related to a denervation-induced 
phosphorylation of the 56,000-dalton protein by glycogen 
synthetase kinases. The phosphorylation of RII catalyzed by 
the glycogen synthetase kinases involving serines 44, 47, 74 
and 76 has been found to occur exclusively on a 17,000-dalton 
phosphopeptide. This 17,000-dalton peptide, however, is not a 
tryptic product of the 39,000-dalton autophosphorylation 
peptide (Carmichael et al., 1982; Hemn:.ings et al., 1982). 
Therefore, it can be concluded that the neurally regulated 
phosphorylation of soluble cytosolic protein occurs at the 
serine 95 autophosphorylation site on the 56,000-dalton RII 
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protein. 
The neurally regulated increase in the ~~ x~~IQ 
autophosphorylation of RII from the denervated muscle 
indicates an increase in the number of available autophos-
phorylation sites ~D vivo. An increase in the number of RII 
autophosphorylation sites in the denervated muscle may be due 
to an increased type I I h o 1 o enzyme con centra t ion .iD Y~.Y.Q or 
an increased association of the type II cyclic AMP-dependent 
protein kinase subunits (R and C) in vivo without a change in 
the concentration of holoenzyme. These interpretations are 
consistent with an increase in the capacity of RII tc 
incorporate 32p from [gamma-32p]ATP when assayed~~ x.i~IQ 
and, therefore, suggest a decreased autophosphorylation of 
RII .iD y~yQ. Demonstration of a neural regulation of RII 
a u t o p h o s p h o r y 1 a t i o n i n d e n e r v a t e d m u s c 1 e ~.n .Y.J..Y.Q m i g h t 
provide insight into the validity of these interpretations. 
An increased level of cyclic AMP-dependent protein 
kinase holoenzyme in denervated muscle might be accounted for 
by an increase in the cyclic AMP-stimulated RII protein 
phosphatase activity of the denervated muscle. It has been 
reported that the 56,000-dalton type II regulatory subunit of 
cyclic AMP-dependent protein kir.ase is dephosphorylated by a 
35,000-dalton protein phosphatase which, unlike most protein 
phosphatases, does not require divalent cations for the 
expression of enzyme activity (Chou et al., 1977). This 
cation-independent phosphatase catalyzes the dephosphoryla-
tion of the free RII protein which allows for the reassocia-
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tion of the catalytic and regulatory subunits. This occurs 
due to the increased binding affinity of the dephospho-RII 
for the catalytic subunit relative to phospho-RII (Hofmann et 
al., 1975; Rangel-Aldao and Rosen, 1977). However, when the 
dephosphorylation of the 56,000-dalton phosphoprotein was 
specifically studied in 24 hr denervated short nerve stump-
solei and contralateral, sham-operated solei using EDTA to 
terminate phosphorylation and inhibit cation-dependent phos-
phatase activity, very little cation-independent RII phospha-
tase activity was observed and differences in phosphatase 
activity between the two muscle samples were not apparent. 
Additionally, very little cation-dependent protein phospha-
tase activity was found in either muscle as well. Therefore, 
it is unlikely that the two-fold increase in RII autophos-
phorylation observed in denervated muscle could be accounted 
for by an increase cf either the RII protein phosphatase or 
protein phosphatase activity. 
An apparent increase in the state of association 
and inactivation of the type II cyclic AMP-dependent protein 
kinase holoenzyme in denervated muscle might also be 
explained by a decrease in the concentration of cyclic AMP in 
that tissue relative to sham-operated muscles. The marked 
increase in the phosphorylation of exogenous histone in sham-
operated solei relative to 24 hr denervated short nerve 
stump-solei, presumably by the endogenous catalytic subunit 
of cyclic AMP-dependent protein kinase, suggests that the 
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concentration of free catalytic subunit is greater in sham-
operated muscles relative to denervated muscles. Since the 
concentration of free catalytic subunit may be related to the 
concentration of cyclic AMP, these results in turn suggest 
that the concentration of cyclic AMP is greater in sham-
operated muscles relative to denervated muscles. This would 
also be con~istent with an increased state of association of 
the holoenzyme in denervated muscles. However, these results 
must be interpreted with caution since histone reportedly can 
increase the dissociation of cyclic AMP-dependent protein 
kinase. Also, histone can be phosphorylated by kinases other 
than cyclic AMP-dependent protein kinase (reviewed in Weller, 
1979). 
The results of combining equal aliquots of cytosolic 
fractions from denervated and sham-operated solei indicate 
that the concentration of an endogenous inhibitor of the 
denervation period and nerve stump length-dependent cytosolic 
phosphorylation reaction is greater in sham-operated muscles 
relative to 24 hr denervated short nerve stump-solei. Cyclic 
A~1P dissociates the holoenzyme and inhibits the autophoshory-
lation reaction. If the concentration of cyclic AMP is 
greater in sham-operated muscles than denervated muscles, 
then the state of dissociation of the holoenzyme might be 
relatively greater in sham-operated muscles. Therefore, it 
seems likely that cyclic AMP is the endogenous inhibitor 
because the evidence presented with the "mixing" experi~ents 
is consistent with the inhibitory action of cyclic AMP upon 
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the autophosphorylation of 56,000-dalton RII. 
It is now well established that the physiological 
actions of some neurotransmitters and non-steriod hormones 
are mediated by cyclic AMP-dependent protein kinases (Green-
gard, 1978). Although autophosphorylation of RII apparently 
alters the activity of cyclic AMP-dependent prcteir. kir:ase, 
the physiological significance of this reaction is not known. 
The functional significance of phospho and dephospho forms of 
cyclic AMP-dependent protein kinase type II has been studied 
in bovine heart (Hofmann et al., 1975; Rangel-Aldao and 
Rosen, 9 7 7 ) • An alteration in the kinetics of 
association/dissociation of the cyclic AMP-dependent prcteiL 
kinase has been observed with the phosphorylated form of RII. 
This alteration is reportedly due to an increase in the 
binding affinity of phosphorylated RII for cyclic AMP 
(Hofmann et al., 1975; Rangel-Aldao and Rosen, 1977). These 
results suggest that the increased intramolecular autophos-
phorylaticn of RII alters the conformation of this subunit. 
This, in turn, increases its sensitivity to subtle changes in 
cyclic AMP flux. However, a conformational change in the RII 
protein corresponding to a change in cyclic AMP binding has 
not been shown experi~entally. Also of interest is the 
recent finding that steroid hormones alter the autophosphory-
1 a t i o n of R I I ..1..n .Y.i.t...r.Q ( L i u e t a 1 . , 1 9 8 1 ) . S i n c e s t e r o i d s 
are not known to act at membrane receptors via an adenylate 
cyclase/cyclic AMP mechanism, the link between steroids and 
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cyclic AHP-mediated events involving RII is not clear. It 
was suggested from these studies that autophosphorylation may 
link steroid-induced cellular processes with cyclic AMP-
mediated events. 
Interestingly, an autophosphorylation has been 
described for several protein kinases including the catalytic 
subunit of cyclic AMP-dependent protein kinase (Chiu and Tao, 
1978; Shoji et al., 1979), cyclic GMP-dependent protein 
kinase (deJonge and Rosen, 1977), phosphorylase kinase (Walsh 
et al., 1971), myosin light chain kinase (Wolff and Hoffman, 
1980) and virus-induced transformation-related phospho-
tyrosine kinases (Erikson et al., 1979). A function has been 
proposed for the latter of these autophosphorylations because 
the self-catalyzed incorporation of phosphate has been shown 
to be related to a change in their enzyme activities. 
Functions of the RII protein independent of the 
catalytic subunit and associated with changes in nuclear 
events have been described (Jungmann et al., 197ll; Chc-Chung, 
1979; Boynton et al., 1981; Nesterova et al., 1981). 
Presumably, these RII-dependent nuclear changes come about 
after the nuclear translocation of the protein (reviewed ir. 
Jungmann et al, 1975; Jungmann and Russell, 1977; Jungmann 
and Kranias, 1977; Rosenfeld and Barrieux, 1979; Sharma, 
1982). However, a specific function of RII in the genome of 
eukaryotic cells has not been established. Interestir,g 
speculations concerning the nuclear function of RII can be 
made in that a recent report has shown that eukaryotic RII 
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and the E. coli cyclic AMP receptor protein (commonly refer-
red to as the catabolite gene activator protein) have signi-
ficant primary and secondary sequence homology (Weber et al., 
1982). The authors suggested from these studies that the 
eukaryotic RII protein may have a nuclear function similar to 
the E. coli protein in activating specific gene expression. 
This suggestion is supported experimentally by the work of 
Severin and Nesterova (1981) who reported that RII functions 
in eukaryotic gene transcription by increasing the number of 
RNA polymerase binding sites on chromatin. These authors 
also showed that RII binds to eukaryotic chromatin with a 
high affinity (Kd = 10-10 M). This indicates a highly 
specific interaction between RII and eukaryotic chromatin. 
The high affinity bi~ding of RII for chromatin has also been 
recently reported by others (Tang and Catapano, 1983). 
Other recent studies have shewn that RII is not 
translocated in transformed cells (SVl.!O virally-transformed 
3T3 cell line) which exhibit a decreased cyclic AMP concen-
tration relative to the normal cell (Nesterova et al., 1981). 
Also, addition of cyclic AMP to the system restored RII 
translocation. Using this transformed cell line, these 
authors recently reported (Nesterova et al., 1982) that 
addition of a cyclic AMP-RII complex results in the induced 
synthesis of a small protein of Mr = 15,000 (P-15 proteir,). 
Synthesis of this protein was not observed with normal 3T3 
cells and cyclic AMP alone could not induce synthesis of P-15 
in the virally-transformed cells. 
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These results imply a 
close relationship between the induction of P-15, the nuclear 
translocation of the RII-cyclic AMP complex, binding of this 
complex to chromatin and altered gene activity. It was also 
reported that the phosphorylated RII protein is not trans-
1 o c a t e d a n d d o e s no t a f f e c t .i.n .Y.i..t..r.Q t r a n s c r i p t i o n ( S e v e r i n 
and Nesterova, 1981). Additionally, it was observed in 
porcine ovary (Hunzicker-Dunn, 1982) and a mammalian tumor 
cell line (Cho-Chung et al., 1979) that both steroids and 
cyclic AMP stimulate the specific translocation of RII. 
Also, an increase in nuclear RII derived from the cytoplasm 
is related to the development of the ovary (Hunzicker-Dunn, 
1982). Interestingly, both cyclic AMP and steroids (Liu et 
al., 1981) inhibit the autophosphorylation of RII .in vitro. 
It is not known whether the non-impulse related 
neural regulation of RII autophosphorylation in rat soleus 
muscle is related to the alterations in nuclear events 
(i.e., phosphorylation of nuclear proteins and increased 
activity of RNA polymerases I and II) which also occur early 
after denervation of the rat soleus muscle, but not 
immediately after nerve transection (Held, 1978; Held, 1983). 
However, before these relationships can be established, the 
temporal changes in the nuclear events must be re-examined 
with particular attention to denervation period and nerve 
stump length-dependency. Whether the neurotrophic regulation 
of RII autophosphorylation in rat soleus m~scle is also 
related to a change in the nuclear translocation of the 
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protein and an alteration in gene activity is not known and 
would provide a stimulating and potentially important project 
for future investigation. 
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V. SUMMARY 
The non-impulse related neural regulation of the 
autophosphorylation of RII has been established. I have 
found that the ~ vitro phosphorylation of soluble cytosolic 
protein in the slow-twitch soleus muscle of the rat is heat-
labile, dependent upon t-!g2+ and cyclic AMP, but independent 
of ca2+ or cyclic GMP. The predominant substrate for this 
cyclic AMP-dependent phosphorylation is a 56,000-dalton 
soluble cytosolic protein. The 56,000-dalton soluble 
cytosolic phosphoprotein has been identified as the regula-
tory subunit of type II cyclic AMP-dependent protein kinase 
(RII) based upon several criteria: 1) RII and the 56,000-
dalton protein from soleus muscle have a similar molecular 
weight as determined by SDS gradient slab PAGE; 2) RII and 
the 56,000-dalton protein have a similar isoelectric point; 
3) RII and the 56,000-dalton protein are cyclic AMP-binding 
proteins; 4) RII and the 56,000-dalton protein are able to 
tightly bind to anti-RII immunoaffinity resin; 5) based on 
the effects observed with zn2+, cyclic AMP and the specific 
inhibitor of the free catalytic subunit of cyclic AMP-
dependent protein kinase, RII and the 56,000-dalton protein 
are autophosphorylatable when associated with the catalytic 
subunit of protein kinase; 6) RII and the 56,000-dalton 
protein yield a similar tryptic phosphopeptide map, including 
the 39,000-dalton autophosphorylation peptide. 
A nerve stump length paradigm was employed to 
demonstrate that the autophosphorylation of the 56,000-dalton 
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RII protein from rat soleus muscle is regulated by non-
impulse related neural influences. The ..i.n vitro phosphoryla-
tion of the 56,000-dalton RII protein is directly correlated 
with the denervation period and the distal nerve stump 
length. Also, the denervation-induced increase in cytosolic 
protein phosphorylation observed with 2~ hr denervated short 
nerve stump-solei and 66 hr denervated long nerve stump-solei 
is quantitatively comparable to the increase in phosphoryla-
tion of the 56,000-dalton phosphoprotein resolved from these 
muscles and in the increased autophosphorylation of the 
39,000-dalton phosphopeptide generated from the tryptic 
proteolysis of the 56,000-dalton protei~. Based upon these 
findings, I suggest that some neurotrophic message(s) 
communicates with skeletal muscle through the auto-
phosphorylation of the regulatory subunit of the type II 
cyclic AMP-dependent protein kinase. The denervation pericd 
and nerve stump length-dependent alteration of the autophos-
phorylation of the 56,000-dalton RII protein also suggests 
that the phosphorylative modification of this protein may be 
related to a depletion of axonally transported trophic 
factors. Other non-impulse related neural factors, however, 
have not been ruled out experimentally. These results, 
therefore, provide new insight into the neurotrophic communi-
cation between motor nerve and adult skeletal muscle by 
identifying a physiologically significant reaction which is 
the earliest reported biochemical change directly related to 
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denervation period and nerve stump length. 
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Figure 35. Calibration curve for the estimation of relative 
molecular weights of 32P-radiolabeled soluble phosphoproteins 
in Figure 10 resolved from the cytosolic fractions of 
denervated and sham-operated rat solei by Sephadex gel 
filtration chromatography. The protein standards of known 
molecular weight (i.e., bovine serum albumin (BSA)-66,000; 
ovalbumin (OVAL)-45,000; ribonuclease A-13,700 and cytochrome 
c-12,270) were obtained from Pharmacia Chemical Co., 
Piscataway, NJ. Standard proteins were prepared as solutions 
of 1 mg protein/ ml of buffer (50 mM Tris HCl, pH 7.5, 0.1 M 
NaCl and 2 mM MgC1 2 ). The individual solutions were pooled 
and an aliquot of the combined solution containing 500 ug of 
protein was applied to the gel filtration column. partition 
coefficients were determined according to the equation given 
in Method J and are shown as the values obtained from a 











...J 3 0 
:E 
2 
RIBONUCLEASE A CYTOCHROME C 
0.1 0.2 0.3 0.4 0.5 0.6 0.7 a a 0.9 1.0 
PARTITION COEFFICIENT (Kav) 
Figure 36. Calibration curve for the estimation of relative 
molecular weights of 32P-radiolabeled soluble phosphoproteins 
(Figure 11) resolved from the cytosolic fractions of 
denervated and sham-operated solei by HPLC. The protein 
standards of known molecular weight (i.e. bovine serum 
albumin (BSA)-66,000; ovalbumin (OVAL)-45,000; ribonuclease 
A-13,700 and cytochrome c-12,270) were obtained from 
Pharmacia Chemical Co., Piscataway, NJ. The molecular weight 
marker proteins were prepared as solutions of 1 mg protein/ 
ml of buffer (0.05 M sodium phosphate, pH 7.4). The 
solutions were pooled and an aliquot of the combined solution 
containing 100 ug of each protein was injected onto the HPLC 
column. Partition coefficients were determined according to 
the equation given in Method J and are shown as the means 
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Figure 37. Calibration curve for the estimation of the 
relative molecular weights of 3 2 P-labeled soluble cytosolic 
proteins phosphorylated in the presence of the protein kinase 
modulators, cyclic AMP, zn2+ and protein kinase inhibitor. 
The protein standards of known molecular weight (i.e., bovine 
serum albumin (BSA)-66,000; ovalbumin (OVAL)-45,000; aldolase 
(ALD)-40,000; trypsinogen (TRYP)-24,000 and lysozyme (LYS)-
14,300) were purchased from commercial sources (described in 
the legend of Figure 16). Standard proteins were prepared as 
solutions of 1 mg protein/ml of buffer (0.0625 M Tris-HCl, pH 
6.8, 0.1% SDS and 5% 2-mercaptoethanol). The protein 
solutions were boiled for 2 min prior to electrophoresis to 
denature the proteins •. Ten micrograms of each protein was 
applied to the slab gel. Relative mobilities were calculated 
using the equation given in Method K and are shown as the 
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Figure 38. Calibration curve for the estimation of relative 
molecular weights of 32P-labeled soluble cytosolic proteins 
phosphorylated in the presence of the specific modulators, 
ca2+ and cyclic GMP. The protein standards of known 
molecular weight (i.e. bovine serum albumin (BSA)-66,000; 
ovalbumin (OVAL)-45,000; aldolase (ALD)-40,000; trypsinogen 
(TRYP)-24,000 and lysozyme (LYS)-14,300) were obtained from 
commercial sources (described in the legend of Figure 16). 
Standard proteins were prepared as solutions of 1 mg 
protein/ml buffer (0.0625 M Tris-HCL, pH 6.8, 0.1% SDS and 5% 
2-mercaptoethanol). Proteins were boiled for 2 min prior to 
electrophoresis to denature the proteins and 10 ug of each 
protein were applied to the gel. Relative mobilities were 
calculated according to the equation given in Method K and 
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Figure 39. Calibration curve for the estimation of the 
relative molecular weight of 32P-labeled phosphoproteins 
shown in Figures 23 and 2~ resolved by SDS gradient slab 
PAGE. The protein standards of known molecular weight (i.e. 
bovine serum albumin (BSA)-66,000; ovalbumin (OVAL)-45,000; 
aldolase (ALD)-40,000; trypsinogen (TRYP)-24,000 and lysozyme 
(LYS)-14,300) were obtained from commercial sources 
(described in the legend of Figure 16). Molecular weight 
marker proteins (1 mg protein/ml of 0.0625 M Tris-HCl, pH 
6.8, 0.1% SDS and 5% 2-mercaptoethanol) were boiled for 2 min 
to denature the protein and 10 ug of each protein were 
applied to the gel. Relative mobilities were calc~lated 
according to the equation given in Method K and are the 
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Figure 40. Calibration curve for the estimation of the 
relative molecular weight of the 3 2 P-labeled soluble cyclic 
AMP-binding protein resolved from the cytosolic fraction of 
denervated and sham-operated rat solei by cyclic AMP affinity 
chromatography and SDS gradient slab gel electrophoresis. 
The protein standards of known molecular weight were obtained 
from commercial sources (described in the legend of Figure 
16). The molecular weight marker proteins were prepared as 
solutions of 1 mg protein/ml buffer (0.0625 were boiled for 2 
min prior to electrophoresis to denature the proteins. Ten 
micrograms of each protein were applied to the gel. Relative 
mobilities were calculated according to the equation given in 
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Figure 41. The distibution of 32P-radioactivity associated 
with soluble proteins resolved from the cytosolic fractions 
of denervated and sham-operated rat soleus muscle by SDS 
gradient slab PAGE. The left soleus was denervated 1 hr 
prior to sacrifice by cutting the soleus branch of the 
sciatic nerve 2 mm before insertion into the muscle. Control 
samoles were obtained from sham-operated, contralateral 
solei. Cytosolic fractions were incubaed in a phosphoryla-
tion medium containing [gamma-32p]ATP and soluble cytosolic 
proteins were resolved by SDS gradient slab PAGE. 32p_ 
radioactivity was quantitated in consecutive 2 mm gel slices 
by liquid scintillation spectrometry. An equivalent amount 
of protein (-4o ug) from denervated (top figure) and sham-
operated (bottom figure) samples was applied to individual 
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Figure 42. The distribution of 32P-radioactivity associated 
with soluble proteins resolved from the cytosolic fractions 
of denervated and sham-operated rat solei by SDS gradient 
slab PAGE. The left soleus was denervated 3 hr prior to 
sacrifice by cutting the soleus branch of the sciatic nerve 2 
mm before insertion into the muscle. Control samples were 
obtained from sham-operated, contralateral solei. Cytosolic 
fractions were incubated in a phosphorylation medium containg 
[gamma-32p]ATP and soluble cytosolic proteins were resolved 
by SDS gradient slab PAGE. 32P-radioactivity was quantitated 
in consecutive 2 mm gel slices by liquid scintillation 
spectrometry. An equivalent amount of protein (-40 ug) from 
denervated (top figure) and sham-operated (bottom figure) 
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Figure 43. The distribution of 32P-radioactivity associated 
with soluble proteins resolved from the cytosolic fractions 
of denervated and sham-operated rat solei by SDS gradient 
slab PAGE. The left soleus was denervated 6 hr prior to 
sacrifice by cutting the soleus branch of the sciatic nerve 2 
mm before its insertion into the muscle. Control samples 
were obtained from sham-operated, contralateral solei. 
Cytosolic fractions were incubated in a phosphorylation 
medium containing [gamma-32]ATP and soluble cytosolic 
proteins were resolved by SDS gradient slab PAGE. 3 2 P-
radioactivity was quantitated in consecutive 2 mm gel slices 
by liquid scintillation spectrometry. An equivalent amount 
of protein (-4o ug) from denervated (top figure) and sham-
operated (bottom figure) samples were applied to individual 
sample wells of the gel. 
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Figure 44. The distribution of 32P-radioactivity associated 
with soluble proteins resolved from the cytosolic fractions 
of denervated and sham-operated rat solei by SDS gradient 
slab PAGE. The left soleus was denervated 12 hr prior to 
sacrifice by cutting the soleus branch of the sciatic nerve 2 
mm before insertion into the muscle. Control samples were 
obtained from sham-operated, contralateral solei. Cytosolic 
fractions were incubated in a phosphorylation medium 
containing [gamma-32]ATP and soluble cytosolic proteins were 
resolved by SDS gradient slab PAGE. 32P-radioactivity was 
quantitated in consecutive 2 mm gel slices by liquid 
scintillation spectrometry. An equivalent amount of protein 
c-4o ug) from denervated (top figure) and sham-operated 
(bottom figure) samples was applied to individual sample 
wells of the gel. 
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Figure 45. The distribution of 32P-radioactivity associated 
with soluble proteins resolved from the cytosolic fractions 
of denervated and sham-operated rat solei by SDS gradient 
slab PAGE. The left soleus was denervated 18 hr prior to 
sacrifice by cutting the soleus branch of the sciatic nerve 2 
mm before insertion into the muscle. Control samples were 
obtained from sham-operated, contralateral solei. Cytosolic 
fractions were incubated in a phosphorylation medium containg 
[gamma-32p]ATP and soluble cytosolic proteins were resolved 
by SDS gradient slab PAGE. 32P-radioactivity was quantitated 
in consecutive 2 mm gel slices by liquid scintillation 
spectrometry. An equivalent amount of protein (-4o ug) from 
denervated (top figure) and sham-operated (bottom figure) 
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Figure 46. The distribution of 32P-radioactivity associated 
with soluble proteins resolved fro~ the cytosolic fractions 
of denervated and sham-operated rat solei by SDS gradient 
slab PAGE. The left soleus was denervated 24 hr prior to 
sacrifice by cutting the soleus branch of the sciatic nerve 2 
mm before insertion into the muscle. Control samples were 
obtained from sham-operated, contralateral solei. Cytosolic 
fractions were incubated in a phosphorylation medium 
containing [gamma-32]ATP and soluble cytosolic proteins were 
resolved by SDS gradient slab PAGE. 32P-radioactivity was 
quantitated in consecutive 2 mm gel slices by liquid 
scintillation spectrometry. An equivalent amount of protein 
(-4o ug) from denervated (top figure) and sham-operated 
(bottom figure) samples was apllied to individual sample 








Figure -7. Elution of the partially purified inhibitor ot 
cyclic AMP-dependent protein kinase from DEAE Sephadex. 
The protocol is described in detail in Method F. Conductance 
• 4 is shown along with 32p-radioactivity (CPM) (e 1). 
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Fisure -8. Counting efficiency correlation curves for 32p 
counted with the toluene-based fluor (top tisure) and the 
phase coabins system (PCS) (bottom fisure) in the presence of 
varying concentrations of chloroform. The protocol is 
described in detail in Method o. 
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